aspirin has been researched along with Mucocutaneous Lymph Node Syndrome in 521 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Mucocutaneous Lymph Node Syndrome: An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The Kawasaki disease CAA prevention (KD-CAAP) trial will test the hypothesis that immediate adjunctive corticosteroid treatment to standard of care IVIG and aspirin will reduce coronary artery aneurysm (CAA) rates in unselected KD patients across Europe." | 9.69 | Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA pr ( Brogan, P; Connon, R; Eleftheriou, D; Herberg, J; Kahn, R; Klein, N; Kucera, F; Levin, M; McCormack, R; Moraes, YC; Morillas, MM; Mossberg, M; Pursell, M; Purvis, C; Standing, JF; Swallow, V; Tulloh, R; Walker, AS; Wan, M, 2023) |
| "To study the clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease (KD) complicated by coronary artery aneurysm (CAA)." | 9.30 | [Clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease complicated by small/medium-sized coronary artery aneurysms]. ( Chen, TT; Guo, YH; Li, Y; Liu, YL; Lu, YH; Shi, K; Wang, XM, 2019) |
| " Patients with severe Kawasaki disease were randomly assigned by a minimisation method to receive either intravenous immunoglobulin (2 g/kg for 24 h and aspirin 30 mg/kg per day) or intravenous immunoglobulin plus prednisolone (the same intravenous immunoglobulin regimen as the intravenous immunoglobulin group plus prednisolone 2 mg/kg per day given over 15 days after concentrations of C-reactive protein normalised)." | 9.16 | Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. ( Arakawa, H; Fukazawa, R; Furuno, K; Fuse, S; Hamaoka, K; Hara, S; Hara, T; Ichida, F; Kato, T; Kobayashi, T; Miura, M; Morikawa, A; Nakamura, T; Nomura, Y; Ogawa, C; Ogawa, S; Otani, T; Saji, T; Seki, M; Takatsuki, S; Takeuchi, K; Tokunaga, H, 2012) |
| "To compare the efficacy of low-dose or no aspirin with conventional high-dose aspirin for the initial treatment in the acute-phase of Kawasaki disease (KD)." | 9.12 | Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review. ( Chiang, MH; Liu, HE; Wang, JL, 2021) |
| "To investigate the effect of plasma homocysteic acid (HCA) reduction on serum C-reactive protein (CRP) level in children with Kawasaki disease (KD)." | 9.12 | [Reducing plasma homocysteic acid lowers serum C-reactive protein level in children with Kawasaki disease]. ( Chu, MP; Rong, X; Wu, RZ; Xiang, RL; Xu, Q; Zhang, YH, 2007) |
| "We compared the efficacy of oral administration of pentoxifylline (PTX) and intravenous infusions of gamma globulin (IVGG) combination therapy with that of IVGG in reducing the frequency of coronary-artery lesions (CAL) in children with Kawasaki disease (KD), in a randomized trial." | 9.07 | Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. ( Furukawa, S; Ino, T; Matsubara, T; Motohashi, T; Umezawa, Y; Yabuta, K, 1994) |
| "Aspirin is the basic treatment for Kawasaki disease, however its optimal dose is controversial." | 9.06 | A study on the optimal dose of aspirin therapy in Kawasaki disease--clinical evaluation and arachidonic acid metabolism. ( Akagi, T; Inoue, O; Kato, H; Sato, N, 1990) |
| "The use of IVIG plus high- or low-dose aspirin for the initial treatment of Kawasaki disease remains controversial." | 9.05 | What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis. ( Bao, Y; Bie, S; Du, X; Jia, X; Jiang, M; Li, X, 2020) |
| "To compare the safety and efficacy of warfarin plus aspirin versus aspirin alone for the treatment of children with giant coronary artery aneurysm (CAA) secondary to Kawasaki disease (KD)." | 8.90 | Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis. ( Pang, Y; Qin, S; Su, D; Wang, K, 2014) |
| "Varying observations have been made concerning the use of aspirin (ASA) and/or intravenous immunoglobulin (IVIG) in the prevention of coronary artery aneurysm (CAA) in children with Kawasaki disease." | 8.79 | The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. ( Durongpisitkul, K; Gururaj, VJ; Martin, CF; Park, JM, 1995) |
| "川崎病（Kawasaki disease，KD）是5岁以下儿童常见后天获得性心脏病之一，是一种急性全身性血管炎。经过近60年的研究，静脉注射免疫球蛋白（intravenous immunoglobulin，IVIG）联合阿司匹林（aspirin，Asp）口服成为急性期KD预防冠状动脉病变（coronary artery lesion，CAL）的一线治疗。然而，Asp的作用和最佳剂量仍然存在争议。该共识基于KD治疗的国内外最新的研究成果，并经过国内儿科专家充分讨论而制定，对Asp在KD中一线治疗的使用剂量、用法、疗程等提出了推荐意见。." | 8.12 | [Pediatric expert consensus on the application of aspirin in Kawasaki disease]. ( , 2022) |
| "To evaluate whether initial treatment with low-dose compared with high-dose aspirin in children with KD is associated with an increase in fever recrudescence." | 7.96 | Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin. ( Belarski, E; Carroll, AE; John, CC; Manaloor, J; Ofner, S; Platt, B; Wood, JB, 2020) |
| " Here, we describe a 3-year-old boy with typical KD who had lower gastrointestinal bleeding caused by rectal ulcers on the third day of aspirin therapy." | 7.96 | A case of rectal ulcers during aspirin therapy in acute Kawasaki disease. ( Han, Y; Hu, C; Yu, Y, 2020) |
| "To identify whether lymphocyte hydrogen sulfide production is a potential biomarker for predicting coronary artery lesions (CAL) in children with Kawasaki disease (KD)." | 7.96 | Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study. ( Jiao, F; Lin, J; Ma, L; Wang, W; Zhao, H, 2020) |
| "To explore whether aspirin is necessary for treatment in the acute phase of Kawasaki disease (KD)." | 7.88 | Is aspirin necessary in the acute phase of Kawasaki disease? ( Gong, F; Huang, P; Huang, X; Jin, L; Xia, S; Xie, X; Yuan, J; Zhang, L, 2018) |
| "BackgroundHigh-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki disease (KD)." | 7.88 | Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease. ( Binstadt, BA; Braunlin, EA; Migally, K; Zhang, L, 2018) |
| "Blood samples were collected from 44 patients with Kawasaki disease before aspirin treatment and 7 to 10 days after treatment." | 7.88 | Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease. ( Bao, L; Che, D; Deng, Q; Fang, Z; Gu, X; Li, J; Li, M; Li, W; Lin, S; Liu, T; Liu, Y; Long, H; Pi, L; Zhang, L; Zhang, Y, 2018) |
| " Patients who were febrile at diagnosis received primary IVIG (2 g/kg per 24 h) and oral aspirin (30 mg/kg per day) until the fever resolved, followed by oral aspirin (5 mg/kg per day) for 2 months after Kawasaki disease onset." | 7.88 | Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. ( Chiga, M; Hori, N; Kaneko, T; Komiyama, O; Matsushima, T; Misawa, M; Miura, M; Miyata, K; Morikawa, Y; Nakazawa, M; Obonai, T; Sakakibara, H; Takahashi, T; Tamame, T; Tsuchihashi, T; Yamagishi, H; Yamashita, Y, 2018) |
| "The aim of the study was to identify whether lymphocyte hydrogen sulfide production is a potential biomarker to predict intravenous immunoglobulin (IVIG) resistance in children with Kawasaki disease (KD)." | 7.88 | Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease: A preliminary, single-center, case-control study. ( Jiao, F; Lin, J; Ma, L; Zhao, H, 2018) |
| "Aspirin was first used for patients with Kawasaki disease(KD) at 1970s." | 7.80 | [Aspirin treatment for patients with Kawasaki disease]. ( Hamada, H, 2014) |
| "We sought to determine the effects of treatment with intravenous immunoglobulin (IVIG) and aspirin on the functions of endothelial progenitor cells (EPCs) in patients with Kawasaki disease (KD) as well as its relationship with concentrations of tumor necrosis factor-α (TNF-α) and high-sensitivity C-reactive protein (hs-CRP)." | 7.77 | The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease. ( Men, LN; Meng, XC; Wang, T; Xu, MG; Zhao, CY; Zu, Y, 2011) |
| "To study the effects of intravenous immunoglobulin (IVIG) and aspirin treatment on the functions of circulating endothelial progenitor cells (EPCs) in children with Kawasaki disease (KD) and possible mechanisms." | 7.77 | [Effects of intravenous immunoglobulin and aspirin treatment on the functions of circulating endothelial progenitor cells in children with Kawasaki disease]. ( Men, LN; Meng, XC; Xu, MG; Zhao, CY; Zu, Y, 2011) |
| " The current report describes a Japanese boy who underwent aspirin treatment for Kawasaki disease, and who subsequently presented with the manifestations of DIHS/DRESS syndrome." | 7.75 | Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. ( Fujita, A; Kawakami, T; Muto, S; Soma, Y; Takeuchi, S, 2009) |
| "To determine the prognosis of patients with giant coronary aneurysms (GA) caused by Kawasaki disease (KD) treated with combined oral warfarin and aspirin." | 7.75 | Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. ( Ayusawa, M; Higaki, T; Kudo, Y; Matsuishi, T; Matsumura, M; Miura, M; Nomura, Y; Ogawa, S; Suda, K, 2009) |
| "To evaluate the effect of treatment without aspirin in the acute phase of Kawasaki disease (KD) and to determine whether it is necessary to expose children to high- or medium-dose aspirin." | 7.72 | Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. ( Hsieh, KS; Huang, SM; Huang, TC; Lee, CL; Lin, CC; Weng, KP, 2004) |
| "We describe a boy with Kawasaki disease (KD) whose clinical course was marked by a rapid improvement upon treatment with intravenous immunoglobulin (IVIG) and oral aspirin, which - within 14 days - was followed by the development of a large pericardial effusion with symptoms of impending cardiac tamponade as part of a polyserositis syndrome (pleural effusions, ascites)." | 7.70 | Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease. ( Dahlem, PG; Kuijpers, TW; Lam, J; von Rosenstiel, IA, 1999) |
| " We report the successful use of ticlopidine, together with aspirin, in a 7-month-old infant with Kawasaki disease complicated by a thrombus in a giant coronary aneurysm that failed to resolve with thrombolytic therapy." | 7.70 | Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. ( Baker, AL; Neufeld, EJ; Newburger, JW; O'Brien, M; Parness, IA; Sundel, RP, 2000) |
| "We report on 7 patients with severe, complicated Kawasaki disease treated with oral prednisolone, after apparently unsuccessful intravenous immunoglobulin treatment." | 7.70 | Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. ( Dale, RC; Daw, S; Dillon, MJ; Saleem, MA, 2000) |
| "Although gastrointestinal hemorrhage is a well-recognized complication of aspirin therapy, this side effect has not been previously reported in patients with Kawasaki disease (KD)." | 7.69 | Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. ( Burns, JC; Kashani, IA; Kligerman, M; Mason, W; Matsubara, T, 1996) |
| "Serum salicylate concentrations were measured in 60 patients with acute phase Kawasaki disease (KD), who were treated with intravenous aspirin (IVASP), to evaluate its anti-inflammatory effect in the treatment of KD." | 7.68 | Treatment of Kawasaki disease using the intravenous aspirin anti-inflammatory effect of salicylate. ( Matsuo, N; Saji, T; Umezawa, T, 1992) |
| "To determine the role of cytokines in Kawasaki disease, serial measurements of serum cytokine levels were done in 60 patients treated solely with aspirin." | 7.68 | Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. ( Chiang, B; Hwang, B; Lin, CC; Lin, CY, 1992) |
| "This trial has been designed as a multi-center, prospective, randomized controlled, evaluator-blinded trial with two parallel groups to determine whether IVIG alone as the primary therapy in acute-stage KD is as effective as IVIG combined with high-dose aspirin therapy." | 6.87 | Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. ( Guo, MM; Hsieh, KS; Huang, YH; Kuo, HC; Lo, MH, 2018) |
| " The dosage of aspirin was 30 mg/kg orally during the acute febrile stage and 5-10 mg/kg orally after lysis of fever." | 6.67 | Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease. ( Haneda, N; Mori, C, 1993) |
| "Kawasaki disease is an acute multisystem childhood vasculitis with a predilection for the coronary arteries." | 6.55 | Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease. ( Dhanrajani, A; Yeung, RSM, 2017) |
| "As a mainstay treatment for Kawasaki disease, aspirin may cause liver injury." | 5.91 | The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury. ( Fu, S; Gao, L; Geng, Z; Gong, F; Wang, H; Wang, W; Wang, Y; Xie, C; Xu, Z; Zhang, Y; Zhou, S, 2023) |
| " The Kawasaki disease CAA prevention (KD-CAAP) trial will test the hypothesis that immediate adjunctive corticosteroid treatment to standard of care IVIG and aspirin will reduce coronary artery aneurysm (CAA) rates in unselected KD patients across Europe." | 5.69 | Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA pr ( Brogan, P; Connon, R; Eleftheriou, D; Herberg, J; Kahn, R; Klein, N; Kucera, F; Levin, M; McCormack, R; Moraes, YC; Morillas, MM; Mossberg, M; Pursell, M; Purvis, C; Standing, JF; Swallow, V; Tulloh, R; Walker, AS; Wan, M, 2023) |
| "Acute inflammation of the vasculature, genetic susceptibility and immunopathogenesis based on a transmittable and infectious origin, are the pathologic events involved in the early inflammatory etiology and progression of this disease." | 5.48 | Melatonin: A hypothesis for Kawasaki disease treatment. ( Gil-Martín, E; López-Muñoz, F; Patiño, P; Ramos, E; Reiter, RJ; Romero, A, 2018) |
| "Current guidelines for Kawasaki disease (KD) recommend intravenous immunoglobulin infusion and echocardiography." | 5.42 | Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm. ( Fushimi, K; Matsui, H; Michihata, N; Yasunaga, H, 2015) |
| " We were unable to draw any conclusions regarding acute coronary syndromes, mortality, or length of hospital stay, or for the comparison IVIG versus prednisolone." | 5.41 | Intravenous immunoglobulin for the treatment of Kawasaki disease. ( Broderick, C; Ito, S; Kobayashi, S; Kobayashi, T; Suto, M, 2023) |
| "A patient with Kawasaki disease is reported who had a medium-sized CAA prematurely occluded with thrombi during regression, resulting in myocardial ischemia." | 5.35 | Accelerated thrombotic occlusion of a medium-sized coronary aneurysm in Kawasaki disease by the inhibitory effect of ibuprofen on aspirin. ( Kwon, K; Sohn, S, 2008) |
| "To study the clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease (KD) complicated by coronary artery aneurysm (CAA)." | 5.30 | [Clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease complicated by small/medium-sized coronary artery aneurysms]. ( Chen, TT; Guo, YH; Li, Y; Liu, YL; Lu, YH; Shi, K; Wang, XM, 2019) |
| "Isolated PMNs were obtained from 19 Kawasaki disease patients in three different phases of the illness, (acute phase: 0-12th day, convalescent phase: 13-29th day, restored phase: greater than 30th day)." | 5.28 | [Role of polymorphonucleocyte-produced leukotriene B4 in Kawasaki disease]. ( Hamasaki, Y; Miyazaki, S, 1990) |
| "Although the current consensus recommends a standard treatment of high-dose intravenous immunoglobulin with high-dose aspirin to manage Kawasaki disease (KD), the use of different adjunctive therapies remains controversial." | 5.22 | Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials. ( Cavalcante, JL; Chang, LS; Chen, TY; Chen, YW; Hsu, CW; Kao, YH; Lee, PC; Lei, WT; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Sun, CK; Tseng, PT; Tu, YK; Uehara, R; Wu, YC; Yeh, PY; Zeng, BY, 2022) |
| " Patients with severe Kawasaki disease were randomly assigned by a minimisation method to receive either intravenous immunoglobulin (2 g/kg for 24 h and aspirin 30 mg/kg per day) or intravenous immunoglobulin plus prednisolone (the same intravenous immunoglobulin regimen as the intravenous immunoglobulin group plus prednisolone 2 mg/kg per day given over 15 days after concentrations of C-reactive protein normalised)." | 5.16 | Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. ( Arakawa, H; Fukazawa, R; Furuno, K; Fuse, S; Hamaoka, K; Hara, S; Hara, T; Ichida, F; Kato, T; Kobayashi, T; Miura, M; Morikawa, A; Nakamura, T; Nomura, Y; Ogawa, C; Ogawa, S; Otani, T; Saji, T; Seki, M; Takatsuki, S; Takeuchi, K; Tokunaga, H, 2012) |
| "To compare the efficacy of low-dose or no aspirin with conventional high-dose aspirin for the initial treatment in the acute-phase of Kawasaki disease (KD)." | 5.12 | Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review. ( Chiang, MH; Liu, HE; Wang, JL, 2021) |
| "Treatment of acute Kawasaki disease with intravenous immune globulin and aspirin reduces the risk of coronary-artery abnormalities and systemic inflammation, but despite intravenous immune globulin therapy, coronary-artery abnormalities develop in some children." | 5.12 | Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. ( Atz, AM; Baker, AL; Colan, SD; Gersony, W; Klein, GL; Li, JS; McCrindle, BW; Minich, LL; Mitchell, PD; Newburger, JW; Sleeper, LA; Sundel, RP; Takahashi, M; Vetter, VL, 2007) |
| "To investigate the effect of plasma homocysteic acid (HCA) reduction on serum C-reactive protein (CRP) level in children with Kawasaki disease (KD)." | 5.12 | [Reducing plasma homocysteic acid lowers serum C-reactive protein level in children with Kawasaki disease]. ( Chu, MP; Rong, X; Wu, RZ; Xiang, RL; Xu, Q; Zhang, YH, 2007) |
| "High-dose intravenous gamma-globulin (IVGG) plus aspirin (ASA) treatment is effective in preventing coronary artery complications in acute Kawasaki disease (KD)." | 5.09 | Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness. ( Akagi, T; Eto, G; Hashino, K; Iemura, M; Ishii, M; Kato, H; Sato, N; Sugimura, T; Yamakawa, R, 1999) |
| "In an initial study, three groups of patients with Kawasaki disease received either aspirin alone or alkylated immunoglobulin G intravenous preparation (IGIV) 200 mg/kg daily x 3 days + aspirin, or 400 mg/kg alkylated IGIV daily x 3 days + aspirin." | 5.08 | Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease. ( Hirayama, T; Kiyosawa, N; Matsuda, H; Nakashima, M; Onouchi, Z; Yanagisawa, M, 1995) |
| "We compared the efficacy of oral administration of pentoxifylline (PTX) and intravenous infusions of gamma globulin (IVGG) combination therapy with that of IVGG in reducing the frequency of coronary-artery lesions (CAL) in children with Kawasaki disease (KD), in a randomized trial." | 5.07 | Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. ( Furukawa, S; Ino, T; Matsubara, T; Motohashi, T; Umezawa, Y; Yabuta, K, 1994) |
| "We studied the effect of gamma-globulin (IVGG) and aspirin (ASA) on the development of the coronary artery lesions (CAL) of Kawasaki disease (KD) in three different protocols." | 5.07 | Intravenous gamma-globulin for Kawasaki disease. ( Furusho, K; Hayashidera, T; Hirose, O; Kamiya, T; Kiyosawa, N; Manabe, Y; Nakano, H; Shinomiya, K; Tamura, T; Yokoyama, T, 1991) |
| "The effects of intravenous gammaglobulin (IVGG) on changes in the peripheral blood mononuclear cell subsets during acute Kawasaki disease (KD) were studied by a random selection trial of IVGG plus Aspirin (group G) compared to Aspirin alone (group A)." | 5.06 | Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin. ( Furukawa, S; Jujoh, K; Kato, H; Matsubara, T; Nakachi, S; Sasai, K; Sugawara, T; Yabuta, K, 1990) |
| "Aspirin is the basic treatment for Kawasaki disease, however its optimal dose is controversial." | 5.06 | A study on the optimal dose of aspirin therapy in Kawasaki disease--clinical evaluation and arachidonic acid metabolism. ( Akagi, T; Inoue, O; Kato, H; Sato, N, 1990) |
| "To evaluate the effectiveness of gammaglobulin in decreasing the incidence of coronary artery lesions in Kawasaki disease, a randomized controlled study in 136 patients was conducted using high doses of gammaglobulin 400 mg/kg/d for 3 days plus aspirin 30 mg/kg/d (gammaglobulin group) and aspirin alone at the same dosage (aspirin group)." | 5.06 | High-dose gammaglobulin therapy for Kawasaki disease. ( Matsuoka, H; Matsushima, M; Nagashima, M; Ogawa, A; Okumura, N, 1987) |
| "The use of IVIG plus high- or low-dose aspirin for the initial treatment of Kawasaki disease remains controversial." | 5.05 | What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis. ( Bao, Y; Bie, S; Du, X; Jia, X; Jiang, M; Li, X, 2020) |
| " Although the disease technically is self-limiting, treatment with IV immunoglobulin (IVIG) and high-dose aspirin is necessary to prevent cardiac complications, such as coronary artery aneurysm, pericarditis, or myocarditis." | 5.05 | Kawasaki disease: Shedding light on a mysterious diagnosis. ( Galuppo, J; Kowker, A; Nicholas, J; Rolfs, J; Schmidt, E, 2020) |
| "The ability of high-dose intravenous gammaglobulin (IVGG) to prevent the coronary artery lesion of Kawasaki disease has been studied in a multicentre controlled trial of IVGG plus aspirin versus aspirin alone, aspirin being the conventional treatment for Kawasaki disease." | 5.05 | High-dose intravenous gammaglobulin for Kawasaki disease. ( Furusho, K; Hayashidera, T; Hirose, O; Kamiya, T; Kiyosawa, N; Manabe, Y; Nakano, H; Shinomiya, K; Tamura, T; Yokoyama, T, 1984) |
| "To compare the safety and efficacy of warfarin plus aspirin versus aspirin alone for the treatment of children with giant coronary artery aneurysm (CAA) secondary to Kawasaki disease (KD)." | 4.90 | Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis. ( Pang, Y; Qin, S; Su, D; Wang, K, 2014) |
| "Intravenous immunoglobulin (IVIG) and aspirin is the standard initial therapy in the treatment of Kawasaki disease." | 4.89 | Advances in the treatment of Kawasaki disease. ( Anderson, MS; Dominguez, SR, 2013) |
| "The current recommended therapy for Kawasaki disease (KD) is the combination of intravenous immunoglobulin (IVIG) and aspirin." | 4.88 | A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease. ( Cao, L; Jia, HL; Lv, HT; Shen, YP; Sun, L; Yan, WH; Zhang, JM; Zhu, BH, 2012) |
| "The inclusion of corticosteroids in aspirin-containing regimens for the initial treatment of Kawasaki disease reduces the incidence of coronary aneurysms." | 4.82 | Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. ( Aronoff, SC; Wooditch, AC, 2005) |
| "Varying observations have been made concerning the use of aspirin (ASA) and/or intravenous immunoglobulin (IVIG) in the prevention of coronary artery aneurysm (CAA) in children with Kawasaki disease." | 4.79 | The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. ( Durongpisitkul, K; Gururaj, VJ; Martin, CF; Park, JM, 1995) |
| "川崎病（Kawasaki disease，KD）是5岁以下儿童常见后天获得性心脏病之一，是一种急性全身性血管炎。经过近60年的研究，静脉注射免疫球蛋白（intravenous immunoglobulin，IVIG）联合阿司匹林（aspirin，Asp）口服成为急性期KD预防冠状动脉病变（coronary artery lesion，CAL）的一线治疗。然而，Asp的作用和最佳剂量仍然存在争议。该共识基于KD治疗的国内外最新的研究成果，并经过国内儿科专家充分讨论而制定，对Asp在KD中一线治疗的使用剂量、用法、疗程等提出了推荐意见。." | 4.12 | [Pediatric expert consensus on the application of aspirin in Kawasaki disease]. ( , 2022) |
| " He gradually developed the mucocutaneous features of Kawasaki disease and was treated with intravenous immunoglobulin and aspirin with good outcome." | 4.02 | Kawasaki disease presenting after intussusception: a case report. ( Noorani, M; Osman, RS; Salum, HM, 2021) |
| "To evaluate whether initial treatment with low-dose compared with high-dose aspirin in children with KD is associated with an increase in fever recrudescence." | 3.96 | Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin. ( Belarski, E; Carroll, AE; John, CC; Manaloor, J; Ofner, S; Platt, B; Wood, JB, 2020) |
| " Here, we describe a 3-year-old boy with typical KD who had lower gastrointestinal bleeding caused by rectal ulcers on the third day of aspirin therapy." | 3.96 | A case of rectal ulcers during aspirin therapy in acute Kawasaki disease. ( Han, Y; Hu, C; Yu, Y, 2020) |
| " What is Known: • For treatments of Kawasaki disease at any age in the acute phase, 2-g/kg single-dose intravenous immunoglobulin and aspirin have been the most recommended to reduce fever early and prevent complications of coronary artery abnormalities." | 3.96 | High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more. ( Fushimi, K; Hata, T; Matsui, H; Michihata, N; Suzuki, T; Yasunaga, H; Yoshikawa, T, 2020) |
| "To identify whether lymphocyte hydrogen sulfide production is a potential biomarker for predicting coronary artery lesions (CAL) in children with Kawasaki disease (KD)." | 3.96 | Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study. ( Jiao, F; Lin, J; Ma, L; Wang, W; Zhao, H, 2020) |
| "To investigate the dynamic changes of platelet-derived microparticles (PDMP) in Kawasaki disease (KD) and its clinical significance and to study its relationship with intravenous immunoglobulin (IVIG) resistance, inflammatory indicators and aspirin treatment in children with KD." | 3.91 | Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease. ( Fan, Z; Huang, N; Jin, J; Lu, Y; Ma, L; Wang, J; Yu, H, 2019) |
| "To explore whether aspirin is necessary for treatment in the acute phase of Kawasaki disease (KD)." | 3.88 | Is aspirin necessary in the acute phase of Kawasaki disease? ( Gong, F; Huang, P; Huang, X; Jin, L; Xia, S; Xie, X; Yuan, J; Zhang, L, 2018) |
| "BackgroundHigh-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki disease (KD)." | 3.88 | Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease. ( Binstadt, BA; Braunlin, EA; Migally, K; Zhang, L, 2018) |
| "Blood samples were collected from 44 patients with Kawasaki disease before aspirin treatment and 7 to 10 days after treatment." | 3.88 | Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease. ( Bao, L; Che, D; Deng, Q; Fang, Z; Gu, X; Li, J; Li, M; Li, W; Lin, S; Liu, T; Liu, Y; Long, H; Pi, L; Zhang, L; Zhang, Y, 2018) |
| " Patients who were febrile at diagnosis received primary IVIG (2 g/kg per 24 h) and oral aspirin (30 mg/kg per day) until the fever resolved, followed by oral aspirin (5 mg/kg per day) for 2 months after Kawasaki disease onset." | 3.88 | Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. ( Chiga, M; Hori, N; Kaneko, T; Komiyama, O; Matsushima, T; Misawa, M; Miura, M; Miyata, K; Morikawa, Y; Nakazawa, M; Obonai, T; Sakakibara, H; Takahashi, T; Tamame, T; Tsuchihashi, T; Yamagishi, H; Yamashita, Y, 2018) |
| "The aim of the study was to identify whether lymphocyte hydrogen sulfide production is a potential biomarker to predict intravenous immunoglobulin (IVIG) resistance in children with Kawasaki disease (KD)." | 3.88 | Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease: A preliminary, single-center, case-control study. ( Jiao, F; Lin, J; Ma, L; Zhao, H, 2018) |
| "Standard first-line therapy for Kawasaki disease (KD) consists of intravenous immunoglobulin (IVIG) and aspirin." | 3.85 | Intravenous Immunoglobulin for the Treatment of Kawasaki Disease. ( Shulman, ST, 2017) |
| "Aspirin was first used for patients with Kawasaki disease(KD) at 1970s." | 3.80 | [Aspirin treatment for patients with Kawasaki disease]. ( Hamada, H, 2014) |
| "We sought to determine the effects of treatment with intravenous immunoglobulin (IVIG) and aspirin on the functions of endothelial progenitor cells (EPCs) in patients with Kawasaki disease (KD) as well as its relationship with concentrations of tumor necrosis factor-α (TNF-α) and high-sensitivity C-reactive protein (hs-CRP)." | 3.77 | The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease. ( Men, LN; Meng, XC; Wang, T; Xu, MG; Zhao, CY; Zu, Y, 2011) |
| " She later developed clinical features fulfilling criteria of Kawasaki disease (KD), and was treated with intravenous immunolglobulin and aspirin." | 3.77 | Kawasaki disease in association with urinary tract infection. ( Al-Rashid, M; Husain, EH, 2011) |
| "To study the effects of intravenous immunoglobulin (IVIG) and aspirin treatment on the functions of circulating endothelial progenitor cells (EPCs) in children with Kawasaki disease (KD) and possible mechanisms." | 3.77 | [Effects of intravenous immunoglobulin and aspirin treatment on the functions of circulating endothelial progenitor cells in children with Kawasaki disease]. ( Men, LN; Meng, XC; Xu, MG; Zhao, CY; Zu, Y, 2011) |
| " However, despite an improvement in his clinical condition, the child remained febrile and miserable; 5 days later he developed characteristic signs of Kawasaki disease and was treated with intravenous immunoglobulin and high dose aspirin with good results." | 3.76 | Kawasaki disease presenting with intussusception: a case report. ( Hussain, RN; Ruiz, G, 2010) |
| "Standard therapy, consisting of intravenous immunoglobulin and aspirin, reduces, but does not eliminate, coronary artery aneurysms (CAAs) in patients with Kawasaki disease." | 3.76 | Does abciximab promote coronary artery remodeling in patients with Kawasaki disease? ( McCandless, RT; Minich, LL; Tani, LY; Williams, RV, 2010) |
| " The current report describes a Japanese boy who underwent aspirin treatment for Kawasaki disease, and who subsequently presented with the manifestations of DIHS/DRESS syndrome." | 3.75 | Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. ( Fujita, A; Kawakami, T; Muto, S; Soma, Y; Takeuchi, S, 2009) |
| "To determine the prognosis of patients with giant coronary aneurysms (GA) caused by Kawasaki disease (KD) treated with combined oral warfarin and aspirin." | 3.75 | Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. ( Ayusawa, M; Higaki, T; Kudo, Y; Matsuishi, T; Matsumura, M; Miura, M; Nomura, Y; Ogawa, S; Suda, K, 2009) |
| "To evaluate the effect of treatment without aspirin in the acute phase of Kawasaki disease (KD) and to determine whether it is necessary to expose children to high- or medium-dose aspirin." | 3.72 | Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. ( Hsieh, KS; Huang, SM; Huang, TC; Lee, CL; Lin, CC; Weng, KP, 2004) |
| "A 4-month-old girl with Kawasaki disease, large coronary artery aneurysms, and coronary thrombi was treated with standard therapy followed by abciximab, a platelet glycoprotein IIb/IIIa antagonist, in addition to standard heparin and warfarin sodium anticoagulation and low-dose aspirin." | 3.70 | Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease. ( Etheridge, SP; Minich, LL; Revenaugh, JR; Tani, LY, 1998) |
| "We describe a boy with Kawasaki disease (KD) whose clinical course was marked by a rapid improvement upon treatment with intravenous immunoglobulin (IVIG) and oral aspirin, which - within 14 days - was followed by the development of a large pericardial effusion with symptoms of impending cardiac tamponade as part of a polyserositis syndrome (pleural effusions, ascites)." | 3.70 | Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease. ( Dahlem, PG; Kuijpers, TW; Lam, J; von Rosenstiel, IA, 1999) |
| " We report the successful use of ticlopidine, together with aspirin, in a 7-month-old infant with Kawasaki disease complicated by a thrombus in a giant coronary aneurysm that failed to resolve with thrombolytic therapy." | 3.70 | Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. ( Baker, AL; Neufeld, EJ; Newburger, JW; O'Brien, M; Parness, IA; Sundel, RP, 2000) |
| "To determine initial intravenous gammaglobulin (IVIG) treatment failures in Kawasaki disease (KD) and to report the outcome of retreatment and our use of pulse intravenous (IV) methylprednisolone and cyclophosphamide in patients with persistent KD." | 3.70 | Initial intravenous gammaglobulin treatment failure in Kawasaki disease. ( French, JW; Kahn, SJ; Sherry, DD; Wallace, CA, 2000) |
| "We report on 7 patients with severe, complicated Kawasaki disease treated with oral prednisolone, after apparently unsuccessful intravenous immunoglobulin treatment." | 3.70 | Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. ( Dale, RC; Daw, S; Dillon, MJ; Saleem, MA, 2000) |
| "Although gastrointestinal hemorrhage is a well-recognized complication of aspirin therapy, this side effect has not been previously reported in patients with Kawasaki disease (KD)." | 3.69 | Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. ( Burns, JC; Kashani, IA; Kligerman, M; Mason, W; Matsubara, T, 1996) |
| "Serum salicylate concentrations were measured in 60 patients with acute phase Kawasaki disease (KD), who were treated with intravenous aspirin (IVASP), to evaluate its anti-inflammatory effect in the treatment of KD." | 3.68 | Treatment of Kawasaki disease using the intravenous aspirin anti-inflammatory effect of salicylate. ( Matsuo, N; Saji, T; Umezawa, T, 1992) |
| "To determine the role of cytokines in Kawasaki disease, serial measurements of serum cytokine levels were done in 60 patients treated solely with aspirin." | 3.68 | Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. ( Chiang, B; Hwang, B; Lin, CC; Lin, CY, 1992) |
| "One week after treatment with intravenously administered immune globulin and aspirin, a child with Kawasaki disease had persistent fever and an increase in coronary artery diameter to greater than 3 mm." | 3.68 | Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. ( Berkman, EM; Comenzo, RL; Fulton, DR; Malachowski, ME; Meissner, HC, 1992) |
| "We described the pharmacokinetics of acetylsalicylic acid and salicylic acid in 5 children with prior Kawasaki disease receiving buffered aspirin tablets or intravenous aspirin DL-lysine." | 3.68 | Disposition of single-dose intravenous and oral aspirin in children. ( Ito, S; Oka, R; Tsuchida, A; Yoshioka, H, 1991) |
| "8 years (range 8 months to 8 years), who had Kawasaki disease treated with acetylsalicylic acid (ASA) 30 to 180 mg/kg." | 3.67 | Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. ( Koren, G; MacLeod, SM, 1984) |
| " The patient was diagnosed as having Kawasaki disease, and treatment with aspirin was started." | 3.67 | Kawasaki disease in a 4-year-old boy. ( Haines, JD, 1987) |
| "Ninety-two patients with Kawasaki disease were treated with five different types of drug therapy: a steroid preparation (prednisolone), aspirin, an antibiotic, a combination of steroid plus aspirin, and a combination of steroid plus warfarin." | 3.66 | Kawasaki disease: effect of treatment on coronary artery involvement. ( Kato, H; Koike, S; Yokoyama, T, 1979) |
| "Kawasaki disease is an acute, febrile disease that is not typically fatal if treated and affects infants and children more commonly." | 3.01 | Neurological involvement, immune response, and biomarkers in Kawasaki disease along with its pathogenesis, therapeutic and diagnostic updates. ( Aleti, S; Alsir, O; Amir, O; Elhag, M; Gadam, S; Gupta, K; Inban, P; Mahmoud, M; Prajjwal, P; Sunasra, RR, 2023) |
| "This trial has been designed as a multi-center, prospective, randomized controlled, evaluator-blinded trial with two parallel groups to determine whether IVIG alone as the primary therapy in acute-stage KD is as effective as IVIG combined with high-dose aspirin therapy." | 2.87 | Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. ( Guo, MM; Hsieh, KS; Huang, YH; Kuo, HC; Lo, MH, 2018) |
| "The significance of neutropenia in Kawasaki disease (KD) has not been fully elucidated as yet." | 2.74 | Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm. ( Hamaoka, K; Ito, H; Kiyosawa, N; Onouchi, Z; Ozawa, S; Sakata, K, 2009) |
| "Serum from patients with coronary aneurysms was less active in stimulating HUVEC tube formation than serum from patients without coronary aneurysms or febrile controls." | 2.73 | Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease. ( Hamada, H; Higashi, K; Honda, T; Kanazawa, M; Kohno, Y; Terai, M, 2007) |
| " The dosage of aspirin was 30 mg/kg orally during the acute febrile stage and 5-10 mg/kg orally after lysis of fever." | 2.67 | Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease. ( Haneda, N; Mori, C, 1993) |
| " IVGG was given in a dosage of 400 mg/kg/day for 4 consecutive days." | 2.67 | Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome. ( Chen, MR; Hsu, CH; Hung, HY; Hwang, FY; Kao, HA, 1993) |
| "Kawasaki disease is now the most common cause of acquired heart disease in America's children." | 2.67 | New hope for children with Kawasaki disease. ( Lux, KM, 1991) |
| "Because intravenously administered immune globulin (IVIG) is effective in reducing the incidence of coronary artery aneurysms in Kawasaki syndrome when given at a dose of 400 mg/kg daily for 4 days, we undertook a multicenter clinical trial comparing two dosage regimens of IVIG." | 2.67 | Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin. ( Barron, KS; Cox, DG; Franklin, W; Goldberg, SJ; Higashino, SM; Lee, M; Murphy, DJ; Ruttenberg, HD; Silverman, ED; Wright, GB, 1990) |
| "Kawasaki disease is a childhood vasculitis of unknown origin, whose major complication is the development of coronary artery aneurysms (CAA)." | 2.66 | One year in review: Kawasaki disease. ( Cimaz, R; Giani, T; Marrani, E; Tirelli, F, 2020) |
| "Indeed, Kawasaki disease is induced by overreaction of innate cells following exposition to various viruses, including herpes viruses which trigger STING." | 2.66 | Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? ( Berthelot, JM; Drouet, L; Lioté, F, 2020) |
| "No child had sequelae of Kawasaki disease at a follow-up of 2 to 31 months." | 2.66 | Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary report. ( Bussel, JB; Engle, MA; Fatica, NS; Lesser, ML; O'Loughlin, JE; Snyder, MS, 1989) |
| "To investigate the effect of Kawasaki syndrome on myocardial function, as well as the influence of high-dose intravenous gamma-globulin therapy on resolution of functional abnormalities, we studied 98 patients with Kawasaki syndrome during five time intervals from onset of illness: 1) 10 days or less, 2) 11-31 days, 3) 1-3 months, 4) 3-12 months, and 5) 1-3 years." | 2.66 | Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. ( Beiser, AS; Burns, JC; Colan, SD; Newburger, JW; Parness, IA; Sanders, SP, 1989) |
| "Kawasaki disease is an acute, febrile vasculitis of childhood that affects medium-sized arteries, predominantly the coronary arteries." | 2.61 | Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature. ( Arslanoglu Aydin, E; Aydin, O; Bilginer, Y; Demir, S; Ozen, S, 2019) |
| "The etiology and pathogenesis of Kawasaki disease (KD) remain poorly understood." | 2.58 | Kawasaki disease and vasculitis associated with immunization. ( Chang, A; Islam, S, 2018) |
| "Kawasaki disease is an acute multisystem childhood vasculitis with a predilection for the coronary arteries." | 2.55 | Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease. ( Dhanrajani, A; Yeung, RSM, 2017) |
| "Kawasaki disease is an acute febrile systemic vasculitis that predominantly occurs in children below five years of age." | 2.55 | Kawasaki disease: etiopathogenesis and novel treatment strategies. ( Agarwal, S; Agrawal, DK, 2017) |
| "Indeed, Kawasaki disease is no longer a rare cause of acute coronary syndrome presenting in young adults." | 2.53 | Kawasaki Disease. ( Burns, JC; Newburger, JW; Takahashi, M, 2016) |
| "Untreated Kawasaki disease may lead to the formation of coronary artery aneurysms and sudden cardiac death in children." | 2.52 | Evidence-based management of Kawasaki disease in the emergency department. ( Kharbanda, A; Seaton, KK, 2015) |
| "The presence and severity of coronary aneurysms and obstruction at diagnosis determine treatment options and the need, periodicity, and intensity of long-term cardiovascular monitoring for potential atherosclerosis." | 2.52 | Diagnosis and management of kawasaki disease. ( Fargo, M; Grogan, S; Saguil, A, 2015) |
| "Treatment with aspirin and intravenous immunoglobulins (IVIG) are first-line therapies." | 2.52 | Kawasaki disease: an evolving paradigm. ( de Vincentiis, M; De Virgilio, A; Fusconi, M; Gallo, A; Greco, A; Martellucci, S; Pagliuca, G; Rizzo, MI; Ruoppolo, G; Tombolini, M, 2015) |
| "Here we report a rare case of Kawasaki disease that occurred in a 20-year-old Greek adult." | 2.52 | Adult Kawasaki disease in a European patient: a case report and review of the literature. ( Kontopoulos, DG; Kontopoulou, T; Mousoulis, GP; Vaidakis, E, 2015) |
| "Retropharyngeal edema is a rare but known manifestation of Kawasaki disease." | 2.50 | Retropharyngeal involvement in Kawasaki disease--a report of four patients with retropharyngeal edema verified by magnetic resonance imaging. ( Kajosaari, L; Klockars, T; Nieminen, T; Puhakka, L; Saat, R; Salo, E, 2014) |
| "Recurrence is rare and occurs most commonly in children." | 2.50 | Recurrent Kawasaki disease in a child with retropharyngeal involvement: a case report and literature review. ( Aldemir-Kocabaş, B; Çiftçi, E; Fitöz, S; İnce, E; Kcal, MM; Ramoğlu, MG; Tutar, E, 2014) |
| "This is the second of two updates on Kawasaki disease." | 2.49 | An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes. ( Burgner, D; Cheung, M; Curtis, N; Yim, D, 2013) |
| "The diagnostic challenge of Kawasaki disease and its implications for coronary artery outcomes are discussed, as are the recommended treatment, ongoing treatment controversies, concerns associated with treatment resistance, and the importance of ongoing follow up." | 2.48 | Kawasaki disease. ( Scuccimarri, R, 2012) |
| "Acute Kawasaki disease (KD) is treated with high-dose intravenous immunoglobulin (IVIG), which is proven to decrease the incidence of coronary artery aneurysms from 25% to less than 5%." | 2.48 | Management of acute and refractory Kawasaki disease. ( Burgner, D; Kuijpers, TW; Kuipers, IM; Tacke, CE, 2012) |
| "18-25%)." | 2.44 | Acute Kawasaki disease: not just for kids. ( Hansen, KE; Wolff, AE; Zakowski, L, 2007) |
| "To prevent coronary thrombosis, long-term anti-thrombosis using anti-platelet drugs, such as aspirin, dipyridamole, ticlopidine, clopidogrel, and abciximab, with or without warfarin is recommended by official guidelines." | 2.44 | [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease]. ( Ishii, M; Kudo, Y; Matsuishi, T; Suda, K; Sugawara, Y, 2008) |
| "Kawasaki disease is an acute, self-limited vasculitis of childhood." | 2.44 | Kawasaki disease: an overview. ( Kafetzis, DA; Pinna, GS; Skevaki, CL; Tselkas, OI, 2008) |
| "Coronary aneurysms were less frequent in adults than in children." | 2.43 | Adult Kawasaki disease: report of two cases and literature review. ( Broussolle, C; Durand, DV; Marchand, G; Sève, P; Smail, A; Stankovic, K, 2005) |
| "The etiology of Kawasaki disease (KD) remains unknown despite several years of dedicated research in this direction." | 2.43 | Current perspectives on Kawasaki disease. ( Gupta-Malhotra, M; Rao, PS, 2005) |
| "The principal presentations of Kawasaki disease include fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy." | 2.43 | Kawasaki disease. ( Kim, DS, 2006) |
| "In the developed world, Kawasaki disease is currently the leading cause of pediatric acquired heart disease." | 2.42 | Recent developments and controversies in Kawasaki disease. ( Guzman-Cottrill, JA; Shulman, ST, 2004) |
| "In the United States, Kawasaki disease has now surpassed acute rheumatic fever as the leading cause of acquired heart disease in children." | 2.42 | Kawasaki disease. ( Fulton, DR; Newburger, JW, 2004) |
| "Kawasaki disease is the leading cause of acquired heart disease in childhood." | 2.41 | Long-term cardiac sequelae of Kawasaki disease. ( Fulton, DR; Newburger, JW, 2000) |
| "Kawasaki disease is an acute self-limited vasculitis of infancy and early hildhood that is now the leading cause of acquired heart disease in children in the United States and Japan." | 2.41 | Kawasaki disease. ( Burns, JC, 2001) |
| "The most significant sequelae of acute Kawasaki disease are related to the inflammation of small to medium sized arteries and, in particular, the development of coronary artery aneurysms." | 2.41 | Pharmacological therapy for patients with Kawasaki disease. ( Minich, LL; Tani, LY; Williams, RV, 2001) |
| "Complications of Kawasaki disease include myocardial infarction, which may occur during acute illness or later, as a result of coronary abnormalities." | 2.40 | Kawasaki disease. The mystery continues. ( Bradley, DJ; Glodé, MP, 1998) |
| "The cause of Kawasaki disease remains unknown and this presents many problems in the diagnosis and management of the disease." | 2.40 | Kawasaki disease thirty years on. ( Curtis, N; Levin, M, 1998) |
| "Kawasaki disease has been researched for 32 years but its aetiology is still unknown." | 2.40 | Overview of pharmacological treatment of Kawasaki disease. ( Kawasaki, T; Onouchi, Z, 1999) |
| "Kawasaki disease is now the leading cause of acquired heart disease in children in most developed countries." | 2.39 | Kawasaki disease. ( De Inocencio, J; Hirsch, R; Shulman, ST, 1995) |
| "The role of Kawasaki disease (KD) as a contributor to early childhood cardiac morbidity in Adelaide was investigated by a review of hospital admission and case-note data from January 1979 to June 1990." | 2.38 | Kawasaki disease in Adelaide: a review. ( Goldwater, PN; Smith, PK, 1993) |
| "Kawasaki syndrome was first described in 1967 in Japan." | 2.38 | [Kawasaki syndrome]. ( Odermatt, K; Schaad, UB; Stocker, FP; Weber, JW; Wedgwood, J, 1990) |
| "First described in Japan in 1967, Kawasaki disease is now observed in all countries." | 2.38 | [Kawasaki disease]. ( Floret, D, 1990) |
| "Kawasaki disease is an immunologically mediated diffuse vasculitis of childhood of unknown etiology." | 2.38 | Kawasaki disease. Epidemiology, late prognosis, and therapy. ( Barron, KS, 1991) |
| "Treatment guidelines for Kawasaki disease are being refined." | 2.38 | Treatment of Kawasaki disease. ( Edwards, DL; Nakashima, L, 1990) |
| "Although Kawasaki disease has been reported throughout the world, it is more prevalent in Japan." | 2.37 | [Kawasaki syndrome. Apropos of a case]. ( Borde, M; Kubryk, N, 1984) |
| "A case of facial palsy was reported initially in 1974 by Murayama as one of the neurological manifestations in Kawasaki disease." | 2.37 | Facial palsy in Kawasaki disease. Report of two cases and a review. ( Fukushige, J; Hattori, T; Nanri, T; Tasaki, H; Tokugawa, K; Ueda, K, 1987) |
| "Kawasaki Syndrome is a newly recognized clinical entity characterized by multisystem involvement." | 2.36 | Kawasaki syndrome (the mucocutaneous lymph node syndrome). ( Melish, ME, 1982) |
| "The diagnosis of incomplete Kawasaki disease was confirmed based on clinical grounds supported by investigations and exclusion of differential diagnosis." | 1.91 | Atypical Kawasaki disease presenting with macroscopic hematuria in an infant: a case report. ( Dayasiri, K; Ragunathan, IR; Thadchanamoorthy, V, 2023) |
| "The use of etanercept in Kawasaki disease has demonstrated a clinically favorable response." | 1.91 | Immunoglobulin-resistant Kawasaki disease. ( Arellano-Valdez, A; Bonal-Pérez, MA; Marriaga-Núñez, B; Montaño-Durón, JG; Paz, JPA; Solórzano-Santos, F, 2023) |
| "As a mainstay treatment for Kawasaki disease, aspirin may cause liver injury." | 1.91 | The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury. ( Fu, S; Gao, L; Geng, Z; Gong, F; Wang, H; Wang, W; Wang, Y; Xie, C; Xu, Z; Zhang, Y; Zhou, S, 2023) |
| " A renal biopsy was not performed to identify the cause of the injury as it showed improvements after the start of the specific therapy for Kawasaki disease; intravenous immune globulin at a dose of 2 g/kg, aspirin at a high dosage of 80 mg/kg/day, and prednisolone at 2 mg/kg." | 1.72 | Nontypical presentation of a common disease: a case report. ( Abdulrahman, A; Al Qahtani, F; Aldajani, A; Alhaji, M; Alshammasi, W; Bargawi, A, 2022) |
| "Since the epidemiology of Kawasaki disease in Switzerland is unknown, we conducted a national prospective data collection between 2013 and 2017 to describe its incidence, diagnosis, and treatment." | 1.72 | Epidemiology of Kawasaki Disease in children in Switzerland: a national prospective cohort study. ( Boulos Ksontini, T; Bressieux-Degueldre, S; Di Bernardo, S; Gradoux, E; Mivelaz, Y; Prsa, M; Sekarski, N, 2022) |
| "4 young male KD patients had coronary aneurysm (CAA) complicated with total 7 occurrences of central thrombosis." | 1.72 | Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study. ( Chu, Y; Ma, Q; Wang, C; Wang, H; Xu, Y; Yu, X, 2022) |
| "Coronary angiogram however also revealed coronary aneurysms of all coronaries, identifying an episode of unexplained fever and vasculitis 4 years prior as Morbus Kawasaki." | 1.62 | [Myocardial Infarction and resuscitation of an adolescent: consequences of an unexplained disease]. ( de Jong, JJD; Slenter, RHJ; van Lierop, P; Wagenaar, LJ, 2021) |
| "We describe a case of intussusception followed by KD in a 3-year-old boy." | 1.62 | A Case of Kawasaki Disease with Intussusception. ( Abe, M; Asano, T; Fujita, A; Fukunaga, R; Ito, Y; Matsui, R; Miyatake-Sudoh, C; Ueharu, K; Yoshida, K, 2021) |
| "In total, 33 patients with acute Kawasaki disease were assessed." | 1.56 | Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease. ( Fukuda, K; Ishiguro, A; Nogami, K; Sakai, T; Shima, M; Tsujii, N; Yoshizawa, H, 2020) |
| "We describe adult-onset Kawasaki disease (KD) and review clinical manifestations and treatment guidelines." | 1.51 | Twenty-year-old woman presenting with typical Kawasaki disease. ( Dupuy, EO; Kang, Y; Knowles, BC; Sarantopoulos, GP; Vecerek, N; Worswick, S, 2019) |
| "Few data are currently available for Kawasaki disease (KD) below 12 months especially in Caucasians." | 1.51 | Kawasaki disease in infants less than one year of age: an Italian cohort from a single center. ( Calabri, GB; Cimaz, R; Lasagni, D; Mastrangelo, G; Resti, M; Simonini, G; Trapani, S, 2019) |
| "Kawasaki disease is an acute vasculitis syndrome that typically occurs in children aged 1 to 4 years." | 1.51 | Kawasaki at the Extremes of Age: Thinking Outside the Box. ( Adams, L; Levasseur, K; Patel, F; Rosario, JM, 2019) |
| "Children with coronary aneurysms should undergo check-ups every 6 months." | 1.51 | Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland. ( Smolewska, E; Stasiak, A, 2019) |
| "A role of ADAMTS13 in Kawasaki disease (KD) remains unknown, however." | 1.51 | Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin. ( Fujimura, Y; Fukuda, K; Hayakawa, M; Isonishi, A; Matsumoto, M; Matsuura, K; Nogami, K; Sakai, K; Sakai, T; Shima, M; Takase, T; Tanaka, I; Tsujii, N; Yoshizawa, H, 2019) |
| "In the early stage, Kawasaki disease is often manifested by uncommon symptoms, such as pyuria, meningitis, shock, and retropharyngeal or parapharyngeal abscess, which may delay diagnosis and treatment." | 1.51 | A case of Kawasaki disease presenting with parotitis: A case report and literature review. ( Li, Y; Qiao, H; Yang, Q; Yu, X, 2019) |
| "Diagnosis of Kawasaki Disease (KD) can be challenging due to lack of a diagnostic test, and some children present with 'incomplete' KD when not all diagnostic criteria are met." | 1.48 | Kawasaki Disease - A Review of Treatment and Outcomes in an Irish Paediatric Cohort 2010-14. ( Butler, KM; Flinn, AM; Gavin, PJ; McMahon, CJ; Oslizok, P, 2018) |
| "The patient was treated for presumptive peritonsillar abscess." | 1.48 | Acute peritonsillar swelling: a unique presentation for Kawasaki disease in adolescence. ( Connell, JT; Park, JH, 2018) |
| "Associations between Kawasaki disease and psoriasis, between Kawasaki disease and varicella and between varicella and psoriasis have all been reported in the literature." | 1.48 | Plaque psoriasis following Kawasaki disease and varicella. ( Boiy, T; Maes, M; Sillen, H; Wojciechowski, M, 2018) |
| "Acute inflammation of the vasculature, genetic susceptibility and immunopathogenesis based on a transmittable and infectious origin, are the pathologic events involved in the early inflammatory etiology and progression of this disease." | 1.48 | Melatonin: A hypothesis for Kawasaki disease treatment. ( Gil-Martín, E; López-Muñoz, F; Patiño, P; Ramos, E; Reiter, RJ; Romero, A, 2018) |
| "We present two cases of complete Kawasaki disease seen over a 2 year period and diagnosed as per the criteria defined by the American Heart Association." | 1.48 | Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania. ( Lakhani, N; Noorani, M, 2018) |
| "The etiology of Kawasaki disease (KD) remains unknown." | 1.46 | Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: A case report. ( Abe, J; Fujimoto, T; Fujiwara, M; Fukuda, S; Hanaoka, N; Ito, S; Katsumori, H, 2017) |
| " In Kawasaki disease (KD), endothelial damage and an elevation in coagulant factors provoke thrombosis." | 1.46 | [Transient detection of lupus anticoagulant in acute phase of Kawasaki disease]. ( Imadome, KI; Ishiguro, A; Ito, S; Kobayashi, T; Kubota, M; Masuda, H; Nariai, R; Ono, H, 2017) |
| "Among the children with acute Kawasaki disease investigated in the eighth nationwide survey in the Republic of Korea, 8456 children with adequate data were included in this study." | 1.46 | Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes. ( Han, JW; Hong, YM; Jeong, SI; Joo, CU; Kim, GB; Song, YH; Yoon, KL; Yu, JJ, 2017) |
| "She fulfilled diagnostic criteria for Kawasaki disease on day 7 of fever." | 1.46 | Dengue Fever Triggering Kawasaki Disease. ( Agarwal, E; Gupta, P; Shah, D, 2017) |
| "Acute Kawasaki disease in adults is a rare and under-recognised condition." | 1.43 | Kawasaki disease in a healthcare provider: an adult case in a paediatric resident. ( Garrido-García, LM; López-Amézquita, M; Villaverde-Rosas, R, 2016) |
| "Current guidelines for Kawasaki disease (KD) recommend intravenous immunoglobulin infusion and echocardiography." | 1.42 | Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm. ( Fushimi, K; Matsui, H; Michihata, N; Yasunaga, H, 2015) |
| "The major complication of Kawasaki disease is coronary artery dilatation and aneurysm." | 1.40 | Multiple giant succular and fusiform right and left coronary artery aneurysms after early and adequate treatment of atypical kawasaki disease with unusual presentation. ( Behjati-Ardakani, M; Ferdosian, F, 2014) |
| "We describe a case of recurrent Kawasaki disease (KD) in a non-Asian 6-year-old boy who had been diagnosed with typical KD without cardiac involvement at age 3 years." | 1.40 | Kawasaki shock syndrome complicating a recurrence of Kawasaki disease. ( Bœuf, B; Dauphin, C; Lang, M; Lusson, JR; Merlin, E; Tissandier, C, 2014) |
| "To prevent coronary thrombosis, long term thromboprophylaxis using anti-platelet drugs, such as aspirin, dipyridamole, ticlopidine, clopidogrel, and abciximab, with or without warfarin is recommended by official guidelines." | 1.40 | [Thromboprophylaxis in patients with coronary aneurysms caused by Kawasaki disease]. ( Suda, K, 2014) |
| "We report a 3-year-old girl with Kawasaki disease who presented with retropharyngeal edema and shock syndrome." | 1.40 | Unusual manifestations of Kawasaki disease with retropharyngeal edema and shock syndrome in a Taiwanese child. ( Chen, CK; Chu, SH; Fang, LC; Jim, WT; Kao, YH; Liu, LC; Peng, CC; Shyur, SD, 2014) |
| "At elderly age, Kawasaki disease may remain unrecognized with a subsequent delay in appropriate therapy and an increased risk of coronary artery aneurysms." | 1.39 | Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement. ( Jankauskas, A; Jurkienė, N; Kėvalas, R; Kudzytė, J; Labanauskas, L; Rakauskienė, V; Šileikienė, R, 2013) |
| "Most of acute coronary thrombosis in KD occurred in LAD." | 1.39 | [Six Kawasaki disease patients with acute coronary artery thrombosis]. ( Gong, FQ; Liang, YG; Luo, JP; Qi, YQ; Wang, W; Zhou, SL, 2013) |
| "Moderate tricuspid regurgitation (TR) was found only in the ICU admission group." | 1.39 | Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission. ( Chang, WC; Kuo, HC; Liang, CD; Lin, IC; Lin, YJ; Liu, SF; Yang, KD; Yu, HR, 2013) |
| "A diagnosis of Kawasaki disease (KD) is established using six principal symptoms." | 1.38 | Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder. ( Arata, M; Eguchi, T; Kawano, Y; Koriyama, C; Masuda, K; Nomura, Y; Suruki, N; Ueno, K; Yoshikawa, H, 2012) |
| "We discuss the possible contribution of Gilbert syndrome to the development of jaundice in our patients." | 1.38 | Severe jaundice in two children with Kawasaki disease: a possible association with Gilbert syndrome. ( Attilakos, A; Fretzayas, A; Karpathios, T; Moustaki, M; Papadopoulou, A; Sharifi, F; Yiallouros, P, 2012) |
| "Kawasaki disease was initially described by a Japanese paediatrician, Dr Tomisaku Kawasaki, in 1967." | 1.38 | Kawasaki disease: a case report and overview of symptoms, signs, investigations and treatment. ( Almeida, B; Brogan, P; Chawla, K; Gleeson, P, 2012) |
| "The pathogenesis of Kawasaki disease is unknown, but it involves changes to the coronary artery and other diverse clinical manifestations." | 1.38 | [One case of adult Kawasaki disease]. ( Huang, F; Sun, L; Yan, Z; Yu, X; Zhou, Y, 2012) |
| "The diagnosis of Kawasaki disease must be raised when predisposing factors are present in this group." | 1.37 | [Kawasaki disease in older children and young adults: 10 years of experience in Marseille, France]. ( Bonello, B; Bosdure, E; Bresson, V; Chabrol, B; Dubus, JC; Rousset-Rouvière, C; Serratrice, J, 2011) |
| " The OR adjusted for sex, Gunma score (the predictive score for IVIG unresponsiveness), and dosage of initial IVIG (1 or 2 g/kg) was 0." | 1.37 | Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease: a retrospective study. ( Asano, Y; Hatai, Y; Ishibashi, N; Ishiwata, T; Kanai, T; Kawamura, Y; Kobayashi, T; Nakatani, K; Nishiyama, M; Nonoyama, S; Sato, H; Takeshita, S; Takizawa, M; Tsujimoto, H, 2011) |
| " Five patients out of 32 developed CAA, with no statistical significance when analyzed for IVIG dosage or IVIG-resistance." | 1.36 | Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. ( Angelone, DF; Compagnone, A; De Nisco, A; De Rosa, G; Delogu, AB; Leo, A; Onesimo, R; Rigante, D; Rizzo, D; Valentini, P, 2010) |
| "Aspirin was given in all, sandoglobulin in thirty patients; in 10% of the cases corticosteroids were administered." | 1.36 | Mid-term outcome of patients with Kawasaki disease, single-centre experience. ( Budts, W; Gewillig, M; Gillebert, C; Troost, E; Vandeyk, K, 2010) |
| "In Incomplete Kawasaki disease, children with fever lack the sufficient number of criteria to fulfill the epidemiologic case definition and are diagnosed when coronary artery disease is detected." | 1.35 | Incomplete Kawaski disease: are we missing it? ( Atiq, H; Billoo, AG; Lone, SW; Siddiqui, S, 2009) |
| "We report on a 7-month-old infant with Kawasaki disease (KD) whose only manifestations were high-grade fever of 7 days duration, "non-toxic look" and "extreme irritability", thereby not meeting the criteria for the classical or the atypical form of the disease." | 1.35 | Atypical Kawasaki disease with remarkable paucity of signs and symptoms. ( Chakrabartty, S; Thapa, R, 2009) |
| "We describe an infant who had recurrence of Kawasaki disease and responded to therapy with Intravenous Immune globulin (IVIG) and highlight the need for recognition of this vasculitis, which is being increasingly recognised in the Indian subcontinent." | 1.35 | Recurrent Kawasaki disease. ( Balasubramanian, S; Ganesh, R, 2009) |
| "Kawasaki disease is a systemic vasculitis occurring in children of all ages." | 1.35 | Acute myocardial infarction as the first manifestation of the incomplete Kawasaki disease in a young male. ( Farhang, S; Javadzadegan, H; Mehdizadeh Baghbani, J, 2009) |
| "A patient with Kawasaki disease is reported who had a medium-sized CAA prematurely occluded with thrombi during regression, resulting in myocardial ischemia." | 1.35 | Accelerated thrombotic occlusion of a medium-sized coronary aneurysm in Kawasaki disease by the inhibitory effect of ibuprofen on aspirin. ( Kwon, K; Sohn, S, 2008) |
| "Atypical onset of Kawasaki disease (KD) is a frequent problem leading to diagnostic mistake." | 1.35 | Acute cholestasis: atypical onset of Kawasaki disease. ( Angelone, DF; Ausili, E; De Rosa, G; Focarelli, B; Ranno, O; Schiavino, A; Valentini, P, 2008) |
| "Infants with incomplete and atypical Kawasaki disease are prone to intravenous immunoglobulin treatment failure and are at risk for the development of coronary artery aneurysms." | 1.34 | Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab. ( O'connor, MJ; Saulsbury, FT, 2007) |
| "The 17th nationwide survey on Kawasaki disease covered patients whose onset was in 2001 and 2002." | 1.34 | Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey. ( Nakamura, Y; Oki, I; Uehara, R; Yanagawa, H; Yashiro, M, 2007) |
| "To study the incidence of Kawasaki disease in the population of the French West Indies." | 1.33 | [Kawasaki disease epidemiology in Guadeloupe]. ( Belloy, M; Boralevi, F; Cevallos, L; Dufillot, D; Krim, G; Tourneux, P, 2005) |
| "We report 72 patients with Kawasaki disease seen at this Centre over 7 years." | 1.33 | Cardiovascular involvement in Kawasaki disease. ( Ahamed, MZ; Narayanan, SN; Safia, M, 2005) |
| "Kawasaki disease is not rare in our region." | 1.33 | [Clinical features and course of Kawasaki disease in central Tunisia: a study about 14 cases collected over a period of three years (2000-2002)]. ( Amri, F; Belkadhi, A; Chemli, J; Essoussi, AS; Gueddiche, N; Harbi, A; Kchaou, H, 2005) |
| "We report 6 cases of Kawasaki disease (KD) diagnosed over a period of one year and review of all the cases reported from India." | 1.33 | Kawasaki disease: are we missing the diagnosis? ( Anirudh, D; Goel, H; Kabra, SK; Lodha, R; Sridhar, MR, 2005) |
| "Infections are common at diagnosis of KD." | 1.33 | Infections and Kawasaki disease: implications for coronary artery outcome. ( Benseler, SM; McCrindle, BW; Silverman, ED; Tyrrell, PN; Wong, J; Yeung, RS, 2005) |
| "Adult Kawasaki disease was diagnosed on the basis of the above symptomology." | 1.33 | Adult Kawasaki disease unrelated to epstein-barr virus and group A Streptococcus. ( Ayusawa, M; Harada, K; Hattori, T; Horie, T; Matsukawa, Y; Noto, N; Sawada, S; Sawada, U; Takei, M; Yamaguchi, K; Yamazaki, T, 2005) |
| "From 1994 to 2003, 120 patients with Kawasaki disease diagnosed at our institution were included." | 1.33 | Characteristics of Kawasaki disease in infants younger than six months of age. ( Chang, FY; Chen, SJ; Hwang, B; Lee, PC; Lu, JH; Meng, CC, 2006) |
| "Standard treatment of Kawasaki disease was administered (immunoglobulins, acetylsalicylic acid) and orciprenalin due to described cardiac block." | 1.33 | [Late recognition of Kawasaki disease--difficulties in diagnosis]. ( Berdej-Szczot, E; Giec-Fuglewicz, G; Gołba, E; Kohut, J; Smoleńska-Petelenz, J; Szydłowski, L, 2006) |
| "We report a 1-month-old infant with Kawasaki disease and peripheral gangrene." | 1.33 | Infantile Kawasaki disease and peripheral gangrene. ( Durall, AL; Mullett, CJ; Phillips, JR; Weisse, ME, 2006) |
| "We describe here an incomplete Kawasaki disease occurring in an adult with an unusual manifestation presenting as aseptic purulent meningitis." | 1.33 | [Kawasaki adult disease: case report]. ( Aboutara, M; Belaïda, A; Galempoix, JM; Kaeppler, E; Lanoux, P; Penalba, C, 2006) |
| "The incidence of Kawasaki disease (KD) in Thailand has never been studied before." | 1.33 | Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand. ( Durongpisitkul, K; Khongphatthanayopthin, A; Panamonta, M; Pongpanich, B; Sangtawesin, C; Sittiwangkul, R; Sopontammarak, S, 2006) |
| "The occurrence of Kawasaki disease is unusual in adults." | 1.33 | Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patient. ( Crespo, A; Menezes, L; Velez, AP, 2006) |
| "Kawasaki disease is a multi system disorder with varying clinical expressions." | 1.33 | Hair loss as a sign of Kawasaki disease. ( Amin, R; Nabavizadeh, SH; Safari, M, 2006) |
| "Symptomatic pulmonary manifestations of Kawasaki disease (KD) are uncommon." | 1.32 | Inflammatory pulmonary nodules in Kawasaki disease. ( Cornwall, ML; Crawford, SE; Ferrando-Monleón, S; Finn, LS; Freeman, AF; López-Andreu, JA; Pérez-Tamarit, D; Rowley, AH; Shulman, ST, 2003) |
| "A 3 year-old boy was seen for a febrile exanthema suggestive of Kawasaki disease (bilateral conjunctivitis, red and fissured lips, palmoplantar erythema, scarlet fever-like rash and perineal desquamation) associated with pustular lesions." | 1.32 | [Kawasaki's disease with eruptive pustular and guttate psoriasis]. ( Barat, P; Boralevi, F; Léauté-Labrèze, C; Lepreux, S; Stockman, AL; Taïeb, A, 2003) |
| "She was diagnosed with Kawasaki syndrome, and intravenous immunoglobulin infusion (IVIG) 2 g/kg and aspirin (100 mg/kg/day) were instituted." | 1.32 | An unusual pattern of arthritis in a child with Kawasaki syndrome. ( Duzova, A; Keskin, M; Ozcelik, U; Secmeer, G; Tokgozoglu, AM; Topaloglu, R, 2004) |
| "Other signs typical of the Kawasaki disease occurred a few days later and permitted diagnosis." | 1.32 | Painful jaundice revealing Kawasaki disease in a young man. ( Disdier, P; Ene, N; Granel, B; Habib, G; Igual, JP; Serratrice, J; Weiller, PJ, 2004) |
| "Previous myocardial infarction was found in 70 patients (28%)." | 1.32 | National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. ( Kitamura, S; Tsuda, E, 2004) |
| "Long-term management of patients with Kawasaki disease is tailored to the degree of coronary involvement; recommendations regarding antiplatelet and anticoagulant therapy, physical activity, follow-up assessment, and the appropriate diagnostic procedures to evaluate cardiac disease are classified according to risk strata." | 1.32 | Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. ( Baddour, LM; Baltimore, RS; Bolger, AF; Burns, JC; Falace, DA; Ferrieri, P; Gerber, MA; Gewitz, MH; Levison, ME; Newburger, JW; Pallasch, TJ; Shulman, ST; Takahashi, M; Tani, LY; Taubert, KA; Wilson, WR, 2004) |
| "Long-term management of patients with Kawasaki disease is tailored to the degree of coronary involvement; recommendations regarding antiplatelet and anticoagulant therapy, physical activity, follow-up assessment, and the appropriate diagnostic procedures to evaluate cardiac disease are classified according to risk strata." | 1.32 | Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. ( Baddour, LM; Baltimore, RS; Bolger, AF; Burns, JC; Falace, DA; Ferrieri, P; Gerber, MA; Gewitz, MH; Levison, ME; Newburger, JW; Pallasch, TJ; Shulman, ST; Takahashi, M; Tani, LY; Taubert, KA; Wilson, WR, 2004) |
| "There are no reported cases of Kawasaki disease in postpartum patients." | 1.32 | Kawasaki disease in a postpartum patient. ( Fason, JT; Fry, YW; Smith, D, 2004) |
| "In the acute phase of Kawasaki disease, mRNA expression of prostaglandin H2 synthase (PHS)-2, as determined by reverse transcription-polymerase chain reaction, was markedly enhanced, and thromboxane A2 (TXA2)-synthesizing activity was increased in polymorphonuclear leukocytes (PMNL)." | 1.31 | Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. ( Fujita, I; Hamasaki, Y; Ichimaru, T; Matsuo, M; Miyazaki, S; Tasaki, H; Tashiro, K; Zaitsu, M, 2000) |
| "The mean annual incidence of Kawasaki disease across Canada is about 13 per 100,000 children less than 5 years of age, based on hospital discharge data from 1990 to 1995." | 1.31 | Recognition and management of Kawasaki disease. ( Han, RK; McCrindle, BW; Newman, A; Silverman, ED; Sinclair, B; Taylor, GW; Walsh, P, 2000) |
| "Personal experience in 41 children with Kawasaki disease is reported." | 1.31 | [Cardiac involvement in Kawasaki disease. Our experience]. ( Barone, P; Betta, P; Distefano, G; Falsaperla, R; Marletta, M; Mattia, C; Sciacca, P; Tornambene, G, 2001) |
| " After a transient response to pulse corticosteroids, his disease ultimately subsided with combination therapy with pulse and high dosage corticosteroids and cyclosporin A." | 1.31 | Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. ( Chatila, T; Kim, J; Raman, V; Sharkey, A, 2001) |
| " Kawasaki disease is treated with intravenous gamma--globulin therapy and high dosage acetylsalicylic acid at the beginning of the disease." | 1.31 | [Kawasaki disease--personal observations]. ( Balcar-Boroń, A; Dylewska, K; Kojro-Wojcieszonek, A; Maćkowska, K; Masłowska, E, 2001) |
| "Here we report two cases of Kawasaki disease both of whom had a benign course." | 1.31 | Kawasaki disease--Indian perspective. ( Bhandari, B; Bhandari, H; Pendse, RN; Vats, AK, 2001) |
| "A case of possible Kawasaki disease presenting with bilateral subdural collections is reported." | 1.31 | Bilateral subdural collections--an unusual feature of possible Kawasaki disease. ( Allcut, D; Bailie, NM; Hensey, OJ; King, MD; Ryan, S, 2001) |
| "We report an uncommon case of Kawasaki disease in 10 months old male child with the analysis of its natural history, etiopathology, treatment and prognosis of the disease." | 1.31 | Kawasaki disease. ( Saraf, S; Singh, RK, 2001) |
| "Synonyms for Kawasaki disease include "Kawasaki syndrome" and "mucocutaneous lymph node syndrome" (MCLS, MLNS, MCLNS)." | 1.29 | [Kawasaki disease]. ( Gliwińska, E, 1995) |
| "Since then, Kawasaki disease has been described worldwide in children of all racial groups and has been recognized as a leading cause of acquired heart disease among children in the United States (Figure 1)." | 1.29 | Kawasaki disease and its cardiac sequelae. ( Newburger, JW; Sundel, RP, 1993) |
| "Of 443 patients with Kawasaki disease, 57 (13%) were less than 1 year of age, including 14 (3%) less than 6 months." | 1.29 | Kawasaki disease in infants less than one year of age. ( Corydon, KE; Rosenfeld, EA; Shulman, ST, 1995) |
| "Twenty-one patients with acute state Kawasaki disease (15 boys, 6 girls; age range, 1-8 years) had equilibrium multigated blood pool ventriculography (EMBPV) before treatment." | 1.29 | Equilibrium multigated blood pool ventriculography to evaluate the effects of high-dose gamma-globulin treatment for left ventricular functions in Kawasaki disease. ( Chen, YC; Hsieh, KS; Kao, CH; Wang, SJ; Yeh, SH, 1994) |
| "For every 100 patients with Kawasaki syndrome, the cost was reduced by $323,400 when aspirin therapy alone was changed to IVIG-HD therapy and 14 cases of coronary artery dilation were thereby prevented." | 1.29 | Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome. ( Gafni, A; Klassen, TP; Rowe, PC, 1993) |
| "During 1984-1992 we diagnosed Kawasaki disease in 35 patients." | 1.29 | [New therapeutic aspects in Kawasaki syndrome and personal experiences]. ( Neudorf, U, 1993) |
| "A misdiagnosis of Kawasaki disease was made initially for two patients with Reiter syndrome." | 1.29 | Reiter syndrome initially misdiagnosed as Kawasaki disease. ( Bauman, C; Cron, RQ; Francis, JS; Sherry, DD, 1996) |
| "We report seven cases of Kawasaki disease (KD) who were admitted to Hospital University Sains Malaysia over a period of 8 years." | 1.29 | Kawasaki disease in Malaysia. ( Malik, AS, 1996) |
| "Two children with Kawasaki disease (KD), a girl 3 yrs." | 1.29 | [Mucocutaneous lymph node syndrome (Kawasaki disease) in 2 children]. ( Gruszka, J; Kuchar, E; Szychowska, Z, 1996) |
| " Treated with a high dosage of aspirin, the patient is asymptomatic after a 7-month follow-up, with regression of coronary lesions." | 1.28 | [Kawasaki disease in Pernambuco, Brazil. Considerations on a case seen in a general hospital]. ( Barros, GS; Brindeiro Filho, D; de França, NA; Pontes, GA; Saraiva, LR, 1992) |
| "Isolated PMNs were obtained from 19 Kawasaki disease patients in three different phases of the illness, (acute phase: 0-12th day, convalescent phase: 13-29th day, restored phase: greater than 30th day)." | 1.28 | [Role of polymorphonucleocyte-produced leukotriene B4 in Kawasaki disease]. ( Hamasaki, Y; Miyazaki, S, 1990) |
| "This is a report on one case of Kawasaki disease which during its clinical course developed facial nerve palsy and spontaneous recovery without specific treatment." | 1.28 | Facial nerve paralysis associated with Kawasaki disease. ( Kim, HM; Kim, JS; Lee, HY; Lim, BK; Park, MS; Yang, JS, 1991) |
| "Aspirin was used in most patients often in conjunction with dipyridamole and from 1986 intravenous immunoglobulin was given routinely to those patients seen early in the illness." | 1.28 | Clinical aspects of 100 patients with Kawasaki disease. ( Dillon, MJ; Levin, M; Suzuki, A; Tizard, EJ, 1991) |
| "The incidence of wheezing in Kawasaki disease (KD) has been investigated retrospectively." | 1.28 | Plasma immunoreactive leukotriene C4 levels in patients with Kawasaki disease. ( Fukuda, Y; Furukawa, S; Sasai, K; Yabuta, K, 1990) |
| "In 10 boys with coronary aneurysms following Kawasaki syndrome echocardiography was performed and compared to angiography with respect to its reliability in detecting coronary aneurysms." | 1.28 | [Coronary aneurysm following Kawasaki syndrome]. ( Engelhardt, W; Hofstetter, R; Keutel, J; Kluitmann, G; Mühler, E; Oberhoffer, R; von Bernuth, G, 1990) |
| "Although the etiology of Kawasaki syndrome remains poorly understood, new evidence points to an inherited defect in T-lymphocyte immunoregulation." | 1.28 | Kawasaki syndrome: still a fascinating enigma. ( Barron, KS; Murphy, DJ, 1989) |
| "50 children with Kawasaki disease were seen between September 1983 to March 1988." | 1.28 | Kawasaki disease--the Singapore experience. ( Ng, MP; Tan, CL; Tan, KW; Wong, KY, 1989) |
| "Twenty-six patients suffering from Kawasaki Disease (24 from the U." | 1.27 | Kawasaki disease: a report of 26 patients. ( Gray, JA; Welsby, PD, 1984) |
| "The incidence of acute rheumatic fever has declined remarkably in the past three decades, but the disease has not been eradicated, as some physicians believe." | 1.27 | Incidence of acute rheumatic fever. A suburban community hospital experience during the 1970s. ( Hepner, SI; Schwartz, RH; Ziai, M, 1983) |
| "Patients with Kawasaki disease are mostly in Japan, however, an increasing number of patients have recently been published in the foreign literatures, and this entity has become an important cause of heart disease in children." | 1.27 | [Kawasaki disease: new and important problems in cardiology]. ( Ichinose, E; Kato, H, 1983) |
| "Pretreatment thromboxane B2 was elevated compared with age-matched controls, fell moderately with high-dose aspirin (60 to 100 mg/kg/day) and marginally increased with low-dose aspirin (3 to 5 mg/kg/day) 6 to 8 weeks after treatment." | 1.27 | Effects of current therapy of Kawasaki disease on eicosanoid metabolism. ( Fulton, DR; Meissner, C; Peterson, MB, 1988) |
| "Thrombocytopenia was observed in 10 (2." | 1.27 | Thrombocytopenia: a complication of Kawasaki disease. ( Akeda, H; Aoki, T; Fukushige, J; Hara, T; Hijii, T; Honda, S; Mizuno, Y; Sunagawa, H; Ueda, K; Yamaguchi, Y, 1988) |
| "The prediction of the severity of Kawasaki disease in terms of coronary artery disease is important for the evaluation of prognosis as well as for making decisions on an appropriate form of treatment." | 1.27 | Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy. ( Nakano, H, 1987) |
| "An 18-month-old child with Kawasaki syndrome twice developed severe recurrence of symptoms when the acetylsalicylic acid (Aspirin) dosage was decreased from 80 mg/kg/day." | 1.27 | Relapsing Kawasaki's disease. ( Brady, S; Feild, C; Lowe, B, 1987) |
| "The diagnosis of Kawasaki disease and echocardiographic evaluation of the coronary arteries should be considered in young infants with prolonged fever of unknown origin." | 1.27 | Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. ( Burns, JC; Glodé, MP; Leung, DY; Newburger, JW; Toews, WH; Wiggins, JW; Wilson, H, 1986) |
| "Coronary aneurysms were demonstrated echocardiographically in 34 of 186 patients who presented with Kawasaki syndrome between 1979 and 1983." | 1.27 | Regression of coronary aneurysms in patients with Kawasaki syndrome. ( Lewis, AB; Mason, W; Takahashi, M, 1987) |
| "Kawasaki disease is a mucocutaneous lymph node syndrome with important cardiovascular complications that usually afflicts young children." | 1.27 | Transient heart failure in an adult with Kawasaki disease. ( Bégin, P; Genest, P; Laramée, P; Leclerc, G, 1986) |
| "We hypothesize that Kawasaki disease may be an etiologic factor in some cases of early atypical coronary atherosclerosis." | 1.26 | Regression of aneurysms in Kawasaki disease: a pathological study. ( Kato, H; Sasaguri, Y, 1982) |
| " Optimum drug or combination of drugs and dosage are still controversial." | 1.26 | [Inhibition of platelet function in pediatric medicine (author's transl)]. ( Schmidt, B, 1982) |
| "Kawasaki syndrome is a newly described, acute symptom complex of children that has a predictable clinical course." | 1.26 | Kawasaki syndrome: a new infectious disease? ( Melish, ME, 1981) |
| "Oral aspirin therapy was started at a dosage of 100 mg/kg/day, every six hours." | 1.26 | Salicylate hepatitis: a complication of the treatment of Kawasaki's disease. ( Bertino, JS; Reed, MD; Speck, WT; Willis, ED, 1981) |
| "First reported in Japan in 1967, Kawasaki disease appeared in Virginia this year." | 1.26 | Kawasaki disease is diagnosed in Virginia. ( Kesler, RW; Lohr, JA, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 96 (18.43) | 18.7374 |
| 1990's | 84 (16.12) | 18.2507 |
| 2000's | 122 (23.42) | 29.6817 |
| 2010's | 161 (30.90) | 24.3611 |
| 2020's | 58 (11.13) | 2.80 |
| Authors | Studies |
|---|---|
| Selamet Tierney, ES | 1 |
| Runeckles, K | 2 |
| Tremoulet, AH | 2 |
| Dahdah, N | 5 |
| Portman, MA | 2 |
| Mackie, AS | 2 |
| Harahsheh, AS | 2 |
| Lang, SM | 1 |
| Choueiter, NF | 2 |
| Li, JS | 2 |
| Manlhiot, C | 2 |
| Low, T | 2 |
| Mathew, M | 3 |
| Friedman, KG | 1 |
| Raghuveer, G | 2 |
| Norozi, K | 2 |
| Szmuszkovicz, JR | 2 |
| McCrindle, BW | 8 |
| de Jong, JJD | 1 |
| Slenter, RHJ | 1 |
| van Lierop, P | 1 |
| Wagenaar, LJ | 1 |
| Lin, Y | 1 |
| Wang, L | 1 |
| Li, A | 1 |
| Zhang, H | 1 |
| Shi, L | 1 |
| Alshammasi, W | 1 |
| Bargawi, A | 1 |
| Abdulrahman, A | 1 |
| Alhaji, M | 1 |
| Al Qahtani, F | 1 |
| Aldajani, A | 1 |
| Lei, WT | 1 |
| Chang, LS | 1 |
| Zeng, BY | 1 |
| Tu, YK | 1 |
| Uehara, R | 4 |
| Matsuoka, YJ | 1 |
| Su, KP | 1 |
| Lee, PC | 2 |
| Cavalcante, JL | 1 |
| Stubbs, B | 1 |
| Lin, PY | 1 |
| Wu, YC | 1 |
| Hsu, CW | 1 |
| Chen, TY | 1 |
| Chen, YW | 1 |
| Yeh, PY | 1 |
| Sun, CK | 1 |
| Tseng, PT | 1 |
| Kao, YH | 2 |
| Scherler, L | 1 |
| Haas, NA | 1 |
| Tengler, A | 1 |
| Pattathu, J | 1 |
| Mandilaras, G | 1 |
| Jakob, A | 1 |
| Gradoux, E | 1 |
| Di Bernardo, S | 1 |
| Bressieux-Degueldre, S | 1 |
| Mivelaz, Y | 1 |
| Boulos Ksontini, T | 1 |
| Prsa, M | 1 |
| Sekarski, N | 2 |
| Suzuki, T | 3 |
| Kawai, S | 1 |
| Morihana, E | 1 |
| Kawabe, S | 1 |
| Iwata, N | 1 |
| Saito, K | 1 |
| Yoshikawa, T | 2 |
| Yasuda, K | 1 |
| Sapountzi, E | 1 |
| Fidani, L | 1 |
| Giannopoulos, A | 1 |
| Galli-Tsinopoulou, A | 1 |
| Gottlieb, M | 1 |
| Rice, M | 1 |
| Gore, SR | 1 |
| Chu, Y | 2 |
| Xu, Y | 2 |
| Wang, C | 3 |
| Yu, X | 5 |
| Ma, Q | 2 |
| Wang, H | 3 |
| Williams, K | 2 |
| Power, B | 2 |
| Tiller, G | 2 |
| Renton, WD | 3 |
| Suhaini, SA | 1 |
| Azidin, AH | 1 |
| Cheah, CS | 1 |
| Lee Wei Li, W | 1 |
| Khoo, MS | 1 |
| Ismail, NAS | 1 |
| Ali, A | 1 |
| Thadchanamoorthy, V | 1 |
| Dayasiri, K | 1 |
| Ragunathan, IR | 1 |
| Beck, RA | 1 |
| Spiva, S | 1 |
| Broderick, C | 1 |
| Kobayashi, S | 1 |
| Suto, M | 1 |
| Ito, S | 4 |
| Kobayashi, T | 7 |
| Eleftheriou, D | 1 |
| Moraes, YC | 1 |
| Purvis, C | 1 |
| Pursell, M | 1 |
| Morillas, MM | 1 |
| Kahn, R | 1 |
| Mossberg, M | 1 |
| Kucera, F | 1 |
| Tulloh, R | 5 |
| Standing, JF | 1 |
| Swallow, V | 1 |
| McCormack, R | 1 |
| Herberg, J | 1 |
| Levin, M | 6 |
| Wan, M | 1 |
| Klein, N | 2 |
| Connon, R | 1 |
| Walker, AS | 1 |
| Brogan, P | 2 |
| Amir, O | 2 |
| Prajjwal, P | 2 |
| Inban, P | 2 |
| Gadam, S | 2 |
| Aleti, S | 2 |
| Sunasra, RR | 2 |
| Gupta, K | 2 |
| Elhag, M | 2 |
| Mahmoud, M | 2 |
| Alsir, O | 2 |
| Galeotti, C | 1 |
| Bajolle, F | 2 |
| Belot, A | 1 |
| Biscardi, S | 1 |
| Bosdure, E | 2 |
| Bourrat, E | 1 |
| Cimaz, R | 5 |
| Darbon, R | 1 |
| Dusser, P | 1 |
| Fain, O | 2 |
| Hentgen, V | 1 |
| Lambert, V | 1 |
| Lefevre-Utile, A | 1 |
| Marsaud, C | 1 |
| Meinzer, U | 1 |
| Morin, L | 1 |
| Piram, M | 3 |
| Richer, O | 1 |
| Stephan, JL | 2 |
| Urbina, D | 1 |
| Kone-Paut, I | 3 |
| Liu, HQ | 1 |
| Shi, XY | 1 |
| Jia, PS | 1 |
| Huo, YF | 1 |
| Mu, MM | 1 |
| Xie, L | 3 |
| Wang, HL | 1 |
| Marriaga-Núñez, B | 1 |
| Arellano-Valdez, A | 1 |
| Paz, JPA | 1 |
| Bonal-Pérez, MA | 1 |
| Montaño-Durón, JG | 1 |
| Solórzano-Santos, F | 1 |
| Gao, L | 1 |
| Wang, W | 3 |
| Xu, Z | 1 |
| Zhou, S | 1 |
| Geng, Z | 1 |
| Fu, S | 1 |
| Xie, C | 1 |
| Zhang, Y | 6 |
| Wang, Y | 2 |
| Gong, F | 2 |
| Kuo, NC | 1 |
| Lin, CH | 1 |
| Lin, MC | 1 |
| Jiang, J | 1 |
| Fan, Z | 2 |
| Mao, Y | 1 |
| Liu, YL | 1 |
| Wang, XM | 1 |
| Chen, TT | 1 |
| Shi, K | 1 |
| Lu, YH | 1 |
| Guo, YH | 1 |
| Li, Y | 4 |
| Vecerek, N | 1 |
| Dupuy, EO | 1 |
| Kang, Y | 1 |
| Sarantopoulos, GP | 1 |
| Worswick, S | 1 |
| Knowles, BC | 1 |
| Mastrangelo, G | 1 |
| Calabri, GB | 1 |
| Simonini, G | 2 |
| Lasagni, D | 1 |
| Resti, M | 1 |
| Trapani, S | 1 |
| Tirelli, F | 1 |
| Marrani, E | 1 |
| Giani, T | 1 |
| Moussa, T | 1 |
| Wagner-Weiner, L | 1 |
| Kainth, R | 1 |
| Shah, P | 1 |
| Ferstenfeld, I | 1 |
| Shemer, A | 1 |
| Razon, Y | 1 |
| Yeshayahu, Y | 1 |
| Mammadov, G | 1 |
| Liu, HH | 1 |
| Chen, WX | 1 |
| Fan, GZ | 1 |
| Li, RX | 1 |
| Liu, FF | 1 |
| Samadli, S | 1 |
| Wang, JJ | 1 |
| Wu, YF | 1 |
| Luo, HH | 1 |
| Zhang, DD | 1 |
| Wei, W | 1 |
| Hu, P | 2 |
| Dionne, A | 3 |
| Singh-Grewal, D | 1 |
| Burgner, DP | 1 |
| Newburger, JW | 20 |
| de Ferranti, SD | 1 |
| Arslanoglu Aydin, E | 1 |
| Demir, S | 1 |
| Aydin, O | 1 |
| Bilginer, Y | 1 |
| Ozen, S | 1 |
| Asada, D | 1 |
| Taura, Y | 1 |
| Itoh, H | 1 |
| Tatsumi, Y | 1 |
| Rosario, JM | 1 |
| Patel, F | 1 |
| Levasseur, K | 1 |
| Adams, L | 1 |
| Lee, CH | 1 |
| Kim, U | 1 |
| Platt, B | 1 |
| Belarski, E | 1 |
| Manaloor, J | 1 |
| Ofner, S | 1 |
| Carroll, AE | 1 |
| John, CC | 1 |
| Wood, JB | 1 |
| Yellamaty, V | 1 |
| Steele, RW | 1 |
| Faraji, E | 1 |
| Sukumaran, S | 1 |
| Vijayan, V | 1 |
| Blonz, G | 1 |
| Lacroix, S | 1 |
| Benbrik, N | 1 |
| Warin-Fresse, K | 1 |
| Masseau, A | 1 |
| Trewick, D | 1 |
| Hamidou, M | 1 |
| Néel, A | 1 |
| Jia, X | 1 |
| Du, X | 1 |
| Bie, S | 1 |
| Li, X | 1 |
| Bao, Y | 1 |
| Jiang, M | 1 |
| Han, Y | 1 |
| Hu, C | 1 |
| Yu, Y | 1 |
| Tang, B | 1 |
| Lo, HH | 1 |
| Lei, C | 1 |
| U, KI | 1 |
| Hsiao, WW | 1 |
| Guo, X | 1 |
| Bai, J | 1 |
| Wong, VK | 1 |
| Law, BY | 1 |
| Rauf, A | 1 |
| Vijayan, A | 1 |
| John, ST | 1 |
| Krishnan, R | 1 |
| Latheef, A | 1 |
| Galuppo, J | 1 |
| Kowker, A | 1 |
| Rolfs, J | 1 |
| Nicholas, J | 1 |
| Schmidt, E | 1 |
| Tsujii, N | 2 |
| Nogami, K | 2 |
| Yoshizawa, H | 2 |
| Sakai, T | 2 |
| Fukuda, K | 2 |
| Ishiguro, A | 2 |
| Shima, M | 2 |
| Berthelot, JM | 1 |
| Drouet, L | 1 |
| Lioté, F | 1 |
| Furui, S | 1 |
| Seki, M | 3 |
| Minami, T | 1 |
| Goto, M | 1 |
| Yamagata, T | 1 |
| Ueharu, K | 1 |
| Asano, T | 1 |
| Fukunaga, R | 1 |
| Matsui, R | 1 |
| Yoshida, K | 1 |
| Miyatake-Sudoh, C | 1 |
| Abe, M | 1 |
| Fujita, A | 2 |
| Ito, Y | 1 |
| Murphey, AC | 1 |
| Morrison Ponce, D | 1 |
| Hashikawa, AN | 1 |
| Michihata, N | 2 |
| Hata, T | 1 |
| Matsui, H | 2 |
| Fushimi, K | 2 |
| Yasunaga, H | 2 |
| Gallerani, M | 1 |
| Pala, M | 1 |
| Fabbian, F | 1 |
| De Giorgi, A | 1 |
| McGrath, E | 1 |
| Jadcherla, Y | 1 |
| Held, J | 1 |
| Ang, JY | 1 |
| Chiang, MH | 1 |
| Liu, HE | 1 |
| Wang, JL | 1 |
| Ramanan, AV | 2 |
| Liu, E | 1 |
| Gonzalez, J | 1 |
| Siu, A | 1 |
| Xu, M | 1 |
| Liu, J | 1 |
| Pan, L | 1 |
| Yang, S | 1 |
| Osborne, J | 1 |
| Friedman, K | 1 |
| Giglia, TM | 1 |
| Dallaire, F | 2 |
| Yetman, AT | 1 |
| Burns, JC | 16 |
| Jain, S | 2 |
| Mondal, T | 1 |
| Crean, A | 1 |
| Cherqaoui, B | 1 |
| Yager, H | 1 |
| Bourgeois, FL | 1 |
| He, L | 2 |
| Liu, F | 2 |
| Yan, W | 2 |
| Huang, M | 2 |
| Guo, Y | 1 |
| Xu, X | 1 |
| Chu, C | 2 |
| Wu, L | 2 |
| Liang, X | 2 |
| Sun, S | 1 |
| Wang, F | 1 |
| Zhao, L | 2 |
| Zhao, Q | 1 |
| Ma, X | 1 |
| Huang, G | 2 |
| Cattalini, M | 1 |
| Della Paolera, S | 1 |
| Zunica, F | 1 |
| Bracaglia, C | 1 |
| Giangreco, M | 1 |
| Verdoni, L | 1 |
| Meini, A | 1 |
| Sottile, R | 1 |
| Caorsi, R | 1 |
| Zuccotti, G | 1 |
| Fabi, M | 1 |
| Montin, D | 1 |
| Meneghel, A | 1 |
| Consolaro, A | 1 |
| Dellepiane, RM | 1 |
| Maggio, MC | 1 |
| La Torre, F | 1 |
| Marchesi, A | 1 |
| Villani, A | 1 |
| Ravelli, A | 1 |
| Taddio, A | 1 |
| Yoshikane, Y | 1 |
| Okuma, Y | 1 |
| Miyamoto, T | 1 |
| Hashimoto, J | 1 |
| Fukazawa, R | 2 |
| Kato, T | 2 |
| Takeda, A | 1 |
| Suda, K | 4 |
| Matsushita, T | 1 |
| Hiroe, M | 1 |
| Imanaka-Yoshida, K | 1 |
| Osman, RS | 1 |
| Salum, HM | 1 |
| Noorani, M | 2 |
| Fukuda, S | 1 |
| Fujiwara, M | 1 |
| Abe, J | 2 |
| Hanaoka, N | 1 |
| Fujimoto, T | 1 |
| Katsumori, H | 1 |
| Fortier-Morissette, Z | 1 |
| Blais, S | 1 |
| Dhanrajani, A | 3 |
| Basodan, D | 1 |
| Renaud, C | 1 |
| De Souza, AM | 1 |
| Blanchard, J | 1 |
| Saulnier, H | 1 |
| Kaspy, K | 1 |
| Rached-d'Astous, S | 1 |
| Human, DG | 1 |
| Scuccimarri, R | 2 |
| Kim, HJ | 1 |
| Choi, EH | 1 |
| Lim, YJ | 1 |
| Kil, HR | 1 |
| Yeung, RSM | 1 |
| Ohnishi, Y | 1 |
| Mori, K | 1 |
| Inoue, M | 1 |
| Satake, N | 1 |
| Yano, M | 1 |
| Sakulchit, T | 1 |
| Benseler, SM | 2 |
| Goldman, RD | 1 |
| Chen, J | 1 |
| Ma, L | 6 |
| Zhang, YY | 2 |
| Yu, HG | 1 |
| Sun, Q | 1 |
| Zhang, J | 1 |
| Yang, Y | 2 |
| Poddighe, D | 1 |
| Ho, LGY | 1 |
| Curtis, N | 4 |
| Huang, X | 1 |
| Huang, P | 1 |
| Zhang, L | 3 |
| Xie, X | 1 |
| Xia, S | 1 |
| Yuan, J | 1 |
| Jin, L | 1 |
| Chan, M | 1 |
| Pau, S | 1 |
| Ellsworth, J | 1 |
| Petty, R | 1 |
| Guzman, J | 1 |
| Tiewsoh, K | 1 |
| Sharma, D | 1 |
| Jindal, AK | 1 |
| Bhisikar, S | 1 |
| Suri, D | 3 |
| Singh, S | 4 |
| Tang, Y | 1 |
| Sun, L | 4 |
| Xu, Q | 2 |
| Ding, Y | 1 |
| Lv, H | 1 |
| Nariai, R | 1 |
| Masuda, H | 1 |
| Ono, H | 1 |
| Imadome, KI | 1 |
| Kubota, M | 1 |
| Son, MBF | 1 |
| Migally, K | 1 |
| Braunlin, EA | 1 |
| Binstadt, BA | 1 |
| Guile, L | 1 |
| Parke, S | 1 |
| Kelly, A | 1 |
| Chang, A | 1 |
| Islam, S | 1 |
| Pi, L | 1 |
| Che, D | 1 |
| Long, H | 1 |
| Fang, Z | 1 |
| Li, J | 1 |
| Lin, S | 1 |
| Liu, Y | 2 |
| Li, M | 1 |
| Bao, L | 1 |
| Li, W | 1 |
| Deng, Q | 1 |
| Liu, T | 1 |
| Gu, X | 1 |
| Wan, H | 1 |
| Du, M | 1 |
| Deng, H | 1 |
| Fu, J | 1 |
| Wang, X | 1 |
| Liu, R | 1 |
| Kuo, HC | 4 |
| Guo, MM | 2 |
| Lo, MH | 2 |
| Hsieh, KS | 6 |
| Huang, YH | 2 |
| Flinn, AM | 1 |
| Gavin, PJ | 1 |
| McMahon, CJ | 2 |
| Oslizok, P | 1 |
| Butler, KM | 1 |
| De Rosa, G | 3 |
| Andreozzi, L | 1 |
| Piastra, M | 1 |
| Castelli, B | 1 |
| Rigante, D | 2 |
| Rezkalla, J | 1 |
| Chang, P | 1 |
| Peck, E | 1 |
| Schimelpfenig, M | 1 |
| Connell, JT | 1 |
| Park, JH | 1 |
| Sillen, H | 1 |
| Maes, M | 1 |
| Boiy, T | 1 |
| Wojciechowski, M | 1 |
| Ramos, E | 1 |
| Patiño, P | 1 |
| Reiter, RJ | 1 |
| Gil-Martín, E | 1 |
| López-Muñoz, F | 1 |
| Romero, A | 1 |
| Jin, J | 1 |
| Wang, J | 1 |
| Lu, Y | 1 |
| Huang, N | 1 |
| Yu, H | 1 |
| Yeo, WS | 2 |
| Miyata, K | 1 |
| Kaneko, T | 1 |
| Morikawa, Y | 1 |
| Sakakibara, H | 1 |
| Matsushima, T | 1 |
| Misawa, M | 1 |
| Takahashi, T | 1 |
| Nakazawa, M | 1 |
| Tamame, T | 1 |
| Tsuchihashi, T | 1 |
| Yamashita, Y | 1 |
| Obonai, T | 1 |
| Chiga, M | 1 |
| Hori, N | 1 |
| Komiyama, O | 1 |
| Yamagishi, H | 1 |
| Miura, M | 3 |
| Yamazaki-Nakashimada, MA | 1 |
| Gámez-González, LB | 1 |
| Murata, C | 1 |
| Honda, T | 2 |
| Yasukawa, K | 1 |
| Hamada, H | 4 |
| Lakhani, N | 1 |
| Lin, J | 2 |
| Zhao, H | 2 |
| Jiao, F | 2 |
| Ito, T | 2 |
| Hoshina, T | 2 |
| Taku, K | 1 |
| Kusuhara, K | 2 |
| Sosa, T | 1 |
| Brower, L | 1 |
| Divanovic, A | 1 |
| Liu, X | 2 |
| Lu, N | 1 |
| Wang, M | 1 |
| Stasiak, A | 1 |
| Smolewska, E | 1 |
| Matsumoto, M | 1 |
| Takase, T | 1 |
| Tanaka, I | 1 |
| Hayakawa, M | 1 |
| Sakai, K | 1 |
| Isonishi, A | 1 |
| Matsuura, K | 1 |
| Fujimura, Y | 1 |
| Zheng, X | 1 |
| Yue, P | 1 |
| Liu, L | 1 |
| Tang, C | 1 |
| Ma, F | 1 |
| Duan, H | 1 |
| Zhou, K | 1 |
| Hua, Y | 1 |
| Wu, G | 1 |
| Yang, Q | 1 |
| Qiao, H | 1 |
| Doi, M | 1 |
| Furuichi, Y | 1 |
| Yim, D | 1 |
| Cheung, M | 1 |
| Burgner, D | 9 |
| Peyre, M | 1 |
| Laroche, C | 1 |
| Etchecopar, C | 1 |
| Brosset, P | 1 |
| Saha, A | 1 |
| Khalil, S | 1 |
| Kapoor, K | 1 |
| Gupta, A | 2 |
| Dubey, NK | 1 |
| Bayers, S | 1 |
| Shulman, ST | 21 |
| Paller, AS | 1 |
| Yahata, T | 1 |
| Suzuki, C | 1 |
| Yoshioka, A | 1 |
| Hamaoka, A | 1 |
| Ikeda, K | 3 |
| Terreri, MT | 1 |
| Clemente, G | 1 |
| Garnett, GM | 1 |
| Kimball, S | 1 |
| Melish, ME | 5 |
| Thompson, KS | 1 |
| Puapong, DP | 1 |
| Johnson, SM | 1 |
| Woo, RK | 1 |
| Šileikienė, R | 1 |
| Kudzytė, J | 1 |
| Jankauskas, A | 1 |
| Labanauskas, L | 1 |
| Rakauskienė, V | 1 |
| Jurkienė, N | 1 |
| Kėvalas, R | 1 |
| Zhou, SL | 1 |
| Luo, JP | 1 |
| Qi, YQ | 1 |
| Liang, YG | 1 |
| Gong, FQ | 2 |
| Jaggi, P | 1 |
| Jimenez-Fernandez, S | 1 |
| Pancheri, JM | 1 |
| Sun, X | 1 |
| Kanegaye, JT | 1 |
| Kovalchin, JP | 2 |
| Printz, BF | 1 |
| Ramilo, O | 1 |
| Du, Z | 1 |
| Rahbarimanesh, A | 1 |
| Taghavi-Goodarzi, M | 1 |
| Mohammadinejad, P | 1 |
| Zoughi, J | 1 |
| Amiri, J | 1 |
| Moridpour, K | 1 |
| Bhatt, ST | 1 |
| Hageman, JR | 1 |
| Bartlett, A | 1 |
| Trivedi, K | 1 |
| Puhakka, L | 1 |
| Saat, R | 1 |
| Klockars, T | 1 |
| Kajosaari, L | 1 |
| Salo, E | 1 |
| Nieminen, T | 1 |
| Su, D | 2 |
| Wang, K | 2 |
| Qin, S | 2 |
| Pang, Y | 3 |
| Behjati-Ardakani, M | 1 |
| Ferdosian, F | 1 |
| Nakada, T | 1 |
| Harnden, A | 4 |
| Gordon, JB | 1 |
| Tissandier, C | 1 |
| Lang, M | 1 |
| Lusson, JR | 1 |
| Bœuf, B | 1 |
| Merlin, E | 1 |
| Dauphin, C | 2 |
| Serpytis, P | 1 |
| Petrulioniene, Z | 1 |
| Gargalskaite, U | 1 |
| Gedminaite, A | 1 |
| Panaviene, V | 1 |
| Aldemir-Kocabaş, B | 1 |
| Kcal, MM | 1 |
| Ramoğlu, MG | 1 |
| Tutar, E | 2 |
| Fitöz, S | 1 |
| Çiftçi, E | 2 |
| İnce, E | 2 |
| Loomba, RS | 1 |
| Seaton, KK | 1 |
| Kharbanda, A | 1 |
| Kuijpers, T | 1 |
| Ueno, K | 3 |
| Nomura, Y | 5 |
| Morita, Y | 2 |
| Eguchi, T | 3 |
| Masuda, K | 3 |
| Kawano, Y | 3 |
| Saguil, A | 1 |
| Fargo, M | 1 |
| Grogan, S | 1 |
| Greco, A | 1 |
| De Virgilio, A | 1 |
| Rizzo, MI | 1 |
| Tombolini, M | 1 |
| Gallo, A | 1 |
| Fusconi, M | 1 |
| Ruoppolo, G | 1 |
| Pagliuca, G | 1 |
| Martellucci, S | 1 |
| de Vincentiis, M | 1 |
| Kontopoulou, T | 1 |
| Kontopoulos, DG | 1 |
| Vaidakis, E | 1 |
| Mousoulis, GP | 1 |
| Rowley, AH | 8 |
| Akagi, K | 1 |
| Tanaka, K | 1 |
| Tomotaki, S | 1 |
| Iki, Y | 1 |
| Ueda, K | 3 |
| Nakata, M | 1 |
| Yoshioka, T | 1 |
| Shiota, M | 1 |
| Hata, A | 2 |
| Watanabe, K | 1 |
| Hata, D | 1 |
| Lynch, J | 1 |
| Patra, KP | 1 |
| Vijay, C | 1 |
| Mitchell, M | 1 |
| Moffett-Bradford, K | 1 |
| Alcamo, AM | 1 |
| Astudillo, CL | 1 |
| Gray, SB | 1 |
| Klein, M | 1 |
| Camacho-Lovillo, MS | 1 |
| Melón, M | 1 |
| Moreno, MD | 1 |
| Ardanuy, AV | 1 |
| Neth, O | 1 |
| Zhang, S | 1 |
| Liu, G | 1 |
| Yu, T | 1 |
| Zhou, G | 1 |
| Zheng, R | 1 |
| Guan, Y | 1 |
| Fan, XC | 1 |
| Lu, FY | 1 |
| Song, LM | 1 |
| Patel, RM | 1 |
| Aoyagi, R | 1 |
| Sato, Y | 1 |
| Suzuki, H | 1 |
| Onouchi, Y | 1 |
| Ebata, R | 1 |
| Nagashima, K | 1 |
| Terauchi, M | 1 |
| Terai, M | 3 |
| Hanaoka, H | 1 |
| Fraison, JB | 1 |
| Sève, P | 2 |
| Mahr, A | 1 |
| Gomard-Mennesson, E | 1 |
| Varron, L | 1 |
| Pugnet, G | 1 |
| Landron, C | 1 |
| Roblot, P | 1 |
| Oziol, E | 1 |
| Chalhoub, G | 1 |
| Galempoix, JM | 2 |
| Humbert, S | 1 |
| Humbert, P | 1 |
| Sbidian, E | 1 |
| Grange, F | 1 |
| Bayrou, O | 1 |
| Cathebras, P | 1 |
| Morlat, P | 1 |
| Epaulard, O | 1 |
| Pavese, P | 1 |
| Huong, du LT | 1 |
| Zoulim, A | 1 |
| Stankovic, K | 2 |
| Bachelez, H | 1 |
| Smail, A | 2 |
| Bachmeyer, C | 1 |
| Granel, B | 2 |
| Serratrice, J | 3 |
| Brinchault, G | 2 |
| Mekinian, A | 1 |
| Costedoat-Chalumeau, N | 1 |
| Bourgarit-Durand, A | 1 |
| Puéchal, X | 1 |
| Guillevin, L | 1 |
| Garrido-García, LM | 1 |
| López-Amézquita, M | 1 |
| Villaverde-Rosas, R | 1 |
| Krishnamurthy, S | 1 |
| Jagadeesh, A | 1 |
| Chandrasekaran, V | 1 |
| Mahadevan, S | 1 |
| Rajesh, NG | 1 |
| Agarwal, S | 2 |
| Bhattad, S | 1 |
| Rawat, A | 1 |
| Singhal, M | 1 |
| Rohit, M | 1 |
| Novais, C | 1 |
| Fortunato, F | 1 |
| Bicho, A | 1 |
| Preto, L | 1 |
| Takahashi, M | 9 |
| Kamal, S | 1 |
| Khan, MA | 1 |
| Altorok, N | 1 |
| Kraszewska-Głomba, B | 1 |
| Kuchar, E | 2 |
| Szenborn, L | 1 |
| Agrawal, DK | 1 |
| Kim, JH | 1 |
| Kim, M | 1 |
| Oh, JH | 2 |
| Lee, JY | 1 |
| Lee, KY | 2 |
| Koh, DK | 1 |
| Kim, GB | 1 |
| Yu, JJ | 1 |
| Yoon, KL | 1 |
| Jeong, SI | 1 |
| Song, YH | 1 |
| Han, JW | 2 |
| Hong, YM | 1 |
| Joo, CU | 1 |
| Agarwal, E | 1 |
| Shah, D | 1 |
| Gupta, P | 1 |
| Dhawan, SR | 1 |
| Vaidya, PC | 1 |
| Singhi, PD | 1 |
| Yang, G | 1 |
| Thompson, D | 1 |
| Warren, A | 1 |
| Fimbres, AM | 1 |
| Kawakami, T | 1 |
| Takeuchi, S | 1 |
| Muto, S | 1 |
| Soma, Y | 1 |
| Langley, EW | 1 |
| Kirse, DK | 1 |
| Barnes, CE | 1 |
| Covitz, W | 1 |
| Shetty, AK | 1 |
| Billoo, AG | 1 |
| Lone, SW | 1 |
| Siddiqui, S | 1 |
| Atiq, H | 1 |
| Roderick, M | 1 |
| Ramani, P | 1 |
| Thapa, R | 3 |
| Chakrabartty, S | 1 |
| Kudo, Y | 2 |
| Higaki, T | 1 |
| Matsumura, M | 1 |
| Ayusawa, M | 2 |
| Ogawa, S | 2 |
| Matsuishi, T | 2 |
| Zhao, W | 1 |
| Li, F | 1 |
| Chen, LJ | 1 |
| Dai, K | 1 |
| Balasubramanian, S | 1 |
| Ganesh, R | 1 |
| Alvarez-Coca González, J | 1 |
| Caballero Mora, FJ | 1 |
| Alonso Martín, B | 1 |
| Martínez Pérez, J | 1 |
| Ercan, TE | 1 |
| Ercan, G | 1 |
| Arpaozu, M | 1 |
| Onouchi, Z | 4 |
| Hamaoka, K | 3 |
| Ozawa, S | 2 |
| Sakata, K | 2 |
| Kiyosawa, N | 6 |
| Ito, H | 1 |
| Yilmazer, MM | 1 |
| Mese, T | 1 |
| Demirpençe, S | 1 |
| Tavli, V | 1 |
| Devrim, I | 1 |
| Guven, B | 1 |
| Oner, T | 1 |
| Orgun, LT | 1 |
| Vitrinel, A | 1 |
| Lim, TC | 1 |
| Loke, KY | 1 |
| Quek, SC | 3 |
| Javadzadegan, H | 1 |
| Mehdizadeh Baghbani, J | 1 |
| Farhang, S | 1 |
| Kaur, S | 1 |
| Kulkarni, KP | 1 |
| Dubey, PN | 1 |
| Ozdemir, H | 1 |
| Tapisiz, A | 1 |
| Atalay, S | 1 |
| Dogru, U | 1 |
| Valentini, P | 2 |
| Rizzo, D | 1 |
| Leo, A | 1 |
| Onesimo, R | 1 |
| De Nisco, A | 1 |
| Angelone, DF | 2 |
| Compagnone, A | 1 |
| Delogu, AB | 1 |
| Kuroiwa, Y | 1 |
| Oyanagi, R | 1 |
| Fuse, S | 2 |
| Mori, T | 1 |
| Kamada, A | 1 |
| Tsutsumi, H | 1 |
| Hussain, RN | 1 |
| Ruiz, G | 1 |
| Pal, P | 1 |
| Latino, GA | 1 |
| Yeung, RS | 3 |
| Chahal, N | 1 |
| McCandless, RT | 1 |
| Minich, LL | 4 |
| Tani, LY | 5 |
| Williams, RV | 2 |
| Hayashi, M | 1 |
| Monma, F | 1 |
| Katagiri, Y | 1 |
| Kawaguchi, M | 1 |
| Chemli, J | 2 |
| Hassayoun, S | 1 |
| Ketata, S | 1 |
| Ajmi, H | 1 |
| Ayeche, H | 1 |
| Zouari, N | 1 |
| Abroug, S | 1 |
| Boujaafar, N | 1 |
| Harbi, A | 2 |
| Gillebert, C | 1 |
| Vandeyk, K | 1 |
| Troost, E | 1 |
| Gewillig, M | 1 |
| Budts, W | 1 |
| Furuyama, H | 1 |
| Kinugawa, Y | 1 |
| Nakajima, M | 1 |
| Okajima, M | 1 |
| Okajima, S | 1 |
| Nakayama, T | 1 |
| Sawada, H | 1 |
| Ohta, Y | 1 |
| Muneuchi, J | 1 |
| Ishimura, M | 1 |
| Takada, H | 1 |
| Utsunomiya, R | 1 |
| Yamaguchi, K | 2 |
| Ohga, S | 1 |
| Hara, T | 4 |
| Karia, VR | 1 |
| Hescock, GC | 1 |
| Gedalia, A | 2 |
| Gedelia, A | 1 |
| Ross-Ascuitto, N | 1 |
| Xu, MG | 2 |
| Men, LN | 2 |
| Zu, Y | 2 |
| Zhao, CY | 2 |
| Meng, XC | 2 |
| Wang, T | 1 |
| Kallada, S | 1 |
| Türel, O | 1 |
| Güzeltaş, A | 1 |
| Aydoğmuş, C | 1 |
| Hatipoğlu, N | 1 |
| Hatipoğlu, H | 1 |
| Siraneci, R | 1 |
| Bresson, V | 1 |
| Bonello, B | 1 |
| Rousset-Rouvière, C | 1 |
| Chabrol, B | 1 |
| Dubus, JC | 1 |
| Davaalkham, D | 1 |
| Nakamura, Y | 2 |
| Baigalmaa, D | 1 |
| Davaa, G | 1 |
| Chimedsuren, O | 1 |
| Sumberzul, N | 1 |
| Lkhagvasuren, T | 1 |
| Yanagawa, H | 3 |
| Kawasaki, T | 5 |
| Campos-Franco, J | 1 |
| Lopez, R | 1 |
| Alende, R | 1 |
| Gonzalez-Quintela, A | 1 |
| Gill, PJ | 1 |
| Kossiva, L | 1 |
| Lydia, K | 1 |
| Karanassios, E | 1 |
| Evangelos, K | 1 |
| Papadopoulos, G | 1 |
| George, P | 1 |
| Karavanaki, K | 1 |
| Kyriaki, K | 1 |
| Budnik O, I | 1 |
| Hirsch B, T | 1 |
| Fernández C, C | 1 |
| Yánez P, L | 1 |
| Zamorano R, J | 1 |
| Zhu, BH | 1 |
| Lv, HT | 1 |
| Zhang, JM | 1 |
| Cao, L | 1 |
| Jia, HL | 1 |
| Yan, WH | 1 |
| Shen, YP | 1 |
| Husain, EH | 1 |
| Al-Rashid, M | 1 |
| Weng, KP | 2 |
| Ou, SF | 1 |
| Lin, CC | 3 |
| Kanai, T | 2 |
| Ishiwata, T | 1 |
| Sato, H | 1 |
| Takizawa, M | 1 |
| Kawamura, Y | 1 |
| Tsujimoto, H | 1 |
| Nakatani, K | 1 |
| Ishibashi, N | 1 |
| Nishiyama, M | 1 |
| Hatai, Y | 1 |
| Asano, Y | 1 |
| Takeshita, S | 1 |
| Nonoyama, S | 1 |
| Arata, M | 1 |
| Koriyama, C | 1 |
| Suruki, N | 1 |
| Yoshikawa, H | 1 |
| Neudorf, U | 2 |
| Karpathios, T | 1 |
| Moustaki, M | 1 |
| Yiallouros, P | 1 |
| Sharifi, F | 1 |
| Attilakos, A | 1 |
| Papadopoulou, A | 1 |
| Fretzayas, A | 1 |
| Garweg, JG | 1 |
| Suter, C | 1 |
| Aebi-Ochsner, C | 1 |
| Villiger, R | 1 |
| Peng, Q | 1 |
| Chen, C | 1 |
| He, H | 1 |
| Wu, Q | 1 |
| Liao, J | 1 |
| Li, B | 1 |
| Luo, C | 1 |
| Hu, X | 1 |
| Zheng, Z | 1 |
| Hyams, C | 1 |
| Day, TG | 1 |
| Ramroop, S | 1 |
| Paget, S | 1 |
| Howard, S | 1 |
| McMillan, M | 1 |
| Vora, S | 1 |
| de Keyser, P | 1 |
| Saji, T | 2 |
| Otani, T | 1 |
| Takeuchi, K | 1 |
| Nakamura, T | 2 |
| Arakawa, H | 1 |
| Ichida, F | 3 |
| Ogawa, C | 1 |
| Furuno, K | 2 |
| Tokunaga, H | 1 |
| Takatsuki, S | 1 |
| Hara, S | 1 |
| Morikawa, A | 3 |
| Fang, LC | 1 |
| Shyur, SD | 1 |
| Peng, CC | 1 |
| Jim, WT | 1 |
| Chu, SH | 1 |
| Chen, CK | 1 |
| Liu, LC | 1 |
| Almeida, B | 1 |
| Gleeson, P | 1 |
| Chawla, K | 1 |
| Zhou, Y | 1 |
| Yan, Z | 1 |
| Huang, F | 1 |
| Shiraishi, H | 1 |
| Momoi, MY | 1 |
| Coustasse, A | 1 |
| Larry, J | 1 |
| Lee, D | 1 |
| Lin, YJ | 1 |
| Lin, IC | 1 |
| Yu, HR | 1 |
| Yang, KD | 1 |
| Chang, WC | 1 |
| Liang, CD | 1 |
| Liu, SF | 1 |
| Ataya, A | 1 |
| Alraiyes, AH | 1 |
| Auron, M | 1 |
| Alraies, MC | 1 |
| Laux, D | 1 |
| Wang, YM | 1 |
| Cao, YC | 1 |
| Xu, ZJ | 1 |
| Tacke, CE | 1 |
| Kuipers, IM | 1 |
| Kuijpers, TW | 2 |
| Dominguez, SR | 1 |
| Anderson, MS | 1 |
| Callaway, LK | 1 |
| Bennett, CJ | 1 |
| Callaway, JK | 1 |
| Lang, B | 1 |
| Duffy, CM | 2 |
| Saulsbury, FT | 2 |
| Sundel, RP | 5 |
| Noyon, V | 1 |
| Roussel, M | 1 |
| Gacouin, A | 1 |
| Michelet, C | 1 |
| Freeman, AF | 2 |
| Crawford, SE | 1 |
| Finn, LS | 1 |
| López-Andreu, JA | 1 |
| Ferrando-Monleón, S | 1 |
| Pérez-Tamarit, D | 1 |
| Cornwall, ML | 1 |
| Boralevi, F | 2 |
| Barat, P | 1 |
| Lepreux, S | 1 |
| Stockman, AL | 1 |
| Taïeb, A | 1 |
| Léauté-Labrèze, C | 1 |
| Palazzi, DL | 1 |
| McClain, KL | 1 |
| Kaplan, SL | 1 |
| Morgan, GJ | 1 |
| MacLeod, C | 1 |
| Jenkins, J | 1 |
| Stewart, C | 1 |
| Craig, B | 1 |
| Barbaro, G | 1 |
| Di Lorenzo, G | 1 |
| Barbarini, G | 1 |
| Tsai, HJ | 1 |
| Wu, WM | 1 |
| Chang, YC | 1 |
| Wang, CM | 1 |
| Hong, HS | 1 |
| Managoli, S | 1 |
| Chaturvedi, P | 1 |
| Okada, Y | 2 |
| Minakami, H | 1 |
| Tomomasa, T | 2 |
| Kato, M | 1 |
| Inoue, Y | 1 |
| Kozawa, K | 1 |
| Kimura, H | 1 |
| Sun, ZY | 1 |
| Wei, ZX | 1 |
| Bhatnagar, SK | 1 |
| Paul, G | 1 |
| Subramanian, R | 1 |
| Al Hosni, MS | 1 |
| Al Khusaiby, SM | 1 |
| Duzova, A | 1 |
| Topaloglu, R | 1 |
| Keskin, M | 1 |
| Ozcelik, U | 1 |
| Secmeer, G | 1 |
| Tokgozoglu, AM | 1 |
| Ene, N | 1 |
| Igual, JP | 1 |
| Habib, G | 1 |
| Disdier, P | 1 |
| Weiller, PJ | 1 |
| de Ruijter, FT | 1 |
| Wolfs, TF | 1 |
| Geelen, SP | 1 |
| Faber, TE | 1 |
| Guzman-Cottrill, JA | 1 |
| Hwong, TM | 1 |
| Arifi, AA | 1 |
| Wan, IY | 1 |
| Thung, KH | 1 |
| Wan, S | 1 |
| Sung, RY | 1 |
| Yim, AP | 1 |
| Tsuda, E | 2 |
| Kitamura, S | 1 |
| Weijer, O | 1 |
| Hack, WW | 1 |
| Clur, SA | 1 |
| Fulton, DR | 4 |
| Maya Enero, S | 1 |
| Cols Roig, M | 1 |
| Ros Viladoms, JB | 1 |
| Pou Fernández, J | 1 |
| Gerber, MA | 2 |
| Gewitz, MH | 2 |
| Bolger, AF | 2 |
| Ferrieri, P | 2 |
| Baltimore, RS | 2 |
| Wilson, WR | 2 |
| Baddour, LM | 2 |
| Levison, ME | 2 |
| Pallasch, TJ | 2 |
| Falace, DA | 2 |
| Taubert, KA | 2 |
| Huang, TC | 1 |
| Lee, CL | 1 |
| Huang, SM | 1 |
| van Bever, HP | 1 |
| Lim, T | 1 |
| Fason, JT | 1 |
| Fry, YW | 1 |
| Smith, D | 1 |
| Tourneux, P | 1 |
| Dufillot, D | 1 |
| Belloy, M | 1 |
| Cevallos, L | 1 |
| Krim, G | 1 |
| Shiraishi, I | 1 |
| Itoi, T | 1 |
| Lee, JS | 1 |
| Lee, BC | 1 |
| Royle, J | 1 |
| Mason, WH | 2 |
| Hauger, SB | 1 |
| Janai, H | 1 |
| Bastian, JF | 1 |
| Wohrley, JD | 1 |
| Balfour, I | 1 |
| Shen, CA | 1 |
| Michel, ED | 1 |
| Durand, DV | 1 |
| Marchand, G | 1 |
| Broussolle, C | 1 |
| Ohno, T | 1 |
| Lilje, C | 1 |
| Joyce, JJ | 1 |
| Gupta-Malhotra, M | 1 |
| Rao, PS | 1 |
| Ball, SC | 1 |
| Wooditch, AC | 1 |
| Aronoff, SC | 1 |
| Narayanan, SN | 1 |
| Ahamed, MZ | 1 |
| Safia, M | 1 |
| Kchaou, H | 1 |
| Amri, F | 1 |
| Belkadhi, A | 1 |
| Essoussi, AS | 1 |
| Gueddiche, N | 1 |
| Sridhar, MR | 1 |
| Goel, H | 1 |
| Anirudh, D | 1 |
| Lodha, R | 1 |
| Kabra, SK | 1 |
| Su, JT | 1 |
| Taylor, MD | 1 |
| Krishnamurthy, R | 1 |
| Muthupillai, R | 1 |
| Chung, T | 1 |
| Vick, GW | 1 |
| Silverman, ED | 4 |
| Tyrrell, PN | 1 |
| Wong, J | 1 |
| Hattori, T | 2 |
| Matsukawa, Y | 1 |
| Takei, M | 1 |
| Yamazaki, T | 1 |
| Sawada, U | 1 |
| Sawada, S | 1 |
| Horie, T | 1 |
| Noto, N | 1 |
| Harada, K | 4 |
| Chang, FY | 1 |
| Hwang, B | 2 |
| Chen, SJ | 1 |
| Meng, CC | 1 |
| Lu, JH | 1 |
| Metules, T | 1 |
| Bauer, J | 1 |
| Kawamata, K | 1 |
| Neki, R | 1 |
| Echigo, S | 1 |
| Chiba, Y | 1 |
| Du, JB | 1 |
| Huang, XM | 1 |
| Kang, ML | 1 |
| Qian, BQ | 1 |
| Low, AF | 1 |
| Yip, J | 1 |
| Kohut, J | 1 |
| Gołba, E | 1 |
| Giec-Fuglewicz, G | 1 |
| Smoleńska-Petelenz, J | 1 |
| Berdej-Szczot, E | 1 |
| Szydłowski, L | 1 |
| Durall, AL | 1 |
| Phillips, JR | 1 |
| Weisse, ME | 1 |
| Mullett, CJ | 1 |
| Kaeppler, E | 1 |
| Lanoux, P | 1 |
| Belaïda, A | 1 |
| Aboutara, M | 1 |
| Penalba, C | 1 |
| Durongpisitkul, K | 2 |
| Sangtawesin, C | 1 |
| Khongphatthanayopthin, A | 1 |
| Panamonta, M | 1 |
| Sopontammarak, S | 1 |
| Sittiwangkul, R | 1 |
| Pongpanich, B | 1 |
| Bartlett, AH | 1 |
| Dishop, MK | 1 |
| Baker, CJ | 1 |
| Velez, AP | 1 |
| Menezes, L | 1 |
| Crespo, A | 1 |
| Husain, E | 1 |
| Hoque, E | 1 |
| Kim, DS | 1 |
| Nabavizadeh, SH | 1 |
| Safari, M | 1 |
| Amin, R | 1 |
| Sleeper, LA | 1 |
| Gersony, W | 1 |
| Vetter, VL | 1 |
| Atz, AM | 1 |
| Baker, AL | 3 |
| Colan, SD | 2 |
| Mitchell, PD | 1 |
| Klein, GL | 1 |
| Epps, RE | 1 |
| Wolff, AE | 1 |
| Hansen, KE | 1 |
| Zakowski, L | 1 |
| O'connor, MJ | 1 |
| Yashiro, M | 1 |
| Oki, I | 1 |
| Higashi, K | 1 |
| Kanazawa, M | 1 |
| Kohno, Y | 1 |
| Usta Guc, B | 1 |
| Cengiz, N | 1 |
| Yildirim, SV | 1 |
| Uslu, Y | 1 |
| Celik, U | 1 |
| Alhan, E | 1 |
| Arabaci, F | 1 |
| Sohn, S | 1 |
| Kwon, K | 1 |
| Isaka, N | 1 |
| Furukawa, T | 1 |
| Kishiro, M | 1 |
| Akimoto, K | 1 |
| Nagata, S | 1 |
| Shimizu, T | 2 |
| Yamashiro, Y | 2 |
| Chu, MP | 1 |
| Rong, X | 1 |
| Wu, RZ | 1 |
| Xiang, RL | 1 |
| Zhang, YH | 1 |
| Ausili, E | 1 |
| Schiavino, A | 1 |
| Focarelli, B | 1 |
| Ranno, O | 1 |
| Douvoyiannis, M | 1 |
| Belamarich, PF | 1 |
| Litman, N | 1 |
| Sugawara, Y | 1 |
| Ishii, M | 2 |
| Lega, JC | 1 |
| Mitsutake, R | 1 |
| Shirai, K | 1 |
| Nishikawa, H | 1 |
| Saito, N | 1 |
| Miura, S | 1 |
| Saku, K | 1 |
| Pinna, GS | 1 |
| Kafetzis, DA | 1 |
| Tselkas, OI | 1 |
| Skevaki, CL | 1 |
| Helwig, H | 1 |
| Chabali, R | 1 |
| Haynes, RE | 1 |
| Denning, DW | 1 |
| Kubryk, N | 1 |
| Borde, M | 1 |
| Jacobs, AH | 1 |
| Furusho, K | 3 |
| Kamiya, T | 3 |
| Nakano, H | 4 |
| Shinomiya, K | 3 |
| Hayashidera, T | 3 |
| Tamura, T | 3 |
| Hirose, O | 3 |
| Manabe, Y | 3 |
| Yokoyama, T | 5 |
| Hayashi, H | 1 |
| Kisamori, K | 1 |
| Kaneko, M | 1 |
| Masumura, Y | 1 |
| Kamikawa, T | 1 |
| Kobayashi, A | 1 |
| Suzuki, Y | 1 |
| Yamazaki, N | 1 |
| Yamaguchi, T | 1 |
| Harada, Y | 1 |
| Cheatham, JP | 1 |
| Kugler, JD | 1 |
| Pinsky, WW | 1 |
| Hofschire, PJ | 1 |
| Gray, JA | 1 |
| Welsby, PD | 1 |
| Koren, G | 5 |
| MacLeod, SM | 1 |
| Crowley, DC | 1 |
| Stein, MT | 1 |
| Short, RK | 1 |
| Barlow, JF | 1 |
| Schwartz, RH | 1 |
| Hepner, SI | 1 |
| Ziai, M | 1 |
| Fuller, L | 1 |
| Sutton, T | 1 |
| Sullivan, B | 1 |
| Kato, H | 9 |
| Ichinose, E | 3 |
| Shirahata, A | 1 |
| Asakura, A | 1 |
| Horstmann, E | 1 |
| Daweke, H | 1 |
| Black, CA | 1 |
| Bocchini, JA | 1 |
| Everist, J | 1 |
| Zulaíca, D | 1 |
| Ruíz, M | 1 |
| Alba, A | 1 |
| Higes, A | 1 |
| Damiano, A | 1 |
| Sasaguri, Y | 1 |
| Schmidt, B | 1 |
| Hicks, RV | 1 |
| Reddy, V | 2 |
| Fritz, ME | 1 |
| Giambonini, S | 1 |
| Jenni, R | 1 |
| D'Apuzzo, V | 1 |
| Bertino, JS | 1 |
| Willis, ED | 1 |
| Reed, MD | 1 |
| Speck, WT | 1 |
| Gomberg, R | 1 |
| Hamm, P | 1 |
| Martin, A | 1 |
| Fukushige, J | 3 |
| Nihill, MR | 1 |
| McNamara, DG | 1 |
| Nahmias, AJ | 1 |
| Teixeira, OH | 1 |
| Martin, L | 1 |
| Carpenter, BF | 1 |
| Sellers, FJ | 1 |
| Beitzke, A | 1 |
| Urban, C | 1 |
| Grubbauer, HM | 1 |
| Rasmussen, NH | 1 |
| Pedersen, IL | 1 |
| Thelle, T | 1 |
| Grymer, LF | 1 |
| Christensen, MF | 1 |
| Jacobs, JC | 3 |
| Gururaj, VJ | 1 |
| Park, JM | 1 |
| Martin, CF | 1 |
| Gliwińska, E | 1 |
| De Inocencio, J | 1 |
| Hirsch, R | 1 |
| Rico Corral, MA | 1 |
| Aznar Martín, A | 1 |
| de la Vega Vázquez, JM | 1 |
| Holgado Silva, C | 1 |
| Domínguez Castellano, A | 1 |
| Cerro González, R | 1 |
| Haneda, N | 1 |
| Mori, C | 1 |
| Rosenfeld, EA | 1 |
| Corydon, KE | 1 |
| Yanagisawa, M | 1 |
| Hirayama, T | 1 |
| Matsuda, H | 1 |
| Nakashima, M | 1 |
| Abinun, M | 1 |
| Cant, AJ | 1 |
| Kao, CH | 2 |
| Chen, YC | 2 |
| Wang, SJ | 2 |
| Yeh, SH | 2 |
| Furukawa, S | 3 |
| Matsubara, T | 3 |
| Umezawa, Y | 1 |
| Motohashi, T | 1 |
| Ino, T | 1 |
| Yabuta, K | 4 |
| Pontell, J | 1 |
| Rosenfeld, RM | 1 |
| Kohn, B | 1 |
| Sundell, R | 1 |
| Wyatt, LS | 1 |
| Frenkel, N | 1 |
| Dhillon, R | 1 |
| Newton, L | 1 |
| Rudd, PT | 1 |
| Hall, SM | 1 |
| Hsu, CH | 2 |
| Chen, MR | 1 |
| Hwang, FY | 1 |
| Kao, HA | 1 |
| Hung, HY | 1 |
| Klassen, TP | 1 |
| Rowe, PC | 1 |
| Gafni, A | 1 |
| Smith, PK | 1 |
| Goldwater, PN | 1 |
| Meissner, HC | 3 |
| Leung, DY | 6 |
| Wang, YL | 1 |
| Mason, W | 3 |
| Kashani, IA | 1 |
| Kligerman, M | 1 |
| Hwang, KP | 1 |
| Wu, JR | 1 |
| Huang, LY | 1 |
| Liou, CC | 1 |
| Huang, TY | 1 |
| Bauman, C | 1 |
| Cron, RQ | 1 |
| Sherry, DD | 2 |
| Francis, JS | 1 |
| Shinohara, M | 2 |
| Sone, K | 2 |
| Kosuda, T | 1 |
| Desgripes, A | 1 |
| Blanc, P | 1 |
| Debray, D | 1 |
| Carbajal, R | 1 |
| Paupe, A | 1 |
| Lenclen, R | 1 |
| Olivier-Martin, M | 1 |
| Malik, AS | 1 |
| Szychowska, Z | 1 |
| Gruszka, J | 1 |
| Fanconi, A | 1 |
| Lips, U | 1 |
| Aboussad, A | 1 |
| Payot, M | 1 |
| Bendet, M | 1 |
| Ravi, KV | 1 |
| Brooks, JR | 1 |
| Madrigal Terrazas, A | 1 |
| Sánchez Bayle, M | 1 |
| Tamariz Martel, A | 1 |
| Bradley, DJ | 1 |
| Glodé, MP | 4 |
| Rossomando, V | 1 |
| Baracchini, A | 1 |
| Chiaravalloti, G | 1 |
| Assanta, N | 1 |
| Buti, G | 1 |
| Matteucci, L | 1 |
| Ceccarelli, M | 1 |
| Saphyakhajon, P | 1 |
| Greene, GR | 1 |
| Etheridge, SP | 1 |
| Revenaugh, JR | 1 |
| Bavdekar, SB | 1 |
| Vaswani, LK | 1 |
| Shalini, H | 1 |
| Chandu, KV | 1 |
| Gaikwad, R | 1 |
| Kamat, JR | 1 |
| Ghazal, SS | 1 |
| Alhowasi, M | 1 |
| el Samady, MM | 1 |
| Sato, N | 2 |
| Sugimura, T | 1 |
| Akagi, T | 2 |
| Yamakawa, R | 1 |
| Hashino, K | 1 |
| Eto, G | 1 |
| Iemura, M | 1 |
| Dahlem, PG | 1 |
| von Rosenstiel, IA | 1 |
| Lam, J | 1 |
| Wurzburger, BJ | 1 |
| Avner, JR | 1 |
| Forsberg, S | 1 |
| Rainio, A | 1 |
| Chan, L | 1 |
| Chinnock, B | 1 |
| Zaitsu, M | 1 |
| Hamasaki, Y | 3 |
| Tashiro, K | 1 |
| Matsuo, M | 1 |
| Ichimaru, T | 2 |
| Fujita, I | 1 |
| Tasaki, H | 3 |
| Miyazaki, S | 3 |
| Han, RK | 1 |
| Sinclair, B | 1 |
| Newman, A | 1 |
| Taylor, GW | 1 |
| Walsh, P | 1 |
| Yoskovitch, A | 1 |
| Tewfik, TL | 1 |
| Moroz, B | 1 |
| O'Brien, M | 1 |
| Parness, IA | 2 |
| Neufeld, EJ | 1 |
| Wallace, CA | 1 |
| French, JW | 1 |
| Kahn, SJ | 1 |
| Rees, AH | 1 |
| Dale, RC | 1 |
| Saleem, MA | 1 |
| Daw, S | 1 |
| Dillon, MJ | 4 |
| Sciacca, P | 1 |
| Falsaperla, R | 1 |
| Barone, P | 1 |
| Tornambene, G | 1 |
| Mattia, C | 1 |
| Marletta, M | 1 |
| Betta, P | 1 |
| Distefano, G | 1 |
| Raman, V | 1 |
| Kim, J | 1 |
| Sharkey, A | 1 |
| Chatila, T | 1 |
| Dylewska, K | 1 |
| Maćkowska, K | 1 |
| Masłowska, E | 1 |
| Kojro-Wojcieszonek, A | 1 |
| Balcar-Boroń, A | 1 |
| Yi, QJ | 1 |
| Li, CR | 1 |
| Yang, XQ | 1 |
| Pendse, RN | 1 |
| Bhandari, H | 1 |
| Vats, AK | 1 |
| Bhandari, B | 1 |
| Bailie, NM | 1 |
| Hensey, OJ | 1 |
| Ryan, S | 1 |
| Allcut, D | 1 |
| King, MD | 1 |
| Saraf, S | 1 |
| Singh, RK | 1 |
| Calza, AM | 1 |
| Brogan, PA | 1 |
| Bose, A | 1 |
| Shingadia, D | 1 |
| Michie, C | 1 |
| Booy, R | 1 |
| Tse, SM | 1 |
| Liang, H | 1 |
| Yu, S | 1 |
| Wang, Q | 1 |
| Tang, F | 1 |
| Jiang, L | 1 |
| Koike, S | 1 |
| Schlossberg, D | 1 |
| Kandra, J | 1 |
| Kreiser, J | 1 |
| Lohr, JA | 1 |
| Kesler, RW | 1 |
| Cleveland, SS | 1 |
| Beiser, AS | 3 |
| McGill, T | 1 |
| Novak, RE | 1 |
| Harris, JP | 1 |
| Umezawa, T | 1 |
| Matsuo, N | 1 |
| Saraiva, LR | 1 |
| Brindeiro Filho, D | 1 |
| Barros, GS | 1 |
| de França, NA | 1 |
| Pontes, GA | 1 |
| Lin, CY | 1 |
| Chiang, B | 1 |
| St John, MA | 1 |
| Ishmael, RG | 1 |
| Comenzo, RL | 1 |
| Malachowski, ME | 1 |
| Berkman, EM | 1 |
| Blum-Hoffmann, E | 1 |
| Hoffmann, GF | 1 |
| Wessel, A | 1 |
| Gahr, M | 1 |
| Schaad, UB | 1 |
| Odermatt, K | 1 |
| Stocker, FP | 1 |
| Weber, JW | 1 |
| Wedgwood, J | 1 |
| Floret, D | 1 |
| Jujoh, K | 1 |
| Sasai, K | 2 |
| Nakachi, S | 1 |
| Sugawara, T | 1 |
| Lux, KM | 1 |
| Gonzalez-Crussi, F | 1 |
| Odaibo, FS | 1 |
| Goel, KM | 1 |
| Park, MS | 1 |
| Lee, HY | 1 |
| Kim, HM | 1 |
| Yang, JS | 1 |
| Lim, BK | 1 |
| Kim, JS | 1 |
| Barron, KS | 4 |
| Tizard, EJ | 2 |
| Houly, SR | 1 |
| Houly, RS | 1 |
| Oliveira, CC | 1 |
| de Albuquerque, PF | 1 |
| Coutinho, MA | 1 |
| Santos, RJ | 1 |
| Lira, N | 1 |
| Lira Neto, FS | 1 |
| Oka, R | 1 |
| Tsuchida, A | 1 |
| Yoshioka, H | 1 |
| Suzuki, A | 1 |
| Inoue, O | 1 |
| Murphy, DJ | 2 |
| Ruttenberg, HD | 1 |
| Wright, GB | 1 |
| Franklin, W | 1 |
| Goldberg, SJ | 1 |
| Higashino, SM | 1 |
| Cox, DG | 1 |
| Lee, M | 1 |
| Nakashima, L | 1 |
| Edwards, DL | 1 |
| Sánchez Lorente, A | 1 |
| Sanchís Calvo, A | 1 |
| Ferrer Giménez, R | 1 |
| Marquina Vila, A | 1 |
| Fukuda, Y | 1 |
| Engelhardt, W | 1 |
| Mühler, E | 1 |
| Keutel, J | 1 |
| Kluitmann, G | 1 |
| Oberhoffer, R | 1 |
| Hofstetter, R | 1 |
| von Bernuth, G | 1 |
| Chung, KJ | 1 |
| Duffy, CE | 1 |
| Sanders, SP | 2 |
| Feigin, RD | 1 |
| Geha, RS | 1 |
| Nagashima, M | 1 |
| Matsushima, M | 1 |
| Matsuoka, H | 1 |
| Ogawa, A | 1 |
| Okumura, N | 1 |
| Fontaine, JL | 1 |
| Tillous-Borde, I | 1 |
| Nieves-Rivera, F | 1 |
| Martin Pumarejo, M | 1 |
| Villavicencio, R | 1 |
| Meissner, C | 1 |
| Peterson, MB | 1 |
| Engle, MA | 3 |
| Fatica, NS | 3 |
| Bussel, JB | 1 |
| O'Loughlin, JE | 3 |
| Snyder, MS | 2 |
| Lesser, ML | 1 |
| Bourrillon, A | 1 |
| Seban, E | 1 |
| Vitoux-Brot, C | 1 |
| Joffe, LS | 1 |
| Wiggins, J | 1 |
| Clarke, SH | 1 |
| Hathaway, WE | 1 |
| Ikpatt, NW | 1 |
| Ibia, EO | 1 |
| Ng, MP | 1 |
| Wong, KY | 1 |
| Tan, CL | 1 |
| Tan, KW | 1 |
| Jirsenská, Z | 1 |
| Maresová, V | 1 |
| Kadlcáková, E | 1 |
| Habanec, B | 1 |
| Siegel, J | 1 |
| Patrick, AL | 1 |
| Barton, EN | 1 |
| Vincente, JB | 1 |
| Nienaber, CA | 1 |
| Spielmann, RP | 1 |
| Hausdorf, G | 1 |
| Bierman, FZ | 1 |
| Gersony, WM | 1 |
| Okuni, M | 2 |
| Yamaguchi, H | 1 |
| Sonobe, T | 1 |
| Ogino, H | 1 |
| Ogawa, M | 1 |
| Harima, Y | 1 |
| Kono, S | 1 |
| Ohkuni, H | 1 |
| Nishida, M | 1 |
| Kobayashi, Y | 1 |
| Yabuuchi, H | 1 |
| Tokugawa, K | 1 |
| Nanri, T | 1 |
| Mizuno, Y | 1 |
| Akeda, H | 1 |
| Aoki, T | 1 |
| Sunagawa, H | 1 |
| Honda, S | 1 |
| Hijii, T | 1 |
| Yamaguchi, Y | 1 |
| Kusakawa, S | 1 |
| Tatara, K | 1 |
| Iwasa, M | 1 |
| Sugiyama, K | 1 |
| Ando, T | 1 |
| Nomura, H | 1 |
| Katoh, T | 1 |
| Wada, Y | 1 |
| Okazaki, T | 1 |
| Sakatani, T | 1 |
| Sasagawa, S | 1 |
| Ohta, H | 1 |
| Ohnishi, H | 1 |
| Suzuki, K | 1 |
| Somiya, K | 1 |
| Niwa, Y | 1 |
| Fukami, S | 1 |
| Michelson, AM | 1 |
| Usami, H | 1 |
| Neches, WH | 1 |
| Haines, JD | 1 |
| Feild, C | 1 |
| Brady, S | 1 |
| Lowe, B | 1 |
| Musumeci, S | 1 |
| D'Agata, A | 1 |
| Fischer, A | 1 |
| Di Dio, R | 1 |
| Leonardi, S | 1 |
| Klein, AA | 1 |
| Ehlers, KH | 1 |
| Levin, AR | 1 |
| Wiggins, JW | 1 |
| Toews, WH | 1 |
| Wilson, H | 1 |
| Lewis, AB | 1 |
| Daniels, SR | 1 |
| Specker, B | 1 |
| Capannari, TE | 1 |
| Schwartz, DC | 1 |
| Burke, MJ | 1 |
| Kaplan, S | 1 |
| Korkis, JA | 1 |
| Stillwater, LB | 1 |
| Calabro, JJ | 1 |
| Londino, A | 1 |
| Weber, CA | 1 |
| Leclerc, G | 1 |
| Bégin, P | 1 |
| Laramée, P | 1 |
| Genest, P | 1 |
| Rose, V | 1 |
| Lavi, S | 1 |
| Rowe, R | 1 |
| Cheron, G | 1 |
| Billette de Villemeur, T | 1 |
| Lenoir, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Different Doses of IVIG for Kawasaki Disease: a Multicentre, Prospective, Randomised Trial[NCT02439996] | Phase 3 | 404 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| Kawasaki Disease Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan[NCT02951234] | 278 participants (Anticipated) | Interventional | 2016-09-30 | Recruiting | |||
| Infliximab (Remicade®) Plus Intravenous Immunoglobulin (IVIG) for the Primary Treatment of Patients With Acute Kawasaki Disease[NCT00760435] | Phase 3 | 196 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease[NCT02359643] | 300 participants (Anticipated) | Interventional | 2013-05-31 | Enrolling by invitation | |||
| Trial of Pulse Steroid Therapy in Kawasaki Disease (A Trial Conducted by the Pediatric Heart Network)[NCT00132080] | Phase 3 | 199 participants (Actual) | Interventional | 2002-12-31 | Completed | ||
| [NCT00000520] | Phase 2 | 0 participants | Interventional | 1985-07-31 | Completed | ||
| A Randomized Double Blind Placebo Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin (IVIG) in Children With Japanese Encephalitis in Nepal[NCT01856205] | Phase 2 | 22 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
left anterior descending coronary artery Z-score; a Z score is the coronary artery adjusted for body surface area (NCT00760435)
Timeframe: 2 weeks
| Intervention | Z-score (Mean) |
|---|---|
| Infliximab | -0.605 |
| Placebo | -0.313 |
(NCT00760435)
Timeframe: 24 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Infliximab | -6.6 |
| Placebo | -3.6 |
(NCT00760435)
Timeframe: up to 6 weeks
| Intervention | days (Median) |
|---|---|
| Infliximab | 1 |
| Placebo | 2 |
(NCT00760435)
Timeframe: 10 weeks
| Intervention | participants (Number) |
|---|---|
| Infliximab | 11 |
| Placebo | 11 |
107 reviews available for aspirin and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
Topics: Aspirin; Child; Fever; Humans; Immunoglobulins, Intravenous; Infant; Infliximab; Mucocutaneous Lymph | 2022 |
Acute phase of Kawasaki disease: a review of national guideline recommendations.
Topics: Aspirin; Biomarkers; Child; Evidence-Based Medicine; Humans; Immunoglobulins, Intravenous; Mucocutan | 2022 |
Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
Topics: Aspirin; Child, Preschool; Coronary Artery Disease; Humans; Immunoglobulins, Intravenous; Infant; Mu | 2023 |
Intravenous immunoglobulin for the treatment of Kawasaki disease.
Topics: Acute Coronary Syndrome; Aspirin; Child; Fever; Humans; Immunoglobulins, Intravenous; Inflammation; | 2023 |
Neurological involvement, immune response, and biomarkers in Kawasaki disease along with its pathogenesis, therapeutic and diagnostic updates.
Topics: Acute Disease; Aspirin; Biomarkers; Child; Coronary Vessels; Humans; Immunity; Infant; Mucocutaneous | 2023 |
Neurological involvement, immune response, and biomarkers in Kawasaki disease along with its pathogenesis, therapeutic and diagnostic updates.
Topics: Acute Disease; Aspirin; Biomarkers; Child; Coronary Vessels; Humans; Immunity; Infant; Mucocutaneous | 2023 |
Neurological involvement, immune response, and biomarkers in Kawasaki disease along with its pathogenesis, therapeutic and diagnostic updates.
Topics: Acute Disease; Aspirin; Biomarkers; Child; Coronary Vessels; Humans; Immunity; Infant; Mucocutaneous | 2023 |
Neurological involvement, immune response, and biomarkers in Kawasaki disease along with its pathogenesis, therapeutic and diagnostic updates.
Topics: Acute Disease; Aspirin; Biomarkers; Child; Coronary Vessels; Humans; Immunity; Infant; Mucocutaneous | 2023 |
French national diagnostic and care protocol for Kawasaki disease.
Topics: Aspirin; Child; Coronary Aneurysm; Fever; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocu | 2023 |
One year in review: Kawasaki disease.
Topics: Aspirin; Biological Products; Child; Coronary Aneurysm; Early Diagnosis; Fibrinolytic Agents; Humans | 2020 |
Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chest Pain; Chest Tubes; Dr | 2019 |
What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Humans; Mucocutaneous Lymph Node Syndrome | 2020 |
Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Aspirin; Caspase 3; CD40 Antigens; Child; Child, Pr | 2020 |
Kawasaki disease: Shedding light on a mysterious diagnosis.
Topics: Aspirin; Autoimmunity; Child, Preschool; Coronary Aneurysm; Coronary Vessels; Female; Follow-Up Stud | 2020 |
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dip | 2020 |
Low-dose or no aspirin administration in acute-phase Kawasaki disease: a meta-analysis and systematic review.
Topics: Acute-Phase Reaction; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Child; | 2021 |
Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
Topics: Adolescent; Aspirin; C-Reactive Protein; Case-Control Studies; Child; Child, Preschool; Coronary Dis | 2021 |
Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Humans; Immunoglob | 2017 |
Acetylsalicylic acid for children with Kawasaki disease.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Child; Fev | 2017 |
Gallbladder Hydrops Associated With Kawasaki Disease: A Case Report and Literature Review.
Topics: Aspirin; Child; Edema; Follow-Up Studies; Gallbladder Diseases; Humans; Immunoglobulins, Intravenous | 2018 |
What dose of aspirin should be used in the initial treatment of Kawasaki disease?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Coronary Artery Disease; Humans; Mucocutane | 2017 |
Myocarditis and Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Immunoglobulins, Intravenous; Immunologic | 2018 |
Kawasaki Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differential; Drug Therapy, Combination | 2018 |
Kawasaki disease and vasculitis associated with immunization.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Immunoglobulins, Intravenous; Infa | 2018 |
Diagnosis and Management of Kawasaki Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Disease Management; Echocardiography; Human | 2019 |
Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; Dose-Response | 2019 |
An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.
Topics: Aspirin; Biomarkers; Cardiac Catheterization; Echocardiography; Humans; Immunoglobulins, Intravenous | 2013 |
Kawasaki disease: part II. Complications and treatment.
Topics: Adrenal Cortex Hormones; Aspirin; Child; Child, Preschool; Coronary Aneurysm; Coronary Artery Diseas | 2013 |
Retropharyngeal involvement in Kawasaki disease--a report of four patients with retropharyngeal edema verified by magnetic resonance imaging.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Edema; Humans; Immunoglob | 2014 |
Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis.
Topics: Anticoagulants; Aspirin; Child; Coronary Aneurysm; Drug Therapy, Combination; Humans; Mucocutaneous | 2014 |
Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Humans; Immunoglobulins, Intrave | 2014 |
Recurrent Kawasaki disease in a child with retropharyngeal involvement: a case report and literature review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Humans; Immunoglobulins, Intravenous; Male; | 2014 |
Evidence-based management of Kawasaki disease in the emergency department.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Aspirin; Child, Preschool | 2015 |
Management of Kawasaki disease in resource-limited settings.
Topics: Aspirin; Developing Countries; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Mucocutane | 2015 |
Diagnosis and management of kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; Disease Manag | 2015 |
Kawasaki disease: an evolving paradigm.
Topics: Aspirin; Diagnosis, Differential; Fever; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph N | 2015 |
Adult Kawasaki disease in a European patient: a case report and review of the literature.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Erythema; Fever; Humans; | 2015 |
The Complexities of the Diagnosis and Management of Kawasaki Disease.
Topics: Aspirin; Child; Diagnosis, Differential; Disease Management; Fever; Humans; Immunoglobulins, Intrave | 2015 |
Kawasaki disease with pulmonary nodules and coronary artery involvement: a report of two cases and a review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Coronary Angiography; Female; H | 2017 |
Incomplete Kawasaki disease induced by measles in a 6-month-old male infant.
Topics: Aspirin; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Infant; | 2016 |
Kawasaki disease: a comprehensive review of treatment options.
Topics: Aspirin; Coronary Artery Disease; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; In | 2015 |
Kawasaki disease in adults: Observations in France and literature review.
Topics: Adult; Aspirin; Cardiovascular Diseases; France; Humans; Immunoglobulins, Intravenous; Mucocutaneous | 2016 |
Kawasaki Disease.
Topics: Adaptive Immunity; Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Co | 2016 |
Kawasaki disease: etiopathogenesis and novel treatment strategies.
Topics: Animals; Aspirin; Child, Preschool; Drug Resistance; Early Diagnosis; Gene-Environment Interaction; | 2017 |
Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Humans; Immunoglobulins, Intravenous; Mu | 2009 |
A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; | 2012 |
Recent advances in the treatment of Kawasaki disease.
Topics: Adrenal Cortex Hormones; Aspirin; Coronary Artery Disease; Hydroxymethylglutaryl-CoA Reductase Inhib | 2011 |
Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; | 2012 |
Can Kawasaki disease be managed?
Topics: Antipyretics; Aspirin; Child, Preschool; Humans; Immunoglobulins, Intravenous; Immunologic Factors; | 2012 |
[Kawasaki disease: what you need to know].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; | 2012 |
Management of acute and refractory Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Der | 2012 |
Advances in the treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; Child; Drug Therapy, Combi | 2013 |
Incomplete (atypical) Kawasaki disease.
Topics: Adenovirus Infections, Human; Aspirin; Child; Diagnosis, Differential; Fever; Humans; Immunoglobulin | 2002 |
Controversies in the management of Kawasaki disease.
Topics: Aspirin; Child; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Heart Transpla | 2002 |
Update on the treatment of Kawasaki disease in childhood.
Topics: Abciximab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Aspirin; Child; Humans; Immunoglobulin | 2002 |
Hemophagocytic syndrome after Kawasaki disease.
Topics: Aspirin; Child; Drug Therapy, Combination; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immun | 2003 |
Refractory Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Cyclosporine; Drug Therapy, Combination; Fever; Humans; Immunoglo | 2004 |
Recent developments and controversies in Kawasaki disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Progression; Dru | 2004 |
Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; C | 2004 |
The diagnosis and management of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Female; Humans; Immunoglobulins, | 2005 |
Kawasaki disease: what is the epidemiology telling us about the etiology?
Topics: Air Pollutants; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Infections; Child; Commu | 2005 |
Adult Kawasaki disease: report of two cases and literature review.
Topics: Adult; Age of Onset; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; | 2005 |
[Kawasaki disease (Kawasaki syndrome)].
Topics: Aspirin; Bacterial Proteins; Bacterial Toxins; Capillary Permeability; Chemokine CCL2; Cytokines; En | 2005 |
Current perspectives on Kawasaki disease.
Topics: Aspirin; Atherosclerosis; Coronary Aneurysm; Coronary Stenosis; Coronary Thrombosis; Female; Humans; | 2005 |
Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Coronary Aneurysm; | 2005 |
Kawasaki disease.
Topics: Aspirin; Cardiovascular Diseases; Child, Preschool; Glucocorticoids; Humans; Immunoglobulins, Intrav | 2006 |
Acute Kawasaki disease: not just for kids.
Topics: Acute Disease; Adult; Aspirin; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymph Node | 2007 |
[Myocardial infarction in infants and children].
Topics: Adolescent; Aspirin; Child; Child, Preschool; Coronary Artery Bypass; gamma-Globulins; Humans; Infan | 2007 |
[Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Thrombosis; Humans; Infant; Mucocutaneous Lym | 2008 |
Kawasaki disease: an overview.
Topics: Aspirin; Child, Preschool; Heart Diseases; Humans; Immunoglobulins, Intravenous; Infant; Mucocutaneo | 2008 |
Cardiovascular involvement in Kawasaki syndrome.
Topics: Adrenal Cortex Hormones; Age Factors; Arrhythmias, Cardiac; Arteritis; Aspirin; Cardiovascular Disea | 1983 |
[Kawasaki syndrome. Apropos of a case].
Topics: Aspirin; Cardiovascular Diseases; Child; Coronary Vessels; Diagnosis, Differential; Fever; Humans; I | 1984 |
Kawasaki disease in Nebraska: a review of the literature.
Topics: Adrenal Cortex Hormones; Aneurysm; Anticoagulants; Aspirin; Blood Sedimentation; Child; Child, Presc | 1983 |
[Mucocutaneous lymph node syndrome or Kawasaki disease].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aspirin; Child; Child, Preschool; Female; Heart Dise | 1981 |
Kawasaki syndrome (the mucocutaneous lymph node syndrome).
Topics: Adrenal Cortex Hormones; Arthritis; Aspirin; Child; Child, Preschool; Female; Fever; Hawaii; Heart D | 1982 |
The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
Topics: Aspirin; Child; Coronary Aneurysm; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Sy | 1995 |
Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Follow-Up Studies; Humans; Immun | 1995 |
Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Disease; Diagnos | 1995 |
[Kawasaki disease].
Topics: Age Factors; Aspirin; Child; Child, Preschool; Female; gamma-Globulins; Humans; Infant; Japan; Male; | 1993 |
Kawasaki disease in Adelaide: a review.
Topics: Adolescent; Anti-Bacterial Agents; Aspirin; Cardiovascular Diseases; Child; Child, Preschool; Female | 1993 |
Kawasaki syndrome.
Topics: Aspirin; Follow-Up Studies; Humans; Immunotherapy; Mucocutaneous Lymph Node Syndrome | 1995 |
The immunologic effects of IVIG in Kawasaki disease.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Child; Child, Prescho | 1989 |
[Kawasaki disease].
Topics: Aspirin; Child; Child, Preschool; Heart Diseases; Heart Function Tests; Humans; Immunotherapy; Infan | 1996 |
Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Coronary Disease; Female; Humans; Immunoglobulins, Intravenous; In | 1997 |
Peritonsillar abscess--an unusual presentation of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Combined Modality Therapy; Groin; Humans; I | 1997 |
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Vessel Anomalies; Drug Therapy, Combinati | 1997 |
Kawasaki disease. The mystery continues.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Female; Humans; Immunoglo | 1998 |
Kawasaki disease thirty years on.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Glucocorticoids; Humans; Immunoglobulins, I | 1998 |
Controversies in Kawasaki syndrome.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Corona | 1997 |
Kawasaki syndrome.
Topics: Aspirin; Cardiovascular System; Child, Preschool; Diagnosis, Differential; Fever; Humans; Immunoglob | 1998 |
Overview of pharmacological treatment of Kawasaki disease.
Topics: Adrenal Cortex Hormones; Aspirin; Clinical Trials as Topic; gamma-Globulins; Heart Transplantation; | 1999 |
The many faces of Kawasaki syndrome.
Topics: Acute Disease; Aftercare; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; | 2000 |
Pediatric autoimmune cardiovascular disease.
Topics: Adolescent; Antibodies, Antinuclear; Aspirin; Autoimmune Diseases; Child; Child, Preschool; Coronary | 2000 |
Long-term cardiac sequelae of Kawasaki disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiac Catheterization; Child; Child, Pres | 2000 |
Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Disease; Female; Humans | 2001 |
Pharmacological therapy for patients with Kawasaki disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Aspirin; Child, Preschool; Fibrinolytic Agents; Humans; Immu | 2001 |
Kawasaki disease: an update.
Topics: Age Distribution; Aspirin; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration S | 2002 |
[Kawasaki syndrome].
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Female; gamma-Globulins; Heart Diseases; Humans; Infan | 1990 |
[Kawasaki disease].
Topics: Aspirin; Child; gamma-Globulins; Humans; Mucocutaneous Lymph Node Syndrome | 1990 |
Kawasaki syndrome.
Topics: Aspirin; Child; Child, Preschool; Coronary Disease; Drug Therapy, Combination; Female; gamma-Globuli | 1991 |
Kawasaki disease. Epidemiology, late prognosis, and therapy.
Topics: Aspirin; Coronary Disease; Humans; Immunization, Passive; Mucocutaneous Lymph Node Syndrome; Prognos | 1991 |
Kawasaki disease: recent advances.
Topics: Aspirin; Child, Preschool; Coronary Thrombosis; Humans; Immunization, Passive; Infant; Mucocutaneous | 1991 |
Current therapy for acute Kawasaki syndrome.
Topics: Aspirin; Child; Child, Preschool; Humans; Immunization, Passive; Mucocutaneous Lymph Node Syndrome | 1991 |
Treatment of Kawasaki disease.
Topics: Antithrombins; Aspirin; Child, Preschool; Combined Modality Therapy; Humans; Immunization, Passive; | 1990 |
[Kawasaki syndrome].
Topics: Aspirin; Cardiovascular Diseases; Humans; Immunization, Passive; Mucocutaneous Lymph Node Syndrome; | 1989 |
Clinical and immunologic aspects of Kawasaki disease.
Topics: Aspirin; Child, Preschool; Coronary Disease; Endothelium, Vascular; Humans; Immune System; Immunizat | 1989 |
Kawasaki disease: clinical perspective.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aspirin; Child; Child, Preschool; Convalescence; Huma | 1987 |
Salicylates in Kawasaki disease--a review of clinical pharmacokinetics and efficacy.
Topics: Aspirin; Biological Availability; Blood Proteins; Child; Child, Preschool; Clinical Trials as Topic; | 1987 |
Facial palsy in Kawasaki disease. Report of two cases and a review.
Topics: Aspirin; Edema; Facial Paralysis; Female; Humans; Infant; Mucocutaneous Lymph Node Syndrome | 1987 |
Kawasaki disease--a continuing puzzle.
Topics: Adrenal Cortex Hormones; Angiocardiography; Aspirin; Echocardiography; Humans; Immunization, Passive | 1986 |
38 trials available for aspirin and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA pr
Topics: Adolescent; Adrenal Cortex Hormones; Aneurysm; Aspirin; Child; Child, Preschool; Coronary Vessels; H | 2023 |
Comparative effectiveness of two intravenous immunoglobulin products in children with Kawasaki disease, a nationwide cohort study.
Topics: Aspirin; Child; Cohort Studies; Heart Diseases; Humans; Immunoglobulins, Intravenous; Infant; Mucocu | 2023 |
[Clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease complicated by small/medium-sized coronary artery aneurysms].
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Vessels; Fibrinolytic Agents; Humans; Mucoc | 2019 |
Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease.
Topics: Aspirin; Fever; Humans; Immunoglobulins, Intravenous; Infant; Mucocutaneous Lymph Node Syndrome | 2021 |
Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antipyretics; Aspirin; Drug Admi | 2018 |
Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cell-Derived Microparticles; Chil | 2014 |
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; | 2014 |
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial).
Topics: Aspirin; Calcineurin Inhibitors; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; | 2015 |
Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Humans; Immunoglobulins, Intrav | 2009 |
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
Topics: Anti-Inflammatory Agents; Aspirin; Child, Preschool; Coronary Artery Disease; Coronary Vessel Anomal | 2012 |
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Artery Disease; | 2007 |
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Artery Disease; | 2007 |
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Artery Disease; | 2007 |
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Artery Disease; | 2007 |
Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease.
Topics: Angiogenesis Inhibitors; Anticoagulants; Aspirin; Cell Proliferation; Cells, Cultured; Child; Child, | 2007 |
[Reducing plasma homocysteic acid lowers serum C-reactive protein level in children with Kawasaki disease].
Topics: Aspirin; C-Reactive Protein; Child; Child, Preschool; Female; Folic Acid; Homocysteine; Humans; Immu | 2007 |
High-dose intravenous gammaglobulin for Kawasaki disease.
Topics: Acute Disease; Administration, Oral; Aspirin; Child, Preschool; Clinical Trials as Topic; Coronary D | 1984 |
Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.
Topics: Acute Disease; Aspirin; Biopsy; Cardiomyopathies; Child; Child, Preschool; Coronary Aneurysm; Corona | 1993 |
Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease.
Topics: Aspirin; Chi-Square Distribution; Child, Preschool; Drug Administration Schedule; Drug Therapy, Comb | 1995 |
Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Drug Therapy, Combination; Fe | 1994 |
Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
Topics: Aspirin; Chi-Square Distribution; Coronary Vessel Anomalies; Drug Therapy, Combination; Echocardiogr | 1993 |
[Clinical manifestations and effects of IVGG in patients with Kawasaki disease].
Topics: Aspirin; Child; Child, Preschool; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocu | 1996 |
Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Coronary Disease; Cost-Benefit | 1999 |
Effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease.
Topics: Apoptosis; Aspirin; Child; Child, Preschool; DNA Fragmentation; Female; Humans; Immunoglobulins, Int | 2001 |
Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.
Topics: Aged; Aspirin; Blood Cell Count; Child, Preschool; Female; gamma-Globulins; Humans; Immunization, Pa | 1990 |
New hope for children with Kawasaki disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; gamma-Globulins; Humans; Infant; Mucocutaneous Lymph N | 1991 |
Intravenous gamma-globulin for Kawasaki disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Dilatation, Pathologic; Echocardiography; Female; Foll | 1991 |
Intravenous gamma-globulin treatment in Kawasaki disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Dilatation, Pathologic; Dose-Response Relationship, Dr | 1991 |
A study on the optimal dose of aspirin therapy in Kawasaki disease--clinical evaluation and arachidonic acid metabolism.
Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Chi-Square Distribution; Child, Preschool; Female; Hum | 1990 |
Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Echocardiography; Female; Humans; Immunoglobuli | 1990 |
The treatment of Kawasaki syndrome with intravenous gamma globulin.
Topics: Aneurysm; Aspirin; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Echocardio | 1986 |
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.
Topics: Antibodies, Monoclonal; Aspirin; Child, Preschool; Clinical Trials as Topic; Female; gamma-Globulins | 1987 |
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.
Topics: Antibodies, Monoclonal; Aspirin; Child, Preschool; Clinical Trials as Topic; Female; gamma-Globulins | 1987 |
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.
Topics: Antibodies, Monoclonal; Aspirin; Child, Preschool; Clinical Trials as Topic; Female; gamma-Globulins | 1987 |
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.
Topics: Antibodies, Monoclonal; Aspirin; Child, Preschool; Clinical Trials as Topic; Female; gamma-Globulins | 1987 |
High-dose gammaglobulin therapy for Kawasaki disease.
Topics: Aspirin; Child, Preschool; Clinical Trials as Topic; Coronary Disease; Female; gamma-Globulins; Huma | 1987 |
Kawasaki disease: management guidelines.
Topics: Aspirin; Child; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; gamma-Globulins; Humans | 1988 |
Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary report.
Topics: Acute Disease; Adolescent; Aspirin; Child; Child, Preschool; Clinical Trials as Topic; Coronary Dise | 1989 |
Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin.
Topics: Aspirin; Child; Echocardiography; Female; Follow-Up Studies; Humans; Immunization, Passive; Male; Mu | 1989 |
Salicylates in Kawasaki disease--a review of clinical pharmacokinetics and efficacy.
Topics: Aspirin; Biological Availability; Blood Proteins; Child; Child, Preschool; Clinical Trials as Topic; | 1987 |
Japanese gamma globulin trials for Kawasaki disease.
Topics: Aspirin; Child, Preschool; Clinical Trials as Topic; Coronary Disease; Echocardiography; Female; Hum | 1987 |
Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
Topics: Aspirin; Child, Preschool; Clinical Trials as Topic; Coronary Disease; Female; Humans; Immunization, | 1987 |
U.S. gamma globulin trial.
Topics: Aspirin; Child; Child, Preschool; Clinical Trials as Topic; Coronary Disease; Humans; Immunization, | 1987 |
Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease.
Topics: Aspirin; Child; Clinical Trials as Topic; Coronary Disease; Humans; Immunization, Passive; Japan; Mu | 1987 |
377 other studies available for aspirin and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; Female; Human | 2022 |
[Myocardial Infarction and resuscitation of an adolescent: consequences of an unexplained disease].
Topics: Adolescent; Aspirin; Coronary Aneurysm; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Ly | 2021 |
Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
Topics: Aspirin; Blepharoptosis; Child; Child, Preschool; Humans; Immunoglobulins, Intravenous; Male; Mucocu | 2021 |
Nontypical presentation of a common disease: a case report.
Topics: Aspirin; Child; Child, Preschool; Echocardiography; Female; Fever; Humans; Immunoglobulins, Intraven | 2022 |
[Pediatric expert consensus on the application of aspirin in Kawasaki disease].
Topics: Aspirin; Child; Consensus; Coronary Vessels; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lym | 2022 |
Epidemiology of Kawasaki Disease in children in Switzerland: a national prospective cohort study.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Female; Fever; Humans; Immunoglobulins, Intravenous; I | 2022 |
Association of steroid administration with larger coronary artery abnormalities in patients with Kawasaki disease.
Topics: Aspirin; Child, Preschool; Coronary Artery Disease; Humans; Immunoglobulins, Intravenous; Infant; Ma | 2023 |
What Is the Role of Corticosteroids for the Treatment of Kawasaki Disease in Children?
Topics: Adrenal Cortex Hormones; Aspirin; Child; Humans; Infant; Mucocutaneous Lymph Node Syndrome | 2023 |
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; H | 2022 |
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; H | 2022 |
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; H | 2022 |
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; H | 2022 |
Reassuring short-term effect of corticosteroids for Kawasaki disease.
Topics: Adrenal Cortex Hormones; Aspirin; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syn | 2023 |
Reassuring short-term effect of corticosteroids for Kawasaki disease.
Topics: Adrenal Cortex Hormones; Aspirin; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syn | 2023 |
Reassuring short-term effect of corticosteroids for Kawasaki disease.
Topics: Adrenal Cortex Hormones; Aspirin; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syn | 2023 |
Reassuring short-term effect of corticosteroids for Kawasaki disease.
Topics: Adrenal Cortex Hormones; Aspirin; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syn | 2023 |
Kawasaki Disease with Hepatobiliary Manifestations.
Topics: Aspirin; Diagnosis, Differential; Humans; Immunoglobulins, Intravenous; Infant; Malaysia; Mucocutane | 2022 |
Atypical Kawasaki disease presenting with macroscopic hematuria in an infant: a case report.
Topics: Aspirin; Child; Child, Preschool; Fever; Hematuria; Humans; Immunoglobulins, Intravenous; India; Inf | 2023 |
Corticosteroids for the Treatment of Kawasaki Disease in Children.
Topics: Adrenal Cortex Hormones; Aspirin; Child; Humans; Immunoglobulins, Intravenous; Infant; Mucocutaneous | 2023 |
Two cases of Kawasaki disease: Clinical characteristics and onset of fever and gastrointestinal symptoms.
Topics: Aspirin; Child; Exanthema; Female; Fever; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; P | 2023 |
Immunoglobulin-resistant Kawasaki disease.
Topics: Aspirin; Child, Preschool; Etanercept; Female; Fever; Humans; Immunoglobulins, Intravenous; Mucocuta | 2023 |
The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury.
Topics: Alanine Transaminase; Aspirin; Child; Clopidogrel; Drug Therapy, Combination; Humans; Mucocutaneous | 2023 |
A case of multisystem inflammatory syndrome in children: A case report.
Topics: Aspirin; Child; Child, Preschool; Connective Tissue Diseases; COVID-19; Female; Humans; Mucocutaneou | 2023 |
Twenty-year-old woman presenting with typical Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Delayed Diagnosis; Female; Humans; Immunog | 2019 |
Kawasaki disease in infants less than one year of age: an Italian cohort from a single center.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Conjunctivitis; Delayed Diagnosis; | 2019 |
Kawasaki Disease: Beyond IVIG and Aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Immunoglobulins, Intravenous; Immu | 2019 |
Kawasaki disease: origins and evolution.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Autopsy; Coronary Aneurysm; History, 20th Century; | 2021 |
An Uncommon Complication of a Common Disease: Pneumatosis Intestinalis in an Infant with Kawasaki Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colon; Conservative Treatment; Coronary Vessels; E | 2019 |
Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.
Topics: Aspartate Aminotransferases; Aspirin; Biomarkers; C-Reactive Protein; Child; Child, Preschool; Femal | 2020 |
Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey.
Topics: Aspirin; Child; Coronary Aneurysm; Humans; Mucocutaneous Lymph Node Syndrome; Thrombosis | 2020 |
Acute gastrointestinal hemorrhage in Kawasaki disease occurring before aspirin therapy.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Diagnosis, Differential; Gas | 2019 |
Kawasaki at the Extremes of Age: Thinking Outside the Box.
Topics: Administration, Intravenous; Adolescent; Aneurysm; Anti-Inflammatory Agents, Non-Steroidal; Arthralg | 2019 |
Coronary artery aneurysm in Kawasaki disease: from multimodality imaging.
Topics: Anticoagulants; Aspirin; Computed Tomography Angiography; Coronary Aneurysm; Coronary Angiography; C | 2020 |
Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Arte | 2020 |
Kawasaki Disease Presenting as Hydrops of the Gallbladder.
Topics: Aspirin; Diagnosis, Differential; Diagnostic Imaging; Edema; Female; Gallbladder Diseases; Humans; I | 2020 |
A 3 Year Old With Fever and Rash: An Atypical Cause of Shock.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Diagnosis, Differential; Exanthe | 2020 |
Severe Late-Onset Kawasaki Disease Successfully Treated With Anakinra.
Topics: Adolescent; Age of Onset; Anticoagulants; Antirheumatic Agents; Aspirin; Computed Tomography Angiogr | 2020 |
A case of rectal ulcers during aspirin therapy in acute Kawasaki disease.
Topics: Aspirin; Child, Preschool; Colitis; Gastrointestinal Hemorrhage; Humans; Male; Mucocutaneous Lymph N | 2020 |
Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.
Topics: Aspirin; Child, Preschool; Coronavirus Infections; COVID-19; Diagnosis, Differential; Humans; Immuno | 2020 |
Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease.
Topics: Aspirin; Blood Pressure; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Lab-On-A-C | 2020 |
A case of Kawasaki disease complicated by acute disseminated encephalitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Encephalomyelitis, Acute Dissemi | 2020 |
A Case of Kawasaki Disease with Intussusception.
Topics: Age Factors; Aspirin; Child, Preschool; Colon; Colonic Diseases; Humans; Immunoglobulins, Intravenou | 2021 |
Color Changes in the Fingers and Toes of an Infant.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Color; Diagnosis, Differential; Echocardiography; | 2020 |
High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more.
Topics: Adolescent; Aged; Aspirin; Child; Fever; Humans; Immunoglobulins, Intravenous; Infant; Japan; Mucocu | 2020 |
Acute cholestasis as uncommon onset of Kawasaki disease: a case report.
Topics: Adult; Aspirin; Child; Child, Preschool; Cholestasis; Edema; Fever; Humans; Male; Mucocutaneous Lymp | 2020 |
A Real Pain in the Neck.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atlanto-Axial Joint; Cellulitis; Cervical Vertebra | 2021 |
Strengthening the case for primary adjunctive corticosteroids for Kawasaki disease.
Topics: Adrenal Cortex Hormones; Aspirin; Coronary Aneurysm; Global Burden of Disease; Humans; Immunoglobuli | 2021 |
Use of premedication with intravenous immune globulin in Kawasaki disease: A retrospective review.
Topics: Aspirin; Child; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome; Premedicati | 2021 |
Peripheral follicular cytotoxic T -like cells in Kawasaki disease with coronary artery aneurysms: A case report.
Topics: Administration, Oral; Aspirin; Child, Preschool; Coronary Aneurysm; Diagnosis, Differential; Fever; | 2020 |
Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Coronary Aneurysm; Female; Guideline Adherence; Humans; | 2021 |
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
Topics: Age Distribution; Antirheumatic Agents; Aspirin; C-Reactive Protein; Child; Child, Preschool; Corona | 2021 |
Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study.
Topics: Aspirin; Biomarkers; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Fe | 2021 |
Kawasaki disease presenting after intussusception: a case report.
Topics: Aspirin; Child, Preschool; Fever; Humans; Immunoglobulins, Intravenous; Infant; Intussusception; Mal | 2021 |
Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: A case report.
Topics: Adenovirus Infections, Human; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Co | 2017 |
Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease.
Topics: Aspirin; Child, Preschool; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combina | 2017 |
The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.
Topics: Aspirin; Biomarkers; Blood Platelets; Cell-Derived Microparticles; Child, Preschool; Enzyme-Linked I | 2017 |
A case of Kawasaki disease presenting as sigmoid colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Colitis; Colon, Sigmoid; Colonos | 2018 |
Acute Complete Adult-onset Kawasaki Disease in a Middle-Aged Woman.
Topics: Age of Onset; Aspirin; Female; Humans; Immunoglobulins, Intravenous; Middle Aged; Mucocutaneous Lymp | 2017 |
Clinical Manifestations of Kawasaki Disease Shock Syndrome.
Topics: Adolescent; Albumins; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Child; | 2018 |
Complete Kawasaki disease (KD) with peculiar skin manifestations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cheilitis; Conjunctival Diseases; Edema; Female; F | 2017 |
Is aspirin necessary in the acute phase of Kawasaki disease?
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; China; Female; Humans; M | 2018 |
Aspirin Dose in Kawasaki Disease: The Ongoing Battle.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Canada; Child, Preschool; Coronary Aneurysm; Drug | 2018 |
Acute Kidney Injury in Kawasaki Disease: Report of 3 Cases From North India and a Brief Review of Literature.
Topics: Acute Kidney Injury; Aspirin; Child; Child, Preschool; Coronary Vessels; Diagnosis, Differential; Ec | 2018 |
Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Topics: Adolescent; Anticoagulants; Antipyretics; Aspirin; Child; Child, Preschool; China; Coronary Aneurysm | 2018 |
[Transient detection of lupus anticoagulant in acute phase of Kawasaki disease].
Topics: Acute-Phase Reaction; Aspirin; Child, Preschool; Humans; Immunoglobulins, Intravenous; Lupus Coagula | 2017 |
Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Coronary Artery Disease; Coronary Vessels; Drug | 2018 |
Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Coron | 2018 |
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease.
Topics: Aspirin; Blood Platelets; CD40 Ligand; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; F | 2018 |
Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report.
Topics: Aspirin; Capillary Leak Syndrome; Dipyridamole; Diuretics; Furosemide; Glucocorticoids; Humans; Immu | 2018 |
Kawasaki Disease - A Review of Treatment and Outcomes in an Irish Paediatric Cohort 2010-14.
Topics: Adrenal Cortex Hormones; Aspirin; Child; Cohort Studies; Coronary Disease; Humans; Immunoglobulins, | 2018 |
Acute myocarditis as a revealing clue of complete Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Dipyridamole; Drug Substitution; Female; Humans; Immunoglo | 2018 |
A Masquerader of Disease: An Incomplete Presentation of Kawasaki Disease.
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Echocardiography; Female; Humans; Imm | 2018 |
Acute peritonsillar swelling: a unique presentation for Kawasaki disease in adolescence.
Topics: Adolescent; Airway Obstruction; Aspirin; Diagnosis, Differential; Drug Therapy, Combination; Edema; | 2018 |
Plaque psoriasis following Kawasaki disease and varicella.
Topics: Aspirin; Chickenpox; Humans; Immunoglobulins, Intravenous; Infant; Male; Mometasone Furoate; Mucocut | 2018 |
Melatonin: A hypothesis for Kawasaki disease treatment.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Child, Preschool; Communicable Diseases; Genetic Predispos | 2018 |
Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
Topics: Aspirin; Biomarkers; Blood Platelets; Blood Sedimentation; C-Reactive Protein; Cell-Derived Micropar | 2019 |
Kawasaki Disease: A Condition of Many Guises.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Vessels; Diagnosis, Differential; Echocar | 2018 |
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Topics: Aspirin; Child, Preschool; Drug Therapy, Combination; Female; Fever; Glucocorticoids; Humans; Immuno | 2018 |
IgG levels in Kawasaki disease and its association with clinical outcomes.
Topics: Aspirin; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunoglobulin G; Immunoglobulins, I | 2019 |
Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Female; Humans; Immunoglobulins, | 2018 |
Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease: A preliminary, single-center, case-control study.
Topics: Administration, Oral; Adolescent; Aspirin; Biomarkers; Case-Control Studies; Child; Drug Resistance; | 2018 |
Kawasaki disease-related arthritis with synovial involvement.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Aspirin; Child, Preschool; | 2019 |
Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report.
Topics: Aspirin; Coronary Aneurysm; Facial Paralysis; Female; Humans; Immunoglobulins, Intravenous; Infant; | 2019 |
Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.
Topics: Aftercare; Aspirin; Blood Sedimentation; C-Reactive Protein; Child; Child, Preschool; Conjunctivitis | 2019 |
Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin.
Topics: Acute Disease; ADAMTS13 Protein; Aspirin; Case-Control Studies; Child; Child, Preschool; Female; Hum | 2019 |
A case of Kawasaki disease presenting with parotitis: A case report and literature review.
Topics: Aspirin; Child; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymph Node Syndrome; Parot | 2019 |
Psychiatric adverse reaction to non-steroidal anti-inflammatory drugs in a child.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Drug Therapy, Combination; Femal | 2019 |
Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study.
Topics: Aspirin; Biomarkers; Case-Control Studies; Child; Child, Preschool; Coronary Artery Disease; Coronar | 2020 |
[The role of immunosuppressive agents in Kawasaki disease: a discussion of two cases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aortic Aneurysm, Abdominal; Aspirin; Child, Preschool; Coro | 2013 |
Kawasaki shock syndrome presenting as toxic shock syndrome.
Topics: Adolescent; Aspirin; Comorbidity; Coronary Aneurysm; Diagnosis, Differential; Echocardiography; Fema | 2013 |
Developments in large and midsize vasculitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Child; Coronary Angiography; Humans; Hyp | 2013 |
Appendicitis as the presenting manifestation of Kawasaki disease.
Topics: Acute Disease; Anti-Inflammatory Agents; Appendicitis; Aspirin; Child; Child, Preschool; Coronary Ve | 2014 |
Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement.
Topics: Adolescent; Anticoagulants; Aspirin; Coronary Aneurysm; Drug Resistance; Humans; Immunoglobulins, In | 2013 |
[Six Kawasaki disease patients with acute coronary artery thrombosis].
Topics: Acute Disease; Anticoagulants; Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Thrombosis; Ec | 2013 |
[A case of neonatal incomplete Kawasaki disease complicated with aseptic meningitis].
Topics: Aspirin; Female; Fever; Humans; Infant; Mannitol; Meningitis, Aseptic; Mucocutaneous Lymph Node Synd | 2014 |
Comparison of high-dose versus low-dose aspirin in the management of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Female; Humans; Immunoglobulins, Intravenou | 2014 |
A 12-week-old male with a 10-day history of fever.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Aspirin; Coronary Vessels; Diagnosi | 2014 |
Multiple giant succular and fusiform right and left coronary artery aneurysms after early and adequate treatment of atypical kawasaki disease with unusual presentation.
Topics: Aspirin; Child; Coronary Aneurysm; Coronary Angiography; Early Diagnosis; Female; Humans; Immunoglob | 2014 |
Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Drug Interact | 2015 |
Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?
Topics: Anticoagulants; Aspirin; Coronary Aneurysm; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggr | 2014 |
Kawasaki shock syndrome complicating a recurrence of Kawasaki disease.
Topics: Aspirin; Child; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug | 2014 |
Myocardial infarction associated with Kawasaki disease in adult man: case report and review of literature.
Topics: Adolescent; Anti-Inflammatory Agents; Aspirin; Coronary Aneurysm; Drug-Eluting Stents; Echocardiogra | 2015 |
[Aspirin treatment for patients with Kawasaki disease].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Inflammation; Mucocutaneous | 2014 |
[Thromboprophylaxis in patients with coronary aneurysms caused by Kawasaki disease].
Topics: Aspirin; Coronary Aneurysm; Coronary Thrombosis; Humans; Mucocutaneous Lymph Node Syndrome; Platelet | 2014 |
Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Comorbidity; Coronary Ane | 2015 |
Comment on the paper by Su et al. entitled 'safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to kawasaki disease: a meta-analysis'.
Topics: Anticoagulants; Aspirin; Coronary Aneurysm; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggr | 2015 |
Author's Reply.
Topics: Anticoagulants; Aspirin; Coronary Aneurysm; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggr | 2015 |
Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
Topics: Aspirin; beta-Thromboglobulin; Blood Platelets; Child, Preschool; Coronary Vessels; Drug Resistance; | 2015 |
A Case of Fever of Unknown Origin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Aspirin; Diagnosis, Differential; Fema | 2015 |
Uncovering a Unique Cause of Parotitis in an Adolescent.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differential; Echoc | 2016 |
Kawasaki Disease Shock Syndrome (KDSS)--Presentation of 3 Children and Review of the Literature.
Topics: Adrenal Cortex Hormones; Aspirin; Child; Combined Modality Therapy; Female; Follow-Up Studies; Human | 2015 |
Giant right coronary artery aneurysm secondary to Kawasaki disease in child: a case report.
Topics: Aspirin; Child; Coronary Aneurysm; Coronary Angiography; Fibrinolytic Agents; gamma-Globulins; Human | 2015 |
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Topics: Anemia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Child; Child, Preschoo | 2015 |
Kawasaki disease in a healthcare provider: an adult case in a paediatric resident.
Topics: Adult; Aspirin; Echocardiography; Fever; Humans; Male; Mexico; Mucocutaneous Lymph Node Syndrome; Ph | 2016 |
Haemolytic uraemic syndrome with peripheral gangrene and Kawasaki disease in a 15-month-old child.
Topics: Abscess; Anti-Inflammatory Agents; Aspirin; Buttocks; Gangrene; Hemolytic-Uremic Syndrome; Humans; I | 2017 |
[Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].
Topics: Aspirin; Child; Child, Preschool; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Dise | 2015 |
Kawasaki disease in infants below 6 months: a clinical conundrum?
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Delayed Diagnosis; Female; Humans; Im | 2016 |
Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; BCG Vaccine; Cicatrix; Erythema; Fever; Humans; Im | 2016 |
Recurrent Kawasaki Disease: Mind the Age, But It Does Not Matter.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Immunoglobulins, Intravenous; Male; Mucocu | 2016 |
Three episodes of Kawasaki disease including one after the Pneumo 23 vaccine in a child with a family history of Kawasaki disease.
Topics: Aspirin; Child, Preschool; Family Health; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous | 2016 |
Giant Coronary Aneurysms in a one-month-old Infant with Kawasaki Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Humans; Infant; Mucocutaneous L | 2017 |
Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm | 2017 |
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Glucocorticoids; Humans; Immunoglobulins, Intraven | 2017 |
Dengue Fever Triggering Kawasaki Disease.
Topics: Aspirin; Child, Preschool; Dengue; Female; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph | 2017 |
Infantile Kawasaki disease presenting as acute meningoencephalitis.
Topics: Acute Disease; Aspirin; Diagnosis, Differential; Female; Humans; Immunoglobulins, Intravenous; Immun | 2017 |
Late-appearing brachiocephalic aneurysm: an atypical vascular sequella of Kawasaki disease.
Topics: Acute Disease; Aneurysm; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Aspirin; B | 2009 |
Kawasaki disease.
Topics: Algorithms; Aspirin; Child, Preschool; Cross-Sectional Studies; Death, Sudden, Cardiac; Diagnosis, D | 2008 |
Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Drug Hypersensitivity; Eosinophi | 2009 |
Retropharyngeal edema: an unusual manifestation of Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Child, Preschool; Edema; Humans; Immunoglobulins, Intravenous; Im | 2010 |
Incomplete Kawaski disease: are we missing it?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Immunoglobulins, Intravenous; Immu | 2009 |
Age no barrier to diagnosis.
Topics: Adolescent; Age Factors; Aspirin; Diagnosis, Differential; Exanthema; Fever of Unknown Origin; Human | 2009 |
Atypical Kawasaki disease with remarkable paucity of signs and symptoms.
Topics: Aspirin; Coronary Aneurysm; Coronary Vessels; Diagnosis, Differential; Echocardiography; Fever; Foll | 2009 |
Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.
Topics: Administration, Oral; Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Coronary Aneurys | 2009 |
[Kawasaki disease in infants younger than six month of age: report of four cases].
Topics: Aspirin; Diagnosis, Differential; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocu | 2009 |
Recurrent Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differential; Humans; Immunoglobulins, | 2009 |
[Is it advisable to avoid ibuprofen in Kawasaki disease?].
Topics: Analgesics, Non-Narcotic; Aspirin; Child; Contraindications; Humans; Ibuprofen; Mucocutaneous Lymph | 2009 |
An 11-month-old girl with high fever. Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differential; Drug Therapy, Combination | 2009 |
Incomplete (atypical) Kawasaki disease in a young infant with remarkable paucity of signs.
Topics: Aneurysm; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Coronary Artery Disease; Cor | 2010 |
Bilateral facial nerve palsy in Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Facial Nerve Diseases; Facial Paralysis; Humans; Immunoglo | 2009 |
Acute myocardial infarction as the first manifestation of the incomplete Kawasaki disease in a young male.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Biomarkers; Captopril; Child; Coronary Angiograph | 2009 |
Facial palsy in a 2-month-old infant with Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Vessels; Echocardiography; Facial Paralys | 2010 |
Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
Topics: Age Distribution; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Dose-Re | 2010 |
Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome.
Topics: Aspirin; Child; Child, Preschool; Cohort Studies; Comorbidity; Coronary Artery Disease; Drug Resista | 2010 |
Facial palsy in a 2-month-old infant with Kawasaki disease.
Topics: Alanine Transaminase; Antipyretics; Aspirin; Facial Paralysis; Fever; Humans; Immunoglobulins, Intra | 2011 |
Axillary cellulitis as a manifestation of Kawasaki disease.
Topics: Aspirin; Axilla; C-Reactive Protein; Cellulitis; Child, Preschool; Conjunctivitis; Coronary Artery D | 2010 |
Kawasaki disease presenting with intussusception: a case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Dose-Response Relationship, Drug | 2010 |
An elevated value on drug-induced lymphocyte stimulation test for immunoglobulin is an immunological abnormality of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Immunoglobulins; Immunoglobulins, Intraven | 2010 |
Transverse orange-brown chromonychia in Kawasaki disease.
Topics: Aspirin; Child, Preschool; Drug Therapy, Combination; Female; Fingers; Follow-Up Studies; Humans; Im | 2010 |
Macrophage activation syndrome in the acute phase of Kawasaki disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin | 2010 |
Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Child; Child, Preschool; Coronary Vessels; Drug Therapy, | 2010 |
Linear immunoglobulin A bullous dermatosis associated with herpes simplex virus infection and Kawasaki disease.
Topics: Acyclovir; Aspirin; Basement Membrane; Dapsone; Glycoproteins; Herpes Simplex; Humans; Immunization, | 2010 |
[Kawasaki disease and Mycoplasma pneumoniae infection].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary | 2010 |
Mid-term outcome of patients with Kawasaki disease, single-centre experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Belgiu | 2010 |
Congenital atresia of left main coronary artery followed up for ages as a sequela of Kawasaki disease.
Topics: Abnormalities, Multiple; Adolescent; Aortography; Aspirin; Cardiac Catheterization; Coronary Angiogr | 2010 |
Incomplete Kawasaki disease in a patient with chronic granulomatous disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Angiography; Dipyridamole; Follow-Up Studies; | 2010 |
Successful emergent coronary thrombolysis in a neonate with Kawasaki's disease.
Topics: Aspirin; Coronary Angiography; Coronary Thrombosis; Echocardiography; Electrocardiography; Emergency | 2010 |
The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease.
Topics: Aspirin; Cells, Cultured; Child, Preschool; Drug Therapy, Combination; Endothelium, Vascular; Female | 2011 |
A 5-year-old boy with fever and rash. Incomplete Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Exanthema; Fever; Humans; Immuno | 2011 |
Kawasaki disease presenting as meningitis in a two months old infant.
Topics: Aspirin; Diagnosis, Differential; Echocardiography; Erythrocyte Transfusion; Humans; Immunoglobulins | 2011 |
[Kawasaki disease in older children and young adults: 10 years of experience in Marseille, France].
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents, No | 2011 |
Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Clinical Comp | 2011 |
Adult Kawasaki disease.
Topics: Adult; Age Factors; Aspirin; Female; Fever; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymp | 2011 |
Persistent fever and rash in a young child.
Topics: Aspirin; Diagnosis, Differential; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocutaneous | 2011 |
A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Echocardiography; Fatal Outcome | 2012 |
[Kawasaki disease: a clinical serie].
Topics: Aspirin; Child; Child, Preschool; Chile; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; | 2011 |
Kawasaki disease in association with urinary tract infection.
Topics: Anti-Bacterial Agents; Aspirin; Bacteriuria; Escherichia coli Infections; Female; Humans; Immunoglob | 2011 |
Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease: a retrospective study.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Combined Modality | 2011 |
Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Vessels; Drug Therapy, Combination; Humans; I | 2012 |
[Kawasaki disease in children and adolescents].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Coronary Artery Disease; Humans | 2011 |
[Effects of intravenous immunoglobulin and aspirin treatment on the functions of circulating endothelial progenitor cells in children with Kawasaki disease].
Topics: Aspirin; C-Reactive Protein; Child, Preschool; Drug Therapy, Combination; Endothelial Cells; Female; | 2011 |
Severe jaundice in two children with Kawasaki disease: a possible association with Gilbert syndrome.
Topics: Administration, Oral; Aspirin; Child; Child, Preschool; Echocardiography; Female; Gilbert Disease; H | 2012 |
Macular oedema in Kawasaki syndrome.
Topics: Aspirin; Child; Drug Therapy, Combination; Fibrinolytic Agents; Glucocorticoids; Humans; Immunoglobu | 2012 |
Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.
Topics: Aspirin; Case-Control Studies; Chi-Square Distribution; Child; Child, Preschool; China; Echocardiogr | 2012 |
An unusual case of incomplete Kawasaki disease in an adolescent returning from holiday in Montana.
Topics: Adolescent; Aspirin; Diagnosis, Differential; Echocardiography; Humans; Immunoglobulins, Intravenous | 2012 |
Unusual manifestations of Kawasaki disease with retropharyngeal edema and shock syndrome in a Taiwanese child.
Topics: Aspirin; Cervix Uteri; Child, Preschool; Edema; Exanthema; Female; Fever; Humans; Immunoglobulins, I | 2014 |
Kawasaki disease: a case report and overview of symptoms, signs, investigations and treatment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Child, Preschool; Diagnos | 2012 |
[One case of adult Kawasaki disease].
Topics: Adult; Aspirin; gamma-Globulins; Humans; Male; Mucocutaneous Lymph Node Syndrome | 2012 |
Increased α1-antitrypsin levels in acute-phase Kawasaki disease as shown by SELDI-TOF MS analysis.
Topics: alpha 1-Antitrypsin; Aspirin; Case-Control Studies; Child, Preschool; Echocardiography; Female; Huma | 2012 |
Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Child, Preschool; Echocardiogr | 2013 |
Adult Kawasaki disease.
Topics: Adult; Aspirin; Coronary Vessel Anomalies; Diagnosis, Differential; Dilatation, Pathologic; Humans; | 2013 |
[Kawasaki disease complicated with cerebral infarction: a case report].
Topics: Aspirin; Brain; Cerebral Infarction; Epilepsy; Humans; Immunoglobulins, Intravenous; Infant; Male; M | 2012 |
Adolescent Kawasaki disease with uveitis.
Topics: Adolescent; Aspirin; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunoglobulins, Intraven | 2002 |
Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome.
Topics: Aspirin; Child; Child, Preschool; Coronary Artery Disease; Coronary Vessel Anomalies; Fever; Humans; | 2002 |
[Kawasaki's disease in adults: a case report].
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Follow-Up Studies | 2003 |
Inflammatory pulmonary nodules in Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Immunoglobulin A; Immunoglobulins, Intrave | 2003 |
[Kawasaki's disease with eruptive pustular and guttate psoriasis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Buttocks; Child, Preschool; Exanthema; Humans; Imm | 2003 |
IVIG, aspirin, and Kawasaki disease.
Topics: Aspirin; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome | 2003 |
Kawasaki-like syndrome in an HIV-infected adult.
Topics: Adult; Anti-Inflammatory Agents; Antiretroviral Therapy, Highly Active; Aspirin; Drug Therapy, Combi | 2003 |
Annular pustules in Kawasaki disease: a further case indicating the association with psoriasis?
Topics: Aspirin; Child, Preschool; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Mucocutaneous | 2003 |
Kawasaki disease with coronary artery aneurysm and symptomatic pneumonia.
Topics: Anti-Bacterial Agents; Aspirin; Coronary Aneurysm; Drug Therapy, Combination; Echocardiography; Fema | 2003 |
Serum procalcitonin concentration in patients with Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Autoimmune Diseases; Bacterial Infections; C-React | 2004 |
[A case with neonatal Kawasaki disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Vessels; Echocardiography, Doppler, Color | 2003 |
Kawasaki disease in Oman--a clinical study.
Topics: Aspirin; Child, Preschool; Coronary Vessel Anomalies; Female; Humans; Immunoglobulins, Intravenous; | 2003 |
An unusual pattern of arthritis in a child with Kawasaki syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Aspirin; Chickenpox; Diagnosis, Diff | 2004 |
Painful jaundice revealing Kawasaki disease in a young man.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholestasis; Humans; I | 2004 |
[Persistent fever of unknown origin in two young infants caused by the atypical form of Kawasaki disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Vessels; Diagnosis, Differential; Echocar | 2004 |
Rupture of a giant coronary artery aneurysm due to Kawasaki disease.
Topics: Anticoagulants; Aspirin; Cardiac Tamponade; Child, Preschool; Combined Modality Therapy; Coronary An | 2004 |
National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Angioplasty, Balloon, Coronary; Aspirin; Ch | 2004 |
[Persistent fever of unknown origin in two young infants caused by the atypical form of Kawasaki disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Fever of Unknown Origin; Humans; Infant; Male; Muc | 2004 |
[Kawasaki's disease in a 3-month-old infant].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Immunoglobulin G; Infant; Mucocuta | 2004 |
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Coronary Aneurysm; Coronary Ang | 2004 |
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary D | 2004 |
Aspirin, Reye syndrome, Kawasaki disease, and allergies; a reconsideration of the links.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Hypersensitivity; Humans; Mucocutaneous Lymph | 2004 |
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Coronary Aneurysm; Coronary Ang | 2004 |
Kawasaki disease in a postpartum patient.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Femal | 2004 |
[Kawasaki disease epidemiology in Guadeloupe].
Topics: Age Distribution; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Echocar | 2005 |
Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens.
Topics: Acute Disease; Aspirin; Coronary Aneurysm; Coronary Stenosis; gamma-Globulins; Humans; Longitudinal | 2005 |
Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Aspirin; Child, Preschool; Humans; Imm | 2005 |
Infliximab treatment for refractory Kawasaki syndrome.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; A | 2005 |
Images in cardiovascular medicine. Giant coronary artery aneurysms in Kawasaki disease.
Topics: Angiography; Aspirin; Coronary Aneurysm; Electrocardiography; Fever; Heart Murmurs; Humans; Immunogl | 2005 |
Kawasaki-like disease in an HIV-infected patient.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Fe | 2005 |
Cardiovascular involvement in Kawasaki disease.
Topics: Age Distribution; Arrhythmias, Cardiac; Aspirin; Cardiovascular Diseases; Child; Child, Preschool; C | 2005 |
[Clinical features and course of Kawasaki disease in central Tunisia: a study about 14 cases collected over a period of three years (2000-2002)].
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Female; Huma | 2005 |
Kawasaki disease: are we missing the diagnosis?
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Diagnosis, D | 2005 |
Images in cardiovascular medicine. Detection of active coronary arterial vasculitis using magnetic resonance imaging in Kawasaki disease.
Topics: Aspirin; Coronary Disease; Humans; Immunoglobulins, Intravenous; Infant; Magnetic Resonance Imaging; | 2005 |
Infections and Kawasaki disease: implications for coronary artery outcome.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Aneu | 2005 |
Adult Kawasaki disease unrelated to epstein-barr virus and group A Streptococcus.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibodies, Viral; Aspirin; D | 2005 |
Characteristics of Kawasaki disease in infants younger than six months of age.
Topics: Age Factors; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases | 2006 |
Be on the lookout for this seasonal ailment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; Diagnosis, Di | 2006 |
Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan.
Topics: Adolescent; Adult; Aspirin; Cesarean Section; Coronary Artery Bypass; Coronary Disease; Coronary Ves | 2006 |
[Improving the diagnosis and therapy of Kawasaki disease].
Topics: Aspirin; Child; Coronary Aneurysm; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobuli | 2006 |
[Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Aspirin; Biomarkers; Child, Preschool; Dose-R | 2006 |
A case of myocardial infarction complicating Kawasaki disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Angiography; Humans; Male; Mucocut | 2006 |
[Late recognition of Kawasaki disease--difficulties in diagnosis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bradycardia; Child; Coronary Aneurysm; Coronary Ve | 2006 |
Infantile Kawasaki disease and peripheral gangrene.
Topics: Abciximab; Amputation, Surgical; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagulants; Anti | 2006 |
[Kawasaki adult disease: case report].
Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Emergencies; Humans; Lysine; M | 2006 |
Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Sedimentation; Child, Preschool; Coronary An | 2006 |
An unusual cause of appendicitis in a child.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Appendicitis; Aspirin; Child; Diagnosis, Differential; Feve | 2006 |
Revisiting steroids in the primary treatment of acute Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Glucocorticoids; Humans | 2006 |
Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patient.
Topics: Anti-HIV Agents; Aspirin; Drug Therapy, Combination; HIV Infections; Humans; Immune System Diseases; | 2006 |
Meningoencephalitis as a presentation of Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Brain Edema; Cerebral Arteries; Child; Diag | 2006 |
Hair loss as a sign of Kawasaki disease.
Topics: Aspirin; Child, Preschool; Hair Diseases; Hair Follicle; Humans; Immunoglobulins, Intravenous; Male; | 2006 |
Case reports: selected dermatoses in children of color.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Black or African American; Child; Child, Preschool | 2007 |
Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Aspirin; Coronary Aneurysm; Gangren | 2007 |
Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey.
Topics: Aspirin; Drug Administration Schedule; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Nod | 2007 |
Cytomegalovirus infection in a patient with atypical Kawasaki disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Viral; Aspirin; Ceftriax | 2008 |
Incomplete Kawasaki disease: a pediatric diagnostic conflict.
Topics: Aspirin; Cardiovascular Diseases; Child, Preschool; Diagnosis, Differential; Emergency Treatment; Hu | 2007 |
Accelerated thrombotic occlusion of a medium-sized coronary aneurysm in Kawasaki disease by the inhibitory effect of ibuprofen on aspirin.
Topics: Aspirin; Child; Coronary Occlusion; Coronary Thrombosis; Coronary Vessels; Drug Interactions; Heart; | 2008 |
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Child, Preschool; Clinical Protocols; Coronary Aneurysm; D | 2008 |
Acute cholestasis: atypical onset of Kawasaki disease.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Cholestasis; Diagnosis, Diff | 2008 |
Parotitis and kawasaki disease in a child with Noonan syndrome.
Topics: Aspirin; Female; Humans; Immunoglobulins, Intravenous; Infant; Mucocutaneous Lymph Node Syndrome; No | 2008 |
[Kawasaki disease].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Diagnosis, Differential; Disease Pro | 2007 |
Calcified occlusion of the coronary arteries in a young woman diagnosed with Kawasaki disease.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcinosis; Cardiomyopathies; Coronary | 2008 |
[Therapy of Kawasaki syndrome].
Topics: Adrenal Cortex Hormones; Anticoagulants; Aspirin; Child; Humans; Lymphatic Diseases; Mucocutaneous L | 1980 |
Kawasaki disease and aspirin.
Topics: Adult; Aspirin; Child; Humans; Lymphatic Diseases; Mucocutaneous Lymph Node Syndrome | 1983 |
What's new in pediatric dermatology.
Topics: Anti-Bacterial Agents; Aspirin; Epidermolysis Bullosa; Hexachlorocyclohexane; Humans; Impetigo; Infa | 1981 |
Unstable angina in a patient with mucocutaneous lymph node syndrome.
Topics: Aneurysm; Angina Pectoris; Angina, Unstable; Aspirin; Child; Coronary Angiography; Coronary Artery B | 1984 |
Kawasaki disease or mucocutaneous lymph node syndrome. Has it a microbial aetiology?
Topics: Adrenal Cortex Hormones; Aneurysm; Animals; Aspirin; Child, Preschool; Coronary Disease; Humans; Imm | 1984 |
Kawasaki disease: a report of 26 patients.
Topics: Adrenal Cortex Hormones; Aspirin; Child, Preschool; Coronary Disease; Erythema; Female; Humans; Infa | 1984 |
Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Mu | 1984 |
Cardiovascular complications of mucocutaneous lymph node syndrome.
Topics: Aneurysm; Aspirin; Child, Preschool; Coronary Disease; Echocardiography; Female; Heart Diseases; Hea | 1984 |
Kawasaki syndrome in office pediatrics.
Topics: Aspirin; Child, Preschool; Diagnosis, Differential; Female; Humans; Male; Mucocutaneous Lymph Node S | 1984 |
Eleven year old Caucasian male with fever and cervical lymphadenopathy.
Topics: Aspirin; Child; Diagnosis, Differential; Humans; Infections; Lymphatic Diseases; Male; Mucocutaneous | 1983 |
Incidence of acute rheumatic fever. A suburban community hospital experience during the 1970s.
Topics: Acute Disease; Adolescent; Adult; Arthritis, Infectious; Aspirin; Child; Child, Preschool; Diagnosis | 1983 |
Unusual aspects of Kawasaki syndrome.
Topics: Aspirin; Child, Preschool; Diagnosis, Differential; Fever of Unknown Origin; Humans; Male; Mucocutan | 1983 |
[Therapy of Kawasaki disease in the acute phase: steroid and aspirin therapy].
Topics: Acute Disease; Age Factors; Aneurysm; Aspirin; Child, Preschool; Coronary Disease; Humans; Infant; M | 1983 |
[Prevention and treatment of coronary lesions in Kawasaki disease. Treatment with anti-platelet agents and aspirin: optimum dosages and their evaluation].
Topics: Aneurysm; Aspirin; Coronary Disease; Drug Evaluation; Fibrinolytic Agents; Humans; Mucocutaneous Lym | 1983 |
[Kawasaki disease: new and important problems in cardiology].
Topics: Aortic Aneurysm; Aspirin; Coronary Angiography; Coronary Disease; Echocardiography; Humans; Infant; | 1983 |
[Mucocutaneous lymph node syndrome (Kawasaki disease) in adults].
Topics: Adolescent; Age Factors; Aspirin; Female; Humans; Lymphatic Diseases; Mucocutaneous Lymph Node Syndr | 1982 |
Mucocutaneous lymph node syndrome in North Louisiana: review of 15 cases.
Topics: Arteritis; Aspirin; Blood Sedimentation; C-Reactive Protein; Child; Child, Preschool; Coronary Disea | 1983 |
Regression of aneurysms in Kawasaki disease: a pathological study.
Topics: Aneurysm; Aspirin; Axillary Artery; Calcinosis; Child, Preschool; Endothelium; Female; Femoral Arter | 1982 |
[Inhibition of platelet function in pediatric medicine (author's transl)].
Topics: Age Factors; Aspirin; Child; Dipyridamole; Glomerulonephritis; Graft Rejection; Heart Defects, Conge | 1982 |
Kawasaki syndrome: an update.
Topics: Adult; Aspirin; Child; Child, Preschool; Coronary Angiography; Diagnosis, Differential; Follow-Up St | 1982 |
Kawasaki syndrome: a new infectious disease?
Topics: Adrenal Cortex Hormones; Arterial Occlusive Diseases; Aspirin; Child; Coronary Vessels; Epidemiology | 1981 |
[The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
Topics: Aneurysm; Aspirin; Child, Preschool; Coronary Disease; Edema; Erythromycin; Exanthema; Gallbladder D | 1981 |
Salicylate hepatitis: a complication of the treatment of Kawasaki's disease.
Topics: Adult; Aspartate Aminotransferases; Aspirin; Chemical and Drug Induced Liver Injury; Humans; L-Lacta | 1981 |
Mucocutaneous lymph node syndrome (Kawasaki disease) in an adult.
Topics: Adult; Anti-Bacterial Agents; Arteritis; Aspirin; Cardiovascular Diseases; Central Nervous System Di | 1981 |
Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome: analysis of eight cases.
Topics: Adrenal Cortex Hormones; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiovascular Diseas | 1980 |
Kawasaki disease: from children to adults.
Topics: Adult; Aspirin; Child; Humans; Lymphatic Diseases; Mucocutaneous Lymph Node Syndrome | 1980 |
Kawasaki disease, or mucocutaneous lymph node syndrome: report of seven cases in North America.
Topics: Aspirin; Child; Child, Preschool; Coronary Disease; Diagnosis, Differential; Edema; Female; Gallblad | 1980 |
Aspirin treatment and platelet function in Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Female; Humans; Infant; Lymphatic Diseases; Male; Mucocutaneous Ly | 1980 |
[What is your diagnosis?].
Topics: Aspirin; Child, Preschool; Conjunctivitis; Erythema; Fever; Hand; Humans; Lymphatic Diseases; Male; | 1980 |
[Mucocutaneous lymph node syndrome, Kawasaki disease. A review and report of 3 cases].
Topics: Aspirin; Child, Preschool; Female; Humans; Infant; Lymphatic Diseases; Male; Mucocutaneous Lymph Nod | 1980 |
Kawasaki's disease.
Topics: Aspirin; Child; Humans; Lymphatic Diseases; Mucocutaneous Lymph Node Syndrome; United States | 1981 |
[Kawasaki disease].
Topics: Aspirin; Dose-Response Relationship, Drug; Female; gamma-Globulins; Humans; Incidence; Infant; Injec | 1995 |
[Kawasaki disease in a young adult: a case report].
Topics: Adolescent; Aspirin; Diagnosis, Differential; Humans; Male; Mucocutaneous Lymph Node Syndrome | 1995 |
Kawasaki disease and its cardiac sequelae.
Topics: Aspirin; Blood Sedimentation; Child, Preschool; Coronary Disease; Diagnosis, Differential; gamma-Glo | 1993 |
Kawasaki disease in infants less than one year of age.
Topics: Age of Onset; Aspirin; Coronary Aneurysm; Female; Humans; Immunoglobulins, Intravenous; Infant; Male | 1995 |
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Topics: Aspirin; Child; Combined Modality Therapy; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous | 1994 |
Equilibrium multigated blood pool ventriculography to evaluate the effects of high-dose gamma-globulin treatment for left ventricular functions in Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Erythrocytes; Female; Gated Blood-Pool Imaging; Humans; Immunoglob | 1994 |
Kawasaki disease mimicking retropharyngeal abscess.
Topics: Aspirin; Child, Preschool; Diagnosis, Differential; Drainage; Echocardiography; Humans; Immunoglobul | 1994 |
Seroprevalence of human herpesvirus 7 in patients with Kawasaki disease.
Topics: Age of Onset; Antibodies, Viral; Aspirin; Child, Preschool; Herpesviridae Infections; Herpesvirus 7, | 1994 |
Management of Kawasaki disease in the British Isles.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Coronary Disease; Electrocardiography; Female; Humans; | 1993 |
Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome.
Topics: Aspirin; Child; Coronary Disease; Cost-Benefit Analysis; Costs and Cost Analysis; Economics; Humans; | 1993 |
[New therapeutic aspects in Kawasaki syndrome and personal experiences].
Topics: Aspirin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunization, Passive; Male; | 1993 |
Labeled WBC cardiac imaging and two-dimensional echocardiography to evaluate high-dose gamma globulin treatment in Kawasaki disease.
Topics: Aspirin; Coronary Disease; Echocardiography; Female; Heart; Humans; Immunoglobulins, Intravenous; In | 1995 |
Treatment of Kawasaki disease.
Topics: Aspirin; Child; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome | 1996 |
Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Cimetidine; Erythrocyte Transfusion; Female; gamma-Globuli | 1996 |
Aspirin treatment and increased generation of cysteinyl leukotrienes in Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Leukotrienes; Mucocutaneous Lymph Node Syn | 1996 |
Reiter syndrome initially misdiagnosed as Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Aspirin; Child, Preschool; Diagnosis, | 1996 |
Treatment of Kawasaki disease with corticosteroid.
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; I | 1996 |
Treatment of Kawasaki disease with corticosteroid.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combinatio | 1996 |
[Inaugural acute cholestasis of Kawasaki disease].
Topics: Acute Disease; Adolescent; Aspirin; Cholestasis; Humans; Immunization, Passive; Male; Mucocutaneous | 1996 |
Kawasaki disease in Malaysia.
Topics: Anti-Bacterial Agents; Aspirin; Cardiovascular Diseases; Child; Child, Preschool; Drug Therapy, Comb | 1996 |
[Mucocutaneous lymph node syndrome (Kawasaki disease) in 2 children].
Topics: Adrenal Cortex Hormones; Aspirin; Child, Preschool; Electrocardiography; Female; Humans; Male; Mucoc | 1996 |
[Interesting cases in clinical practice concerning Kawasaki syndrome and child abuse].
Topics: Aspirin; Child Abuse; Child Welfare; Child, Preschool; Coronary Aneurysm; Female; Humans; Immunoglob | 1996 |
[Complications and course of Kawasaki disease in 23 patients].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Female; Humans; Infant; M | 1997 |
[Atypical and incomplete Kawasaki disease].
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Infant; Male | 1997 |
Do we need high-dose acetylsalicylic acid (ASA) in Kawasaki disease?
Topics: Aspirin; Child, Preschool; Female; Gastrointestinal Hemorrhage; Humans; Immunoglobulins, Intravenous | 1998 |
Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease.
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiac Catheterization; Coronary Aneury | 1998 |
Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Diagnosis, Differential; Follow-Up Studies; | 1998 |
Kawasaki disease in a paediatric hospital in Riyadh.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Diagnosis, Differential; | 1998 |
High-dose aspirin in Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Humans; Immunogl | 1999 |
Corticosteroids in the treatment of the acute phase of Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination | 1999 |
Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease.
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiac T | 1999 |
Lateral rectus palsy in Kawasaki disease.
Topics: Abducens Nerve Diseases; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Coronary Disease; | 1999 |
[Kawasaki disease in adult].
Topics: Adult; Aspirin; Drug Therapy, Combination; gamma-Globulins; Humans; Male; Mucocutaneous Lymph Node S | 1996 |
Clinicopathological conference: multisystem failure in a child.
Topics: Anti-Bacterial Agents; Aspirin; Child; Clindamycin; Female; Humans; Immunoglobulins, Intravenous; Mu | 2000 |
Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Female; Glycoproteins; Humans; Isoenzymes; Lipopolysaccharides; Ma | 2000 |
Recognition and management of Kawasaki disease.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Coronary Aneurysm; Cross-Sectional Studies; Diagnosis, | 2000 |
Head and neck manifestations of Kawasaki disease.
Topics: Aspirin; Canada; Child; Child, Preschool; Drug Therapy, Combination; Female; gamma-Globulins; Head; | 2000 |
Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.
Topics: Aspirin; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Infant; Male; | 2000 |
Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Aneurysm; Coron | 2000 |
Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Child, Preschool; Drug Therapy, Combination; Glucocorticoi | 2000 |
[Cardiac involvement in Kawasaki disease. Our experience].
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; | 2001 |
Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Cyclos | 2001 |
[Kawasaki disease--personal observations].
Topics: Aspirin; Cardiovascular Diseases; Child, Preschool; Drug Therapy, Combination; Female; gamma-Globuli | 2001 |
Kawasaki disease--Indian perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Conjunctival Diseases; Heart Dis | 2001 |
Bilateral subdural collections--an unusual feature of possible Kawasaki disease.
Topics: Aspirin; Brain; Child, Preschool; Diagnosis, Differential; Dominance, Cerebral; Follow-Up Studies; H | 2001 |
Kawasaki disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Sedimentation; C-Reactive Protein; Humans; I | 2001 |
[Corticosteroids for treating Kawasaki disease].
Topics: Adrenal Cortex Hormones; Aspirin; Child; Coronary Aneurysm; Drug Therapy, Combination; Humans; Immun | 2001 |
Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.
Topics: Adrenal Cortex Hormones; Aspirin; Contraindications; Heart Diseases; Humans; Immunoglobulins, Intrav | 2002 |
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Topics: Acetaminophen; Administration, Oral; Albumins; Analgesics, Non-Narcotic; Aspirin; Canada; Case-Contr | 2002 |
[Dynamic study of platelets surface glycoprotein in Kawasaki disease].
Topics: Aspirin; Blood Platelets; Child; Child, Preschool; Coronary Artery Disease; Female; gamma-Globulins; | 2002 |
Kawasaki disease: effect of treatment on coronary artery involvement.
Topics: Aspirin; Cephalexin; Child, Preschool; Coronary Angiography; Coronary Circulation; Coronary Disease; | 1979 |
Possible Kawasaki disease in a 20-year-old woman.
Topics: Adult; Age Factors; Aspirin; Diagnosis, Differential; Erythromycin; Female; Humans; Lymphatic Diseas | 1979 |
Salicylate treatment of epidemic Kawasaki disease in New York City.
Topics: Aging; Aspirin; Child; Child, Preschool; Disease Outbreaks; Feces; Humans; Infant; Lymphatic Disease | 1979 |
Kawasaki disease is diagnosed in Virginia.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Coronary Angiography; Diagnosis, Differential; Female; | 1978 |
Audiologic profiles of children with Kawasaki disease.
Topics: Aspirin; Audiometry, Pure-Tone; Auditory Threshold; Autoimmunity; Bone Conduction; Child, Preschool; | 1992 |
Treatment of Kawasaki disease using the intravenous aspirin anti-inflammatory effect of salicylate.
Topics: Acute Disease; Aspirin; Child; Child, Preschool; Coronary Disease; Female; Humans; Infant; Inflammat | 1992 |
[Kawasaki disease in Pernambuco, Brazil. Considerations on a case seen in a general hospital].
Topics: Aspirin; Brazil; Echocardiography; Electrocardiography; Humans; Infant; Male; Mucocutaneous Lymph No | 1992 |
Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Female; Humans; Infant; Interleukin-6; Interleukin-8; | 1992 |
Outcome of Kawasaki disease in Barbados.
Topics: Adolescent; Anti-Bacterial Agents; Aspirin; Barbados; Child; Child, Preschool; Female; Fever; Humans | 1992 |
Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease.
Topics: ABO Blood-Group System; Aspirin; Disseminated Intravascular Coagulation; Hemolysis; Humans; Immunogl | 1992 |
[Kawasaki syndrome. Association with exposure to carpet shampoo and successful therapy with immunoglobulins in the second week of the illness].
Topics: Aspirin; Child, Preschool; Detergents; Echocardiography; Female; Floors and Floorcoverings; Househol | 1992 |
[Role of polymorphonucleocyte-produced leukotriene B4 in Kawasaki disease].
Topics: Aspirin; Female; gamma-Globulins; Humans; Immunization, Passive; Leukotriene B4; Male; Mucocutaneous | 1990 |
[Kawasaki disease].
Topics: Aspirin; Child; Combined Modality Therapy; gamma-Globulins; Humans; Mucocutaneous Lymph Node Syndrom | 1991 |
Kawasaki syndrome in 18 children in the west of Scotland.
Topics: Aspirin; Child; Child, Preschool; Drug Administration Schedule; Echocardiography; Female; Follow-Up | 1991 |
Facial nerve paralysis associated with Kawasaki disease.
Topics: Aspirin; Facial Paralysis; Female; gamma-Globulins; Humans; Infant; Mucocutaneous Lymph Node Syndrom | 1991 |
[Regression of coronary artery aneurysm in a patient with Kawasaki's disease].
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Echocardiography; Female; Humans; Infant; Mucocutaneous Ly | 1991 |
Disposition of single-dose intravenous and oral aspirin in children.
Topics: Absorption; Administration, Oral; Aspirin; Biological Availability; Buffers; Child, Preschool; Drug | 1991 |
Clinical aspects of 100 patients with Kawasaki disease.
Topics: Aspirin; Blood Sedimentation; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Dipyrida | 1991 |
[Kawasaki disease. Report of two cases].
Topics: Aspirin; Child, Preschool; Female; Heart Diseases; Humans; Infant; Male; Mucocutaneous Lymph Node Sy | 1990 |
Plasma immunoreactive leukotriene C4 levels in patients with Kawasaki disease.
Topics: Acute Disease; Aspirin; Child; Child, Preschool; Convalescence; Female; Humans; Infant; Male; Mucocu | 1990 |
[Coronary aneurysm following Kawasaki syndrome].
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Coronary Angiography; Coronary Thrombosis; Echo | 1990 |
Treatment of Kawasaki syndrome.
Topics: Aneurysm; Aspirin; Child; Coronary Disease; Drug Therapy, Combination; Female; gamma-Globulins; Huma | 1986 |
[Current clinical and therapeutic aspects of Kawasaki disease].
Topics: Aspirin; gamma-Globulins; Humans; Mucocutaneous Lymph Node Syndrome; Prognosis | 1987 |
Effects of current therapy of Kawasaki disease on eicosanoid metabolism.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Child; Child, Preschool; Drug Therapy, Combination; gamma-Glo | 1988 |
American Academy of Pediatrics, Committee on Infectious Diseases: Intravenous gamma-globulin use in children with Kawasaki disease.
Topics: Aspirin; Child; Drug Therapy, Combination; gamma-Globulins; Humans; Injections, Intravenous; Mucocut | 1988 |
Kawasaki syndrome: still a fascinating enigma.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Heart Diseases; Humans; Immunization, Passive; | 1989 |
Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithrombin III; Aspirin; beta-Thromboglobulin; Blood C | 1989 |
Mucocutaneous lymph node syndrome in Calabar--a case report.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Female | 1989 |
Kawasaki disease--the Singapore experience.
Topics: Age Factors; Aspirin; Child; Child, Preschool; Coronary Vessels; Dilatation, Pathologic; Echocardiog | 1989 |
[Kawasaki syndrome in a 5-month-old girl successfully treated with high doses of acylpyrin].
Topics: Aspirin; Female; Humans; Infant; Mucocutaneous Lymph Node Syndrome | 1989 |
Studies on the effect of long-term use of low dose aspirin in Kawasaki disease.
Topics: Adenosine Diphosphate; Aspirin; Child, Preschool; Collagen; Dose-Response Relationship, Drug; Epinep | 1988 |
Varicella-zoster immunoglobulin for patients with Kawasaki syndrome receiving daily aspirin.
Topics: Aspirin; Chickenpox; Child; Humans; Immune Sera; Immunization, Passive; Mucocutaneous Lymph Node Syn | 1988 |
Kawasaki disease in an adult Trinidadian male.
Topics: Adolescent; Ampicillin; Aspirin; Bed Rest; Combined Modality Therapy; Humans; Male; Mucocutaneous Ly | 1988 |
Management of Kawasaki disease.
Topics: Aspirin; Child; Humans; Immunization, Passive; Mucocutaneous Lymph Node Syndrome; Myocarditis | 1988 |
Dipyridamole-thallium-201 tomography documenting improved myocardial perfusion with therapy in Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; | 1988 |
Thrombocytopenia: a complication of Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Female; Flurbiprofen; Humans; Infant; Male; Med | 1988 |
Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Humans; Immunization, Passive; Mucocutaneous Ly | 1987 |
Efficacies and risks of aspirin in the treatment of the Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Humans; Immunization, Passive; Mucocutaneous Ly | 1987 |
Can consensus be reached in cardiac management of Kawasaki syndrome? Review of a survey among Japanese and U.S. pediatric cardiologists.
Topics: Aspirin; Cardiac Catheterization; Child; Coronary Disease; Data Collection; Echocardiography; Humans | 1987 |
Selection of high-risk children for immunoglobulin therapy in Kawasaki disease.
Topics: Aspirin; Child; Child, Preschool; Coronary Disease; Humans; Immunization, Passive; Mucocutaneous Lym | 1987 |
Enzyme release and O2 production of neutrophils and vascular lesions in gamma globulin therapy of Kawasaki disease.
Topics: Aspirin; Child; Humans; Immunization, Passive; Mucocutaneous Lymph Node Syndrome; Neutrophils; Oxyge | 1987 |
Effect of liposomal encapsulated superoxide dismutase on patients with Kawasaki disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Humans; Immunization, Passive; Infant; Liposomes; Muco | 1987 |
Can early treatment provide better prognosis in Kawasaki disease? A retrospective study on 616 children.
Topics: Aspirin; Child; Child, Preschool; Coronary Disease; Female; Flurbiprofen; Humans; Immunization, Pass | 1987 |
Kawasaki disease in a 4-year-old boy.
Topics: Aspirin; Child, Preschool; Humans; Lymph Nodes; Male; Mucocutaneous Lymph Node Syndrome; Skin | 1987 |
Relapsing Kawasaki's disease.
Topics: Aspirin; Dermatitis; Female; Fever; Humans; Infant; Mucocutaneous Lymph Node Syndrome; Recurrence | 1987 |
Detection and management of cardiac involvement in the Kawasaki syndrome.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Female; Heart Diseases; Humans; Immunization, Passive; | 1987 |
[Kawasaki's disease in Sicily].
Topics: Aspirin; Child; Child, Preschool; Female; Humans; Infant; Italy; Male; Mucocutaneous Lymph Node Synd | 1987 |
Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.
Topics: Aspirin; Child; Child, Preschool; Coronary Aneurysm; Female; Humans; Infant; Male; Mucocutaneous Lym | 1987 |
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination; Echocardiography; Electrocardio | 1986 |
Management strategies in Kawasaki disease.
Topics: Aneurysm; Aspirin; Child; Constriction, Pathologic; Coronary Vessels; Humans; Mucocutaneous Lymph No | 1986 |
Regression of coronary aneurysms in patients with Kawasaki syndrome.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Coronary Aneurysm; Coronary Angiography; Echocardiogra | 1987 |
Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Coronary Aneurysm; Female; Hemoglobins; Humans; Infant | 1987 |
An unusual otolaryngological problem--mucocutaneous lymph node syndrome (Kawasaki's syndrome) case report.
Topics: Aspirin; Cellulitis; Child; Diagnosis, Differential; Humans; Male; Mucocutaneous Lymph Node Syndrome | 1985 |
Preventing coronary involvement in Kawasaki disease.
Topics: Aspirin; Child; Heart Diseases; Humans; Mucocutaneous Lymph Node Syndrome | 1986 |
Transient heart failure in an adult with Kawasaki disease.
Topics: Adult; Aspirin; Diuretics; Echocardiography; Female; Heart Failure; Humans; Mucocutaneous Lymph Node | 1986 |
Kawasaki syndrome, Reye syndrome, and aspirin.
Topics: Aspirin; Child; Child, Preschool; Humans; Mucocutaneous Lymph Node Syndrome; Reye Syndrome; Risk | 1986 |
Aspirin therapy in Kawasaki syndrome.
Topics: Aspirin; Humans; Infant; Mucocutaneous Lymph Node Syndrome | 1985 |
Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease.
Topics: Aneurysm; Aspirin; Child, Preschool; Coronary Disease; Drug Administration Schedule; Echocardiograph | 1985 |
Acetylsalicylic acid and Kawasaki disease.
Topics: Arthritis, Juvenile; Aspirin; Child; Child, Preschool; Humans; Infant; Mucocutaneous Lymph Node Synd | 1985 |